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ABSTRACT 
Several independently-selected methotrexate (MTX) - 
resistant mouse cell lines and their wild-type counterparts 
have been characterized. In the first part of the thesis, 
dihydrofolate reductase (DHFR) protein, RNA and DNA have 
been investigated. Measurements of enzyme activity in crude 
cell extracts and comparisons of polypeptides by SDS-
polyacrylamide gel electrophoresis show that each MTX-resistant 
cell line overproduces DHFR. In vitro MTX inhibition studies 
and peptide mapping by partial proteolysis show that no 
extensive changes in DHFR structure have occurred. Associated 
with this enzyme overproduction is an increase in the 
amount of DHFR-specific RNA and an increase in the number 
of DHFR genes. In most MTX-resistant cell lines, the 
structure of the amplified DHFR genes visualized by DNA 
blotting is identical to that seen In the wild-type cells 
and in mouse liver DNA. However, in three out of four MTX-
resistant EL4 cell lines, extensive DNA rearrangement has 
occurred near the ends of the DHFR genes. This rearrangement 
is different in each case but always affects only a 
proportion of the DHFR genes in the population. 
In the second part of the thesis, amplification of 
other DNA sequences in these cell lines has been investigated. 
Examination of restriction enzyme digests of total nuclear 
DNA separated by gel electrophoresis shows that some of the 
MTX-resistant cell lines possess many bands which wild-
type cells lack. These bands are the same in different cells 
in a single population and in different amplified units in 
a cell, but differ in independently selected cell lines. 
Hybridization of DNA blots using probes of total cDNA from 
wild-type or resistant cells shows that transcribed sequences 
other than DHFR have been amplified; hybridization using 
satellite DNA shows that some of this sequence has been 
amplified; and hybridization using a rabbit f-globin cDNA 
probe shows that a cross-reacting sequence has been 
amplified and/or rearranged. 
In the third part of the thesis, a model for the 
amplification process is proposed. There are two distinct 
phases. First, an amplifiable unit is constructed by 
ligation of random DNA fragments, in a manner similar to 
that seen in DNA-mediated gene transfer experiments. This 
process produces the observed DNA rearrangements and is the 
cause of the observed heterogeneity between independently-
selected cell lines. Second, the intact unit is amplified 
in the population by unequal segregation followed by 
selection of those cells with increased numbers of copies. 
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Methotrexate (MTX) is one of a group of folic acid 
antagonists. These compounds are of interest primarily 
because of their use in cancer chemotherapy. Cancer is 
the cause of about 20 of deaths in the UK (1,2), and 
this figure is likely to be similar in most developed 
countries. It is difficult to find out what proportion 
of cancer patients are treated by chemotherapy, or what 
proportion of those who are treated receive MTX; never- 
-theless it is clear that MTX is an important agent. For 
example, Livingston and Carter (3,p132) write"it is one 
of the most useful anticancer agents so far developed, and 
one of the most commonly employed". However, its usefuilness, 
is limited by the poor response of the more common lethal 
tumors (lung,breast and colorectal), and by the development 
of resistance in those tumors such as the leukemias which 
are initially responsive. The tumors for which MTX is 
never effective are probably inaccessible to the circulating 
drug;f or a discussion see (4). However, the resistance 
acquired after drug treatment, leading to the relapse of a 
patient after an apparently complete regression of the tumor, 
is a different problem. This kind of acquired MTX resistance 
has been investigated in animals, chiefly mice and hamsters, 
in the hope that understanding it will lead to more effective 
therapy. In this thesis the characterization of a number of 
MTX resistant mouse cell lines is described. 
The arrangement of the introduction is as follows. First 
the origin and clinical use of antifolates.ro described; then 
the basis for their effects; and finally the mechanisms by which 
resistance to them can occur. 
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1.1. Structures of folates and antifolates. Part of the numbering 
system for folate is shown. 
1.2. THE CLINICAL USE OF ANTIFOLATES 
1.2.1. The origin of antifolate therapy 
Antifolates have been used in chemotherapy since the 
late 1940 s. The story of their introduction is confused 
by the complex nature of folates from biological sources 
and by the general absence of essential experimental 
detail from the literature. 
In 1944, workers at Lederle (5) reported the isolation 
of a compound which stimulated the growth of Lactobacillus 
casei and Streptococcus lactis R,and which they therefore 
called L easel factor'. They did not report the source 
of the compound or the isolation procedure. 'L easel factor' 
was obtained by ieuchtenberger et al (6) from Lederle and 
tested for antituiliour activity. After 6 weeks of treatment 
it produced "complete regression" in 43% (38 out of 89) 
of mice from three strains with spontaneous breast cancer. 
However, the following year complications appeared when 
this group reported that 'L casei factor' from liver was 
not effective, although they found that 'fermentation L 
easel factor' was effective (7). 
Farber has described (8) how, on the basis of these 
results, he treated 11 children with acute leukemia with 
pteroyltriglutamic acid ( folic acid diglutamate) synthesized 
by Lederle (9), which was thought to be 'fermentation L 
casei factor'. It led to an "acceleration phenomenon": 
le. it caused the children to die more quickly. This 
suggested to Farber that an antagonist of folic acid might 
prolong the lives of his patients. Initial work with 
pteroylaspartic acid and methyipteroic acid was encouraging, 
and when aminopterin became available in 1947 (10) Farber et 
al (11) found that it produced temporary remissions in 10 
out of 16 children with acute leukemia: two of these were 
still alive after more than a year (8). These results 
were spectacular and unprecedented, and must be compared 
with the frequency of spontaneous remission which is low 
( about 107) and has an average duration of about 10 weeks (8). 
Other clinicians found beneficial effects of aminopterin in 
the treatment of acute lukemia in children (12), although 
in adults with chronic or acute lukemia the first results 
were either negligible (12,13) or slightly beneficial.(14) 
The relapses in patients treated with diglutarytIolic 
acid are, in retrospect, understandable; but it is not 
clear, even in retrospect, why regressions were seen in 
mice treated with this compound. 
Subsequently, MTh has replaced aminopterin as the 
clinically used antifoLate. On a molar basis NTX is about 
an order of magnitude less effective, but its theraputic 
index is higher: for a given toxicity level it has greater 
antituniour activity in mice (15) and humans (16). 
1.2.2. The effectiveness of antifolates 
The results that have been obtained using MTX and 
aminopterin on patients with a variety of tumours have 
6Q-& -pai-€4 fb 	FeJ' ck'. -k 	L 	-J-czJ 	Q 
been collected by Livingston and Carter (3).k When A(3 
considering these figures, it must be born in mind that they 
include the work of different practicioners in different 
hospitals at different times and using different dose 
schedules. Thus what constitutes an "evaluable" patient 









Breast 259 87 34 
Colorecta]. 128 19 15 
Lung 101 25 25 
Malignant melanoma 27 3 11 
Lymphoma 45 13 29 
Burkitt's lymphoma 69 19 10 
ALL-AUL (systemic) 159 69 40 
ALL-AUL (CNS disease) 162 133 82 
AML-AMoL 140 23 16 
Head and neck 232 101 44 
(intra-arterial Cervix 
treatment) 71 33 47 
Cervix (systemic 
25 5 20 treatment) 
Brain (intra-arterial) 11 4 36 
Brain (intrathecal) 36 23 64 
Trophoblastic malignancies 230 196 85 
Testicle io 4 40 
Table I.I. The clinical effectiveness of MTX and aminopterin against 
different tumour types. The data hav been derived from ref 3. 
t2.. 
than the total number of patients treated. Also, what 
Constitutes a "response" varies: generally a greater 
than 5Q0/ tumor regression, ie. halving of the turri 
size, was considered a response; a long term remission 
is not implied. 
From table 1.1. it can be seen that MTX is an 
U. 
effective agent for some types of tumct. ALL-AUL and 
trophoblastic malignancies show responses in over 80 
of patients, and sustained complete responses in about 
half this number. For most other cancers MTX is no 
more effective than other chemotherapeutic agents. 
The dose schedules that were used include small 
daily doses and larger monthly doses. Some clinicians 
administer a single dose high enough to produce lethal 
toxicity, followed a few hours later by citrovorum 
factor (5-formyl-THF) to rescue the more sensitive 
tissues in the patient. Another practice, which is now 
general and has largely replaced the use of single agents, 
is combination chemotherapy: MTX is given at the same 
time as other classes of antitum agent. The advantages 
of combination chemotherapy in clinical practice are 
described in reference 16. 
The effectiveness of antifolates is limited by 
several factors. In the short term, there is an upper 
limit to the dose which it is possible to administer 
because toxic side effects occur. The most important 
of these are bone marrow depression and gastrointestinal 
ulceration. More rarely alopecia and dermatitis have 
been observed; when high dose/rescue therapy is used 
renal failure can occur. Attempts are being made to 
overcome these side effects by increasing the proportion 
of MTX delivered to the tumor cells and therefore 
decreasing the relative exposure of other tissues. 
Kosoiski et al (17) have shown that entrapment of MTX 
in lipid vesicles increases its chemotherapeutic activity 
against solid tumors in rats and mice. Alternatively, 
polycations such as poly-L-lysine and DEAE dextran 
have been used to form complexes with MTX (18): these 
complexes can then be taken up by some cells and may 
U 
be selectively taken up by tun -'- cells. Neither of 
these methods has yet been used clinically, and it 
remains to be seen whether they will increase the 
effectiveness of MTX. 
In the long term it is, unfortunately, common for 
U 
tums to develop resistance to MTX after drug treatment. 
This is illustrated by the ultimate relapse and death 
of patients who have had a remission and are on 
maintnence therapy. Relapses are unpredictable and 
their molecular basis has not been determined, although 
work done in animals is relevant to this question. 
This is discussed in sections 1.4. and 1.5. 
1.3. THE BASIS OF MIX CYTOTOXICITY 
MTX was synthesized as a folate analog and thus it 
was expected to act by interfering with folate metabolism. 
This expectation has been born out by all the work that 
has been done, and its mechanism of action is probably 
better understood than that of any other chemotherapeutic 
agent. 
1.3.1. The target enzyme: dihydrofolate reductase 
As early as 1950, Nicol and Welch (19) showed 
that aminopterin blocked the conversion of folate to 
citrovorum factor (CF) in slices of rat liver. When 
the structure of CF was established as N-5-forrnyl-THF, 
attention focused on the enzymes in the pathway: 
F - 	DIIF-*-THF 	N-5-formyl-THF 
Futterman (20), using a partially 	purified chicken 
liver enzyme, found that both the reduction of FA and 
DHF were inhibited by aminopterin. The following year 
Osborn et al (21) purified dihydrofolate reductase (DHFR) 
from chicken liver and showed that activity was inhibited 
by both MTX and aminopterin. DHFR s have since been 
studied from a wide range of organisms: for a review 
see (22). In mammals the same enzyme catalyses both 
DHF--THF and, at about a 10 fold slower rate, F-+DHF. 
All known DHFF are inhibited almost stoich'io metrically 
by MTX: reported K i values are about 10N (22). A 
wide variety of activators are also known, including 
KCI, urea and p-chloromercuriphenyl sulphonic acid, 
but there is no evidence that these are physiologically 
important. 
DHFR s purified to homogeneity from beef heart, 
S 
pig liver, Erlich atites cells (mouse), L1210 cells 
(mouse), S180 cells (mouse) and BFIK cells are fairly 
small proteins with molecular weights in the range 
20 Kd to 23 Kd (22). A size of 33.5 Kd for the calf thymus 
enzyme has been reported (23), but this has not been 
confirmed. Ass6çiation of subunits has not been 
found and the single polypeptide chain is thought to 
be the active enzyme. An N-terminal sequence for the beef 
liver enzyme has been determined (24,25); 	and preliminary 
(26) and revised (27) sequences for the L1210 enzyrne,and the 
sequence of the pig liver enzyme (28) have been published. 
There is 897 identity between mouse and pig enzymes, 
indicating a fair degree of evolutionary conservation. 
Three dimensional structures are not known. 
1.3.2. Folate metabolism 
Folates have a central metabolic role as carriers 
of one-carbon units. Reactions involving them are 
essential for the de novo formation of thymidylate, purines 
and glycine, and also for some amino acid interconversjons. 
The relationships of the various coenzymes, as they are 
described in any standard biochemistry text, are outlined 
in fig.1.2. It should be noted that the active coenzymes 
are all reduced THF derivatives; and that a supply of 
reduced folate is therefore essential for synthesis of 
proteins and nucleic acids. In consequence inhibition 
of DHFR blocks synthesis of these macromolecules, both 
through lack of precursors and 	coenzymes, 
leading to inhibition of cell growth and eventually 
cell death. 
To this oversimplified picture must be added a 
number of complications. As analytical techniques have 
improved in recent years, it has become apparent that 
intracellular folates exist largely in the form of 
polyglutamates or "conjugates" (reviewed in (29)). 
These derivatives have more than one glutamate residue 
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Fig. 1.2. Folate metabolism and the one-carbon pool. 
Key: F = folate 
DHF = dihydrofolate 
THF = tetrahydrofolate 
DHFR = dihydrofolate reductase 
indicates an enzymic interconversion 
indicates a precursor --o-product  relationship 
I7 
Note that the nomenclature of these compounds is confusing: 
for example, THF-diglutamate (abbreviated here THF-G1 u2) 
contains three glutamate residues. 
The occunnce of polyglutamates in micro-organisms 
has been documented for over thirty years , and they have 
been identified in mammals more recently. Noronha and 
Aboobaker (30) showed that they were the predominant 
form of folates inside human blood cells, although the 
monoglutamyl forms were found in the plasma. Folates 
in human liver are polyglutamates with three or more 
glutamate residues (31). The number of glutamates has 
in some cases been preci2ely determined. For instance, 
Houlihan and Scott (32) showed that in rat liver folate 
tetraglutamates were the major species, accounting for 
85-907 of the total folate. 
In mammals there is probably a single enzyme, FPGS 
(folate polyglutamate synthetase), which catalyses the 
stepwise a ition of glutamate residuesi 	such an enzyme 
has been partially purified from rat liver (33). However, 
it is not well characterized and it is not known what 
determines the relative proportions of different 
polyglutamates. Results on substrate specificity vary* 
in rat, THF is a substrate but 5-methyl-THF is not (34); 
in sheep, THF, 5-methyl-THF and 5-f ormyl-THF are comparable 
substrates (35). 
At one time it was thought that polyglutamates were 
storage forms of folate and that the active coenzyme 
forms were monoglutarnates. The opinion was re-inforced 
by the finding that monoglutamates are active in in vitro 
enzyme assays. Now that synthetic polylutamates are 
available, however, it is apparent that the polyglutaniate 
forms are the more active. This has been shown i.n vitro 
for human and mouse DHFR (36), human thymidylate synthetase 
(37), bovine methionine synthetase (38) and chicken AICAR 
transformylase (39). In vivo evidence for the importance 
of polyglutarnates comes from analysis of a mutant CHO 
cell line isolated by McBurney and Whitmore (40) which 
is auxotrophic for glycine, adenosine and thymidine 
(hence GAT). Normal CHO cells contain mostly THF-Glu4  
derivatives, but this mutant has low intracellular 
folates which are mostly monoglutamates. Extracts of 
GAT cells have less that 3% parental FPGS activity (41). 
Thus fig.1.2. must be modified by assuming that 
active folate derivatives are all polyglutamate forms 
with varying numbers of residues. 
1.3.3. Does DHFR inhibition account for MTX cytotoxicity? 
It is clear that MTX strongly inhibits DHFR in vitro. 
But does this inhibition account for its cytotoxicity? In 
this subsection I will consider two topics: in vivo 
modifications of MTX, which might alter its properties; 
and other cytotoxic effects of NIX. 
As analytical techniques have improved, an increasing 
number of metabolic products of MTX have been identified 
and studied. Polyglutamate derivatives have been found 
widely when they have been looked for (29). For example, 
rats treated with MTX formed MTX-Glu1 and MTX-Glu2 in their 
liver and kidneys (42). These were rapidly turned over: 
MTX-Glu1 disappeared at 8 times the rate of NIX. In 
contrast, patients who had received MIX as a therapeutic 
agent accumulated and retained MTX-G1u1 in their livers, 
where it comprised between one third and all of the MIX (43). 
MTX polyglutamates have also been observed in cultured cells; 
eg Rosenblatt et al (44) found that inhuman fibroblasts 
incubated with MTX,they accounted for about 25% of the 
total intracellular MTX after 8 hours. 
Derivatives with more than three glutamate residues 
have not been reported: this may be because MTX in the 
cell rapidly becomes bound to DHFR and is not then 
available for conjugation (29). Two lines of evidence 
suggest that MTX-polyglutamates are formed by FPGS. 
Firstly, MTX is a substrate for the partially purified 
enzyme (33); and secondly, GAT cells do not synthesize 
MTX-polyglutamates (45). 
Some of these derivatives have been shown to inhibit 
some DHFR s as effectively as MTX itself, and this may be 
true of all derivatives. MTX-G1u1 is as, or more (depending 
on the pH) potent an inhibitor of L1210 DHFR in vitro (46); 
and the same has been found for partially purified human 
lymphocyte DHFR (43). 
Thus, synthesis of polyglutamate derivatives of MTX 
is a major occuil-ence but does not significantly alter DHFR 
inhibition. However, in vivo cytotoxic effects may be 
altered because of resulting changes in MTX retention 
by the cell. 
A second form of MTX modification is removal of thlit  
glutamate residue to produce 2, 4-diamino-N(10)-methylpteroic 
acid (DAMPA), and this compound has been detected in 
concentrations greater than or equal to MTX in some 
patients (47,48). Its origin is unclear since no mammalian 
carboxypeptidase G is known; such an enzyme with a high 
affinity for MTX has been found in bacteria (49)  and it 
has been suggested that cleavage is carried out by gut 
flora (50). It isnqt known whether DAMPA inhibits DHFR. 
A third form of modification is cddation of MTX to 
7-OH-MTX; this occurs to varying extents in different 
species. This product has been detected in the urine 
of human patients and Rhesus monkeys (51) treated with 
high doses of MTX, and can form up to one third of 
excreted MTX. 7-OH-MTh is about 2 orders of magnitude 
less effective as an inhibitor of DHFR (52) 	hence this 
is a significant detoxtfication mechanism. In rabbits, 
where the 7-hydroxylation reaction is important even at 
low doses of MTX, the reaction is catalysed by the hepatic 
metalloflavoprotein aldehyde oxidase system (53). It is 
not known whether it is this system which is active in 
primates. 
Thus m6difications of MTX occur extensively and 
are important in determining its toxicity in vivo; their 
importance in cell cultures is at present unclear. In 
particular, 7-hydroxylation has not been investigated 
in cultured cells. 
The second question to be discussed in this section 
is whether MTX has cytotoxic effects in addition to its 
inhibition of DHFR. A priori, it might be expected to 
bind to other folate-utilizing enzymes because of its 
structural similarity to folate. Claims have appeared 
in the literature for detection of such effects; the. 
difficulty is to distinguish direct effects of MIX from 
indirect effects due to DHFR inhibition and the resulting 
depletion of folates; this subject is controversial. 
V 
One line of investigation has been to examine the 
intracellular binding sites of MIX (54). When cells loaded 
with MTX are resuspended in MTX-free medium, part of the MTX 
leaves the cell rapidly (with a half-time of about 2 
minutes), and part is retained (>one hour). These parts 
are referred to as the exchanable and bound pools respectively 
the bound pool is assumed to be bound to DHFR. Goldman (54) 
has provided evidence for the importance of the exchanble 
pool in inhibiting DNA synthesis. Cells which had the 
bound pool saturated with MIX synthesized DNA at 75+10u/o 
of the rate of cells not treated with MTX. An exchangeable 
pool of at least 0.2uM MIX was necessary to reduce DNA 
synthesis to 50%. Goldman therefore suggested that 
saturation of low affinity binding sites was necessary 
for MIX toxicity. Folate using enzymes are candidates 
for these sites. 
In a subsequent paper, however, White and Goldman (51) 
provided evidence that DHFR itself is the source of the 
low affinity binding sites. They found that when the 
bound pool was saturated, conversion of 3H DHF to IHF 
was not significantly affected; an 	exchangable 
intracellular MIX level of about 0.15uM was necessary to 
reduce the THF level to 50: this is comparable to the 
level required to inhibit DNA synthesis to the same 
extent. In contrast, folic acid reduction was more 
sensitive: saturation of the bound pool reduced the 
folic acid 	DHF conversion to 15°'o. The significance 
of the apparently different DHFR affinities is obscures 
Multiple species have not been found in wild-type cells 
(except as artefacts - see (22)). Possibly there are 
101 
different intracellular compartments. 
Borsa and Whitmore (56) have proposed that 
MTX has other site(s) of action on-the basis of 
their study of growth inhibition in L cells. 
Inhibition could be reversed by supplying the cells 
with thymidine plus adenosine, or (competitively with 
MTX) by 5-formyl-THF. The site of competition in 
the latter case could either be at the level of 
entry into the cell, or somewhere beyond the 
DHFR block (since DHFR-MTX association itself 
is noncompetitive). To distinguish between these 
possibilities, Borsa and Whitmore measured the 
reversal of inhibition by 5-formyl-THF in the 
presence of an excess of either deoxyadenosine 
or thymidine. When excess deoxyadenosine was 
used (ie. growth dependent on endogenous 
thymidylate synthesis), reversal was competitive. 
When excess thymidine was used (growth dependent 
on endogenous purine synthesis), reversal was 
noncompetitive. They interpret the difference 
as indicating that entry into the cell is not 
the important factor, and the competitive nature 
of the reversal in the presence of excess deoxyadenosine 
as indicating a site of action for MTX along the pathway 
for the synthesis of thymidine. 
The key candidate enzyme is thymidylate 
synthetase (TS), and in a second paper (57), Borsa 
23 
and Whitmore claim that this enzyme is directly and 
competitively inhfbited in vitro in partially purified 
preparations. It is clear that TS will bind MTX, at 
least in the presence of dUMP (its natural substrate), 
since it can be isolated on a MTX affinity column (58). 
However, other workers have found that inhibition is 
not competitive with respect to MTX (58); also the 
in vitro K1 is too high by a factor of at least 100 
to account for the inhibition observed by Borsa and 
Whitmore in their cultured cells. However, if the 
intracellular levels of MTX in resistant cells 
are higher, MTX could start to cause significant 
inhibition in TS. This will be discussed later. 
A more indirect role for TS has been proposed by 
Moran et al (59) on the basis of their growth inhib-
-ition studies. They found that inhibition by MTX of 
cultured mouse or leukaemic cell growth was reduced 
by 5-f luoro 2'deoxyuridine (FdUrd), hypoxanthine (H) 
or thyrnidine (dThd). They suggested that there was 
a common underlying mechanism: direct (FdUrd) or 
indirect (H and dThd) inhibition of TS. Reduced 
levels of thymidylate synthesis would reduce 
depletion of THF derivatives and therefore 
require less DHFR activity. While such a mechanism 
might facilitate cell survival and subsequent rescue 
from MTX inhibition, it is paradoxical that it 
should facilitate cell growth. Thus, although it is 
possible that MIX has modes of action in vivo other 
2* 
than DHFR inhibition, none has been convincingly 
demonstrated, 
1.4. MIX RESISTANCE 
MIX resistance has been widely studied in 
cultured mouse and hamster. cells, and -to a lesser 
extent in human cells. I do not propose to review 
all the papers published about or using MIX-resistant 
cells, but have selected some of the more pertinent 
work. A summary of the work of Schimkets group 
has appeared (60) but there is no recent general 
review of the field. 
.4.1. Mechanisms of resistance 
Resistance to MIX has been found to arise by 
three main types of mechanism: 1. reduction of 
MIX transport into the cell, so that in spite of 
a high extracellular concentration, the intracellular 
concentration never becomes high enough to inhibit 
DHFR significantly. 2. Alteration of the binding 
properties of DHFR so that its high affinity for 
MIX is lost. 3. Increase in DHFR activity so that 
although at a given MIX level most of the DHFR is 
inhibited, the residual activity can supply the 
needs of the cell. Combinations of these mechanisms 
frequently occur. In addition, inactivation of NIX is a 
possible fourth mechanism, but has not been reported. 
The first three mechanisms will be considered in 
the next three subsections. 
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1.4.2. Resistance due to altered transport 
The first identification of a transport mutant was 
described by Fischer (61) in a clone of mouse L5178Y cells 
selected in vitro. This clone, designated mt, was obtained - 
by a two-step selection procedure, the first selection being 
in 2x10 8M MTX and the second in a concentration not reported. 
L5178Y rut cells required 5.6x10 7M MTX to inhibit the rate 
of cell growth by 50%; this represented about 70-fold 
resistance. An alteration to the MTX transport in resistant 
cells was demonstrated by resuspending sensitive and resistant 
i 3 cells grown in nonselective medium n H-MTX. After 
equilibration, the intracellular MTX concentration in the 
sensitive cells was two to three times that in the medium, 
while in the resistant cells it was 0.1 to 0.2 times: this 
represents a 10 to 30 fold decrease in MTX transport in 
resistant cells, but it is not sufficient to account for 
all the resistance of the cell. Other causes of resistance 
in L5178Y rut were not examined, nor was the basis for 
resistance before the second stage of selection. 
Kessel et al (62) found that sublines of mouse 
L1210 and P288 cells resistant to MTX (selection procedures 
not described) had, in addition to an eight to ten fold 
increase in DHFR activity, four and three fold decreases 
in drug uptake. Another L1210 subline (63) selected in vivo 
for multiple resistance to MTX, S-fluorouracjl and 6-mnercaptopurin 
and called L1210 (XV14), had a fourfold decrease in the rate 
of MTX transport. The V 
max  value for transport 
2k 
was unchanged, but the Km was increased, suggesting 
an alteration in the binding of MIX to a carrier 
protein. Further selection of L1210(XVI4) produced 
L1210(XVJ4 ) which had a 10 fold increase in DHFR 
level but, unexpectedly, normal transport of MTX. 
Chinese hamster cell lines with altered 
transport properties have been obtained by Flintoff 
et al (64) after EMS mutagenesis and single-step 
selection in 1x10 7M MIX. Such clones were 38 to 
58 fold resistant to MIX, had about a ten fold lower 
transport rate, but had normal amounts of the normal 
DHFR. 
Five MTX-resistant sublines of the human lyrnphoblastOd, 
line W1-L2 have been selected by Niethamrner and Jackson (65) 
in successive stages. In the early stages of selection, 
resistance was due to increased enzyme activity and 
alterations in enzyme structure, but in later stages 
transport mutants occured in four of the five sublines. 
The one of these which was studied in detail had an un- 
-altered Km but at least a seven fold decreased Vmax; 
thus it is of a different kind from that found in 
L1210 cells (63). 
Folates and MDC enter the cell by active transport 
when their concentration is low. There are probably 
seperate transport systems for folates and for THF 
derivatives; MIX enters by the latter (66). When 
MDC-binding fragments from L1210 plasma membranes are 
isolated, three major polypeptides are found (67). 
1? 
These have molecular weights of 67Kd, 63Kd and 56Kd. 
MTX interacts directly with the 56Kd polypeptide 
which in turn interacts with the other two polypeptides. 
The molecular basis for altered entry could be a decrease 
in the total amount of carrier, a decrease in its affinity 
for MDC, or a decrease in its rate of transport of MIX. 
The second of these would be effective only at low MDC 
concentrations; the third only at high concentrations. 
One of the mutations in mouse cells (63) is of the 
second type, and it is interesting to note that it 
is lost on further selection to higher levels of 
resistance where it would confer little advantage; the 
human mutations (65) are of the third type and occur late 
in a series of stages of selection where the system is 
presumably operating close to its Vmax  and a decrease in 
Vmax is consequently an advantage. Changes in the 
polypeptides of the transport system have not been 
demonstrated directly. 
1.4.3. Resistance due to altered enzyme 
Reports of the finding of multiple or new DHFR 
species in cells treated with MIX must be interpreted 
with caution because it was not appreciated until the 
mid 1970 S that some of the methods of analysis, 
Sephadex column chromatography and activity gel 
electrophoresis, separate DHFR with different 
cofactors bound, and thus give rise to artefactual 
multiple forms of the enzyme. Nonetheless, enzymes 
with genuinely altered structure have been detected in 
hamster and human cells. 
Biedler and co-workers have characterized such an 
enzyme in Chinese hamster cells. It had been noticed 
that a series of nine subltnes, independently selected 
in vitro for resistance to MTX, seemed to fall into 
two-groups (68). Both groups had increased DHFR 
activity; but for a given level of resistance, group 
A (my terminology) had highly increased DHFR activity 
and were also resistant to a comparable level of MQ 
while group B had slightly increased DHFR activity and were 
only resistant to a lower level of MQ. 	 - 
The DHFR from the two parental cell lines, two members 
of group A and two members of group B were characteried 
with respect to amount and relative inhibition by MTX 
and MQ (69). Parental cell and group A enzymes were 
inhibited stoichiometrically by both MIX and MQ, while 
group B enzymes were stoichiometrically inhibited by MQ 
but only weakly inhibited by MTX; weak inhibition was 
due to weak binding. More recently (70), a comparison 
was made between the polypeptides from the parental cells, 
a line selected for resistance to MQ (71) with a group A 
enzyme, and a line with a group B enzyme. When cytosol 
proteins were run on SDS-polyacrylamide gels a single 
extra band (ie. DHFR) could be seen in each resistant 
cell line, but the migration of this band was slightly 
slower in the group B polypeptides, corresponding to a 
molecular weight of about 21Kd, rather than 20Kd in the 
group A polypeptides. The same phenomenon was seen when 
polypeptides from the in vitro translation of ITIRNA were 
analysed, suggesting that the mobility difference was 
due to a difference in primary structure and not post-
translational modification. 
Another series of modified DHFR; also from Chinese 
hamster cells, have been characterised by Flintoff and 
co-workers (64). They purified DHFR from wild-type cells, 
two independently isolated mutants carrying altered DHFR 
and a third line which carried the altered enzyme but 
which had been further selected for increased amount of 
the altered enzyme. All enzymes had similar Km  s for 
DHF. and FA. Slight differences could be seen in pH 
activation profiles and thermal inactivation kinetics, 
but the striking difference was the six to eight fold 
decrease in affinity for MTh. These workers state that 
the wild-type and mutant enzymes have the same mobility 
on SDS gels, corresponding to a molecular weight of 24Kd. 
However, a close examination of their fig 1 reveals that 
their mutant (NUT1) enzyme runs slightly faster: the 
reverse of the situation found by Biedler et al. The 
difference between the molecular weights reported by 
Biedler and co-workers and those reported by Flintoff 
and co-workers for the wild-type enzymes probably reflects 
a difference in the standards used and the electrophoretic 
conditions rather than a real difference. 
An altered enzyme has also been described in 
human cells by Jackson and Niethammer (72). W1-L2 
cells showing 170 fold resistance , and designated 
WR8.1, had 222 fold increased DHFR activity and were 
grown in 1.6x10 6M MDC. DHFR from these cells had a 
	
K. 	for MTX increased about 50 times and a K M for DHF I .  
increased about 18 times, giving a K/K m ratio of 
about 3. When these cells were further selected 
for resistance in 3.3x10 6M MTX, a 520 fold resistant 
line, designated WR9.1 was obtained; it had 234 fold 
increased DHFR activity. Amazingly, the K and Km  of 
this enzyme had reverted to wild-type. Membrane 
transport was not altered in either of these resistant 
cell lines. Jackson and Niethammer explain what at 
first sight seems a paradoxical result as follows. 
At the high MTX levels that the cells are growing 
in, DHFR inhibition is not the only factor that 
determines toxicity; TS inhibition must also be 
taken into account. Decreasing the affinity of DHFR 
for MTh allows more enzyme activity and hence more 
THF synthesis. However, if TS cannot use the THF 
because it is inhibited by MTX, the cell still 
cannot grow. Increasing the affinity of DHFR for 
MTh (returning it to normal) can decrease the intra-
-cellular MTX concentration and allow TS to function. 
The genetic basis of a change such as that observed 
in the selection of WR9.1 from WR8.1 must, in view 
of current ideas about the mechanism of protein 
overproduction (see section 1.4.4), be considered 
puzzling. I will return to this subject at the end 
of section 1.5.2. 
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1.4.4. Resistance due to increased DHFR activity 	I 
Increased enyme activity has already been mentioned 
in the subsections on other forms of resistance. As a sole 
mechanism of resistance it is well documented, and it 
invariably occurs, alone or in combination with other 
mechanisms, in cell lines resistant to high levels of 
MTX (10 6M). Hakala et al (73) described two derivatives 
of mouse S-180 cells obtained after growth in gradually 
increasing MTX concentrations. One subline was 67 fold 
resistant and had 65 fold increased DHFR activity; the 
other was 174 fold resistant and had 155 fold increased 
activity. Fischer (74) selected L5178Y cells for 
resistance by a two-step procedure. The clone of the 
first-step selection was 2.3 fold resistant and had 
2.0 fold DHFR activity; the clone of the second-step 
selection was 16 fold resistant and had 17 fold activity. 
L5178Y cells selected for resistance to 1.1x1O 3M MTX 
by Courtenay and Robins (75) had about 100 fold increased 
DHFR; a reduction in transport was acting here as well. 
An increase in enzyme activity could, in principle, 
be due either to production of a more active enzyme, or 
to a higher level of an unaltered enzyme. The latter 
mechanism has invariably been shown to be the case when 
this question has been tested. Nakamura and Littlefield (76) 
purified DHFR from wild-type and resistant BilK cells and 
demonstrated thatthe proteins had similar properties, 
including inhibition of enzyme activity by antibodies 
made against the resistant cell DHFR; only the amount was 
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different. Later (77) Hanggi and Littlefield compared 
peptide maps and fund them to be the same. Alt et al (78) 
working on AT-3000, a 3000 fold resistant cell line 
derived from 3-180 by Hakala et al (73), found a 140 
fold increase in DHFR activity. Immunological 
precipitation with anti-DHFR antibody showed that the 
resistant cells had about 150 times more cross-reacting 
material than the sensitive. The properties of the two 
enzymes purified to homogeneity were the same. 
These increases in steady-state amount of protein 
could be due to increase in the rate of synthesis or 
decrease in the rate of degradation. Nakamura and 
Littlefield (76)initially found a 20 fold increase in 
the rate of synthesis in their hamster cells which had a 
140 fold increase in the amount of enzyme, suggesting 
that both mechanisms were operating. However, Haggi and 
Littlefield (77), using a technique less prone to artefacts, 
subsequently found that the rate of synthesis was about 
140 times faster and that the rate of degradation was 
the same. Similarly, Alt et al (78) found that the 
proportion of soluble cell protein precipitated by anti-
DHFR was 7-8% in continuously labelled cells and 67% 
in pulse labelled cells. Thus rate of synthesis is the 
controlling factor. 
Rate of synthesis of protein will depend on the 
amount of mRNA and the efficiency of its translation. 
Chang and Littlefield (79) prepared polysomal RNA from 
sensitive and resistant BI-IK cells and translated it 
in vitro in the wheat germ system. RNA from resistant 
cells directed the synthesis of about 70 times more 
DHFR per unit of total protein than did RNA from 
sensitive cells. Similarly, Kellems et al (80) 
showed that the increase in rate of DHFR synthesis 
in S-180-AT3000 cells could be explained entirely by 
an increase in the amount or efficiency of mRNA, as 
judged by in vitro translation in the rabbit reticulocyte 
system and immunoprecipitation. Thus increased enzyme 
activity is due to protein overproduction, and 
overproduction is due to an increased amount of 
translatable mRNA, 
1.4.5. Resistance in human tumors 
It can be seen from the previous part of this 
section that there are multiple ways in which cells can 
become resistant to MTX. Which are found clinically? 
Changes in the amount of DHFR activity have been seen 
by Bertino et al (81,82) in leukocytes and erythrocytes 
of patients treated with MTX. For example, in one 
patient (VN), the level of enzyme started to increase 
from being initially undetectable to being detectable 
in five days after MTX treatment was initiated, and 
decreased quite rapidly after treatment was stopped on 
day 15. This kind of response, called "induction", was 
seen in patients with leukemia and other malignancies. 
There are considerable changes occuring in the blood 
cells of these patients and the rise in DHFR may be due 
to changes of cell type, or it may be an adaptive 
response of cells already present; in any case it 
cannot be the selection of a genetically resistant 
variant because both the increase and the decrease 
are too rapid. 
Roberts, Hall and co-workers have also investigated 
DHFR levels in blood cells of human patients, using a more 
sensitive enzyme assay. In untreated patients with ALL, 
AGL or CGL the DHFR level was elevated by about an order 
of magnitude; in CGL or non-haematological malignancies 
it was not significantly increased. Elevation was 
because of circulation of immature leucocytes which 
would remain in the bone marrow of a normal individual. 
When MTX was administered to patients with ALL, a transient 
increase in DHFR activity was again seen. It returned 
to pretreatment level while the patients were in remission, 
and remcned at this level if the tumour became resistant 
to MIX (83). 
These same workers also studied permeability of 
lymphocytes from leukemic patients to MTX (84), and 
found a correlation between high MTX uptake and later 
remission following treatment with the drug. However, 
they did not determine whether patients who had relapsed 
after an initial response had developed impaired 
permeability. 
Thus the limited data availiable do not allow 
any conclusion to be drawn about the mechanisms of 
development of resistance to MTX under clinical 
conditions. The only result directly relevant is the 
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lack of significantly increased enzyme activity in 
lymphocytes from leükemic patients resistant to MIX (83) 
and even this is of dubious significance. A slight 
increase was in fact founds this might become significant 
if more data were obtained; also it is not clear whether 
the variation in enzyme measurements, reflected by the 
large standard deviations of the quoted figures, refer to 
poor reproducibility of the assay or real variation 
between patients. 
1.5. THE GENETIC BASIS OF MTX RESISTANCE 
Changesin transport proteins and DHFR account for 
MTX resistance; but what is the basis for these changes 
in protein? 
1.5.1. Classical genetic analysis 
The techniques of classical genetics allow mutation 
rates and the dominant/recessive nature of a mutation to 
be determined. From such data on MTX-res. cells a 
certain amount can be deduced about the molecular basis 
of resistance. Flintoff and co-workers have measured 
spontaneous and EMS-induced mutation rates in hamster cells 
(85). A clone of the wild-type cells was picked and grown 
for approximately 60 generations under nonselective conditions. 
Cells were then plated in 1x1O 7M MTX. 	Three stably 
resistant colonies were obtained, all with alterations to 
enzyme structure. From this small sample of mutants FUntoff 
et al calculated a mutation rate of 2x10 9 per locus per 
generation. No mutants with altered MTX transport 
or increased DHFR activity were seen under these 
conditions. In the presence of EMS, the number of 
mutants with altered enzyme was increased by about 
an order of magnitude; in addition there were about 
an equal number of transport mutants; but still no 
increased activity mutants. At first sight this 
lack of increased activity mutants is surprising, 
considering the high frequency with which they have 
been found in hamster cells by other groups. The 
explanation for this discrepancy probably lies in 
the increase in resistance that the cell is required 
to produce in a single step. When this is low (two 
to three fold), increased activity is the most 
frequent cause of resistance, whereas when it is high 
(10 fold), sufficiently increased activity cannot occur. 
Quanttive analyses of mutation rates for cells 
of other species have not been carried out. Nevertheless, 
it is possible to get an impression of the rates from the 
literature, and there seem to be species-specific 
differences. Thus it is likely that the spontaneous 
appearance of transport mutants in mouse cells is 
significantly higher than in hamster cells, (there are 
many reported), and the appearance of altered enzyme 
mutants is lower (none reported). The situation in 
human cells is more difficult to asess, but from the 
limited data available it seems that all three kinds appear 
at moderate frequencies. These findings are summaraised 
in table 1.2. 
These three kinds of mutation have been studied by 
somatic cell hybridization. Littlefield (86) hybridized 
wild-type and increased activity mutants and found that 
32 out of the 35 hybrid clones examined had intermediate 
levels of DHFR activity. He concluded that increased 
activity was not due to loss of a diffusable repressor, 
a possibility that had been considered by analogy with 
bacterial control systems such as fi-galactosidase in 
E.coli. 
Flintoff et al (85) have also done somatic cell 
hybridization experiments. They made proltne prototrophs 
of their MIX-sensitive cell line and ouabain resistant 
mutants of each of their MIX-resistant derivatives. 
After fusion, hybrids were selected in proline, 
ouabain+ medium and their MIX resistance tested. The 
transport mutants were recessive, but the altered enzyme 
and increased activity mutants were codorninant. These 
are the results expected for transport and altered enzyme 
mutants, and for increased activity mutants if the 
increase is due to constitutive overproduction. 
1.5.2. Molecular genetic analysis 
Mutations which lead to the production of a struct-
-urally altered protein are likely to be point mutations: 
ie. single base substitutions resulting in single amino 
acid changes. The drastic effects on protein structure 








mouse ++ . ++ 
hamster + ++ 
human + + + 
Table 1.2. The occurrence of spontaneous mutations to MTX 
resistance in cultured cells of different mammalian species. 
Key: ++ = many examples known 
+ = a few examples known 
= none reported 
have are well illustrated by the haernoglobins. However, 
it must be emphasised that such events have not been 
identified at the amino acid or DNA level in DHFR or 
MIX transport proteins. 
Protein overproduction by means of an increased 
mRNA level could, in theory, be due to several causes 
including activation (or depression) of a promotor 
leading to more frequent initiation, increased stability 
of the RNA, or more copies of the gene. In fact, only 
gene amplification has been shown to accompany DHFR 
overproduction. This was the work of Alt et al (87). 
They purified DHFR mRNA from MIX-resistant S-180 cells 
by immunoprecipitating polysomes with anti-DHFR antibody, 
and then synthesized cDNA complementary to the polyA-
containing RNA in the precipitate. 15 to 207 of the 
resulting cDNA was DHFR-specific. This was then hybridized 
to excess sensitive cell mRNA, and the non-hybridizing cDNA 
was hybridized to resistant cell mRNA. The hybridizing 
fraction ('DHFR cDNA') was reassociated with an excess 
of total nuclear DNA from sensitive or resistant cells. 
The rate of hybridization was about 200 times faster 
when resistant cell DNA was used, corresponding to a 200 
fold overproduction of protein. Similarly, a MIX-resistant 
L1210 line with 35 fold increased enzyme activity had about 
45 times the number of genes in the sensitive L1210. 
Subsequently, several other cell lines have been shown 
to have amplified DHFR genes. These will be discussed 
at a later stage. 
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At this point we will return to the discussion of 
the results of Jackson and Niethammer. If the DHFR 
overproduction in their WR8.1 is due to gene amplification, 
which seems likely, and overproduction in the WR9.1 is due 
to the same cause, then what has apparently happened has 
been the replacement, in a single step, of multiple copies 
of one type of gene by multiple copies of another. It is 
difficult to see how this could happen. A trivial 
explanation of their observations is crosscontamination 
or mislabelling of their cultures; another is that the 
cultures which, il'should be noted, are not clones, are a 
mixture of cells overproducing normal enzyme and cells 
overproducing mutant enzyme at each stage; 	in the two 
lines 	they may only be observing a change in the 
predominant form in a fluctuating population. 
1.5.3. Chromosomal changes associated with MTX resistance 
There have been several attempts to associate 
specific chromosome changes with NTX resistance. This 
is not simple because the chromosomes of most cultured 
cell lines have multiple rearrangements with respect to 
the original animal, and also vary from cell to cell. 
In 1965 Biedler et al (88) published the results 
of a study on L1210 sublines. Their parental L1210 had 
a subtelocentric marker chromosome and in 10 out of 18 
resistant sublines this was altered. They concluded 
that there was a relationship between the configuration 
of the subtelocentric and DHFR activity, and suggested 
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MTX had a mutagenic activity. MTX is not mutagenic in the Ames 
test (89) although it may lead to alterations in DNA as a 
result of the thymidine-less state it produces. 
Since this work was carried out before chromosome 
banding techniques were introduced, only gross changes 
could have been detected; the significance of the 
relationship they observed is unclear. 
Another kind of alteration described by Biedler 
and Spengler is the development of a homogeneously 
staining region (HSR) on a chromosome (90). Of 20 
MTX- or MQ- resistant hamster subitnes, 13 were near-diploid 
and were karyotyped. Seven of these had HSRc on one of 
chromosomes two, four or, in one case, an unidentified 
chromosome. These HSR were defined b3 their lack of the 
normal banding substructure after trypsin-Giernsa staining. 
In addition, the HS} C-banded, were uniformly and early 
replicating and were located terminally on their 
chromosomes. In a further study (91), cells from two of 
the sublines were cloned ardthen grown in non-selective 
medium. Resistance was lost gradually over a period of 
about a year and there was a corresponding decrease in 
the size of the HSR. 
Another MTX-resistant hamster line has been studied 
by Nunberg et al (92). This line was 50,000 fold resistant 
and had about 150 DHFR genes. There was an HSR, again, on 
chromosome two; and Nunberg et al showed by in situ 
hybridization with mouse DHFR cDNA that most if not all 
of the amplified DHFR genes were localised in the HSR. 
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Judging from photographs of chromosome spreads, they 
estimated that th HSR comprised about 3½% of the 
Chinese hamster genome, which was about 1.6xlO8bp. 
Thus if the DHFR genes were spread evenly along the 
HSR, which the distribution of silver grains seemed 
to suggest, the size of the repeating unit was about 1000kb. 
1.6. OUTLINE OF THIS THESIS 
A conclusion from section 1.4 and 1.5 is that 
amplification of DHFR genes can be a basis for DHFR 
enzyme overproduction and thus for MIX resistance. 
This was an unexpected finding because gene arnplif-
-ication is not a common mechanism by which cells or 
organisms increase their capacity to synthesise a gene 
product (93). The aim of this thesis is the elucidation 
of the mechanism of such amplification. 
The work falls into two parts. In the first part, 
a number of NTX-resistant mouse cell lines are examined in 
or'der to establish whether the basis for resistance in 
these cells is DHFR gene amplification. In the second 
part, other sequences which may have been involved in 
the amplification are investigated. In the light of these 




MATERIALS AND METHODS 
0 
.1. GENERAL 
The experiments described in this thesis were 
carried out over a period of more than a year. During 
this time existing techniques were being learned and 
new techniques developed. In this chapter only the 
methods finally adopted and variations which are 
significant are described; preliminary experiments and 
insignificant variations are omitted. 
2.2. ORIGIN OF THE MTX-RESISTANT CELL LINES 
2.2.1. General features of the cell lines 
All the cells used in this work are transformed lines 
originating in mouse tumours and capable of unlimited 
growth in culture. The MTX-resistant lines which grow 
in high concentrations of MIX have all been obtained by 
stepwise selection in increasing MIX concentrations 
without the use of mutagens. In general, little cloning 
of the cell populations has been carried out, although in 
some cases cells were cloned at the initial and final 
selection steps. The derivation of the cell lines is 
outlined in fig.2.1., and details are given in sections 
2.2.3 to 2.2.7. below. Photographs of the living 
cells are shown in fig. 2.2. 
2.2.2. Nomenclature 
The nomenclature system usef for the PG19 cell 
lines (94) is extended here to include all the MIX- 
resistant cell lines. The cell type or subtype is 
followed by'MTXR'  and a suffix which is the concentration 
Mu. muiculul 
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Fig. 2.1. Summary of the origins of the cell lines used in this 
thesis. The mouse strain and substrain, the wild-type cell line, 





Fig. 2.2. Phase contrast 
light micrographs of 
living cells. 
4I 
of MTX used for selection. Thus L5178YtMTX  
designates a population of L5178Y cells which have 
been selected for growth in 4.4x1O 3M MTX. 
In two instances there is more than one series 
of MTX-resistant cell populations derived from the 
same starting line. The two PG19 series are designated 
PG19T3:MTXRXS1 and PGI.9T3:MTXRXS2; x is the relevant 
MTX concentration. The four EL4 series are designated 
EL4/31MTXR',  EL4/8:MTXR', EL4/11:MTXRX, and EL4/12:MTXRX . 
In all lines the wild-type, parental or sensitive 
cell population is called ....../WILD. 
2.2.3. PG19 
PG19 cells were derived from a spontaneous 
melanoma in a C57B1/6J mouse (95)t the melanoma cells 
were treated with ethyl methane suiphonate and selected 
for resistance to 6-thioguanine. Consequently they lack 
HPRT activity. Before selection for MTX resistance 
was initiated, the cells were passaged through a 
newborn C57B1 mouse; tune cells were re-established 
in culture and one clone was chosen. This is designated 
PG19T3C11. 
Two selections for MTX resistance were carried 
r W•- 9Q4-C6 	rie. 	o 
out.La clone was picked at the initial selection level; 
th 	was 1.27x10 7M MTX (Si) or 1x1O 7M MTX (S2). 
Selection was continued by increasing the MTX 
concentration approximately threefold in subsequent 
stages. Multiple colonies were always seeni individual 
clones were not picked until the final stage was reached. 
In the Si selection, cells growing in 3x1O 5M MTX were 
plated Ln 10M MTX and individual clones selected. 
One of these clones (clone 15) was chosen for detailed 
study because good chromosome preparations were easily 
obtained from it. In the S2 selection, the population 
of cells growing in 10 3M MTX was plated at low density 
in this concentration of MTX and individual clones 
were picked. Intermediate stages in the two selections 
were preserved by freezing down. 
The first stages of the Siselection were carried 
out by V.van Heyningen and P.M.B.Walker; later stages 
were done by C.J.Bostock and E.M.Clark. The initial cxiA 4 
stages of the S2 selection were carried out by me; 
other stages were done by C.J.Bostock and E.N.Clark. 
2.2.4. EL4 
EL4 cells originated in a C57B1 mouse treated with 
9, 10-dimethyl-1,2-benzanthracene in 1945 (96)and were 
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described aslymphogenous leukosis. Investigation of 
their surface antigens has shown that they are Thy-1 
positive (97); therefore they are T-cell derived. EL4/WILD 
cells were plated in soft agar containing 4.4xiO 8M MTX. 
P.esistant clones were selected and subsequently maintained 
separately in suspension culture. The MTX concentration 
was increased in two to three fold steps. The final 
concentration was 2,2x1O 3M (EL4/3) or 1.1x1O 3M (EL4/8, 




LB1 trans cells were derived from a CBA-16 mouse 
embryo (T.Alderson, personal communication) 	Initial 
selection was in 6.6x1O 8M MTX and the final selection 
was in 4.4x1O 3M MIX. Selection was carried out by 
T. Alderson. 
2.2.6. L1210 
The origin of L1210 cells has been described by 
Law et al (98)z the skin of a female DBA subline 
212 mouse was painted with methyichioroanthrene in 
ethyl ether, and cells from the resulting lymphoid 
leukemia were maintained in vivo. Selection for MIX 
resistance, carried out by Harding et al (99), was 
also in vivo. L1210 cells and MIX at a concentration 
of 0.007ug/g body weight were injected intraperiton-
-eally into BDF1 mice. In the absence of MTX, the 
survival time of the mice was about eight days. MTX 
increased survival to 26 days because of inhibition 
LA 	 U 
of growth of the tumc. Some of the resulting turn*  
cells were injected, with MTX, into another mouse 
and a second-generation tumcfr obtained. The procedure 
PA 
was repeated for a total of 20 tum* generations. At 
the final stage the survival of the mice had decreased 
to eight days, the time observed when no MTX was used, 
and therefore the L1210 cells were considered resistant 
to MTX. 
When these resistant cells were received in this 
laboratory, they were grown in vitro in suspension 
culture. They were found to survive in 10 M MTX, 
and were routinely maintained in this concentration. 
Their ability to grow in higher concentrations of MTX 
is unknown. 
2.2.7. L5178Y 
L5178 is another leukemia which arose in DBA/2 
mice, and the line L5178Y was derived from it (100). 
Development of MTX-resistant L5178Y was carried out 
initially by Courtenay and Robins (75) and in the 
final stages by T.Alderson. Selection was initiated 
in 3.3x10 9M MTX; when rapidly growing cells were 
observed in the culture, the MTX concentration 
was doubled and this protocol continued until, 
after 83 days, cells survived in 1.1x10M MTX. 
After maintainence at this concentration by Courtenay 
and Robins, selection was continued by T.Alderson to 
a concentration of 4.4x10 3M MTX. 
2.3. CELL CULTURE 
2.3.1. Maintt. ncnce of cells 
All cells were grown in RPMI 1640 medium (Flow 
Laboratories) supplemented with 10% heat inactivated 
foetal calf serum (Gibco Bio-cult), antibiotics, and 
where appropriate, MTX (Lederle). Antibiotics were 
either 100 units/mi penicillin plus lOOug/ml streptomycin 
(Gibco Blo-cult), or SOug/ml gentarnycin (Schering Corp.). 
J) 
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MTX was obtained either as 25 mg/ml sterile solution, 
or in powder form. Cultures were usually grown in 
plastic flasks (Nunc, 25 cm2, 75cm2 or 174cm2); larger 
scale cultures were grown in horizontally rotating 21 
glass bottles. An atmosphere of 5-107.-Co was used 
and the temperature was 35-370C. 
Routinely, suspension culture cells were diluted 
about three-fold into fregk meduim every two to four 
days; anchored cells were released by trypsinizatiori 
and replated at lower density every two to seven days. 
2.3.2. Cloning of Cells 
PG19 cells were cloned by plating out at low 
density, allowing two to five weeks for colonies to 
grow to the 50-200 cell stage, and then picking individual 
colonies using stainless steel cloning cylinders. 
Attempts to clone NTX-resistant EL4 cells using a 
microwell plate or soft agar were unsuccessful. 
2.4. CHROMOSOME ANALYSIS 	- 
The standard methods used have been described 
in ref. 'p4. 
2.5. CELLULAR DNA PREPARATION 
DNA was prepared from nuclei in order to exclude 
mycoplasmal DNA from contaminants present in some 
of the cultures. 
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2.5.1. Preparation of nuclei 
Nuclei wer& prepared using a modification of 
the chromosome isolation method of M.2o pjl. 	et)c.I*aa (i) 
Harvested cells were washed twice with Dulbecco's 
medium, resuspended in 10 volumes of ice-cold 
20mM Tris-HCL pH 7.5, 1mM CaCl2, 1mM M8C12 and left 
on ice for 20 minutes. This procedure causes the 
cells to swell. All the following steps were carried 
out at 0°C. 5/O1Triton X-100 in the above buffer was 
add e
v  d to give a final Triton X-100 concentration of ((P 
0.5and the mixture left for a further five minutes 
to weaken the cell membranes. Cells were then homogenized 
in a Douce homogenizer with a type B (tight-fitting) 
pestle until they appeared broken when examined in a 
microscope under phase contrast. The nuclei were 
collected by centrifugation at 3,000rpm for five 
minutes in an MSE Chilspip centrifuge. The pellet 
(v/I) 
was resuspended in 0.S7oLTriton X-100, 20mM Tris-HCI 
pH 7,5, 1mM CAM 2, !MM MgCl 2, and one of two procedures 
was adopted. For a crude nuclear preparation the nuclei 
were resedimented as above. For a clean nuclear 
preparation the suspension was layered over 4ml of 
2.2M sucrose in 20mM Tris-HCL pH 7.5, 1mM CAM 2, 
1mM MgCl2, and centrifuged at 30,000rpm in a 10 x 10 
Al rotor for one hour. Nuclei formed a pellet at the 
bottom of the tube while contaminating cells and debris 
remained in the upper layer or at the interface between 
the two layers. 
2.5.2. Cellular DNA preparations 
DNA was prepared by one of two methods. The first 
was the procedure of Gross-Bellard et al (102) with 
modifications. Pronase and protease K were used 
interchangeably. Dialysis against 10mM Tris-HCL pH8, 
10mM EDTA, 10mM NaCl was used instead of dialysis against 
10mM Tris-HC1 pH8, 500mM EDTA, 10mM NaCl since the latter 
seemed an unnecessary expense and would require subsequent 
removal of the EDTA before restriction enzyme digestion 
or electrophoresis could be carried out. A final 
dialysis step against 1mM Tris-HC1 pH8, 0.1mM EDTA 
was added. Volumes used throughout the procedure were 
such that the final DNA concentration was0.1mg/ml. 
The second procedure was that of Ross (103), 
which involves rapid lysis of cells in a buffer 
containing 7M urea to reduce degradation of DNA during 
isolation. DNA was finally dissolved in 1mM Tris-HCI pH8, 
0.1mM EDTA. DNA preparations were stored frozen at 
-200C or, for periods of a few days, at 40C. 
2.6. ORIGIN, GROWTH AND PREPARATION OF RECOMBINANT 
PLASMID DNA 
2.6.1. Origin of the mouse DHFR cDNA-containing plasmids 
Two different plasmids containing mouse DHFR cDNA 
inserts were usedz pDHFR 11 and pDHFR 21. Both were 
gifts from R.T,Schimke (Stanford University). The 
construction of pDHFR 21 has been described (104);. 
a description of the Construction of pDHFR 11 has not 
been published, but- it is thought to have been constructed 
in the same way. pDHFR/-contains a cDNA insert of about 1.5 
kilobases (Kb) which corresponds to the 3' nontranslated 
region and about 90% of the coding region of mouse 
DHFR mRNA; pDHFR 11 has an insert of about 1.6 Kb 
corresponding to the 3' nontranslated'region, all of 
the coding region and part of the 5' nontranslated 
region of mouse DHFR mRNA. The source of the DHFR 
mRNA used was MTX-resistant S-180 cells (73). 
2.6.2. Preparation of plasmid DNA 
E coli C600-SR 1592 cells harbouring these 
plasmids were grown in L broth. pDHFR 21 DNA was prepared 
by acid-phenol extraction (105) followed by cosium 
chloride/ethidium bromide density gradient centrifugation 
(106). pDHFR 11 DNA was a gift from H.J.Cooke. 
2.6.3. Origin of other recombinant plasmids and phage 
I. p 0 (107) contains an insert of rabbit fl-globin cDNA, 
and the purified plasmid DNA was a gift from 
E.M.Southern. 
pCR1-&G59 contains an insert of rabbit a globin cDNA, 
and the purified DNA was a gift from N.Hanscombe. 
pSpG17 contains an insert of sea urchin genomic DNA 
including part of an actin gene. The plasmid was 
constructed by Durica and Schloss and purified DNA 
was a gift from D.Cooper. 
4. Xgt WES. rDNA contains a 66KbEcoR1 insert of 
mouse ribosomal DNA (108). 
2.7. DNA ANALYSIS 
2.7.1. Restriction enzyme digestion 
Restriction enzymes were from several sources. 
Enzymes were prepared in this laboratory by B.Smith and 
C.Graham according to standard procedures. In addition, 
enzymes were purchased from commercial suppliers. Details 
are given in table 2.1. Digestions were done using conditions 
recommended by the suppliers. Complete digestion was ensured 
in various ways. A two to six fold excess of enzyme over 
that expected to be necessary to digest the DNA in the 
time allowed was used; in some casesXDNA was added to the 
reaction as an internal standard, while in other cases X 
DNA was added to an aliquot of the reaction mixture but 
not to the main reaction. Enzymes with recognition sites 
which include CpG present a special problem because this 
doublet may be methylated in mouse DNA and many enzymes 
cleave the methylated DNA slowly or not at all (A.Bird, 
personal communication). At least a ten-fold excess of 
these enzymes over that necessary to digestjethylated 





MRC MGU BRL 	B-M 	NEB 
AccI + . 
Aval + 
Barn HI + + 	 + 
Bgl II + . 
EcORI + . 
Hae II + . 
Hae III + + 
HhaI + . 
Hind III + + 	 + 
HpaI + . 
Hpa II + . 
KpnI . + 
MspI . . 	 . 	 + 
PstI . . 	 + 
Smal + . 
Tad I + 
TaqI + + 
XhoI . + 
Table 2.1. Sources of restriction enzymes. 
Key: !RC MGU: prepared in this laboratory by B Smith and C Graham. 
BRL: purchased from Bethesda Research Laboratories. 
B-M: purchased from Boehringer-Mannheim. 
NEB: purchased from New England Biolabs. 
5-7 
2.7.2. DNA gel electrophoresis 
For most DNA sarnplesagarose gels 3nirn thick, 9, 
18, or 36cm long and 18 or 7 cm wide were used. Gel 
and running buffer was 26mM Na2HPO4 , 3.3mM NaH2PO4 , 
1mM EDTA; running buffer was recirculated between 
cathode and anode during electrophoresis. The 
concentration of agarose varied between 0.25°/ and 2, 
and the voltage gradient between ½V/cm and WV/cm, 
depending on the expected size of the DNA fragments 
of interest. Small DNA fragments were electrophoresed 
on 0.7mm thick, 18cm long and 17cm wide 6% polyacrylarnide 
gels. Gel and running buffer was 40mM Tris-acetate pH8, 
20mM Na acetate, 1mM EDTA and the voltage gradient was 
10V/cm. 
DNA was loaded in gel buffer containing 3°/€ ficoll 
to increase the density, and orange G to provide a visible 
marker so that the rate of migration could be seen. 
2.7.3. Gel staining and hotorauh 
Gels were stained after electrophoresis by immersing, 
them for about half an hour in approximately 500m1 of 
running buffer to which 1 drop of lOmg/ml ethidum bromide 
had been added. Occasionally they were then destained 
by soaking in running buffer without ethidium bromide 
for half an hour. 
For photography gels were transferred to a black 
p3pex plate and illuminated from above with unfiltered 
rA 
ultra-violet e4tting lamps (Mineralight). These lamps 
gave excitation at 254mm and this energetic radiation 
introduced breaks into the DNA molecules, thus making 
a depurination step before transfer to nitrocellulose 
unnecessary. A red filter (Hoya) was placed over the 
camera lens and the flourescence from the DNA recorded 
on 5 inch by 4 inch FF4 film (Ilford). After exposure, 
the film was developed in D76 (Kodak) for about twice 
the recommended time (10 to 20 minutes depending on the 
state of exhaustion of the developer and the temperature), 
and fixed in Amf ix (May and Baker). 
2.7.4. Analysis of gel photograph5 
Generally, photographs were scanned using a Joyce-
Loebel microdensitometer. In one case a more detailed 
analysis of EL4 DNA was carried out by Graham Smith of 
the Royal Observatory, Edinburgh. A 2mm wide strip from 
the centre part of the photograph of each gel track was 
scanned by the densitometer COSMOS, and data was stored 
and manipulated digitally. Unit squares of 16 um 	x 
16 Am were asigned one of 256 density levels; thus 
there were 128 measurements of the density for each 
16 Am strip across the photograph. 
The mode of these densities was determined since 
a mean would have been strongly influenced by artefacts 
such as dust particles on the gel or photograph, and 
qq 
a density versus migration distance profile of the gel 
tracks was obtained - the raw data from the raw data. 
A smooth background curve was calculated to fit this 
'raw data", and was subtracted from the the raw data 
to give the "background subtracted data". These 
curves were also compared with one another by 
subtraction. 
2.7.5. Transfer to nitrocellulose 
Transfer of DNA to nitrocellulose filters was 
carried out according to the method of Southern (109). 
Nitrocellulose was from Millipore, Schleicher and Schull, 
or Sartorius. Filters were stored at room temperature 
after be king, often for many months. 
2.7.6. Preparation of radioactive orobes 
DNA was labelled with 32P by nick translation (110), 
usually using two 0j?P cjfO1'-U.Ck4.Q 	t'4f(Amersham). 
The specific activity of the 32  P labelled product obtained 
varied between 1O 7 and 3x108 dprn per ug. The most highly 
radioactive probes did not lead to the highest levels of 
hybridization, 	so a specific activity of about 10  dpm 
per ug was commonly used. Total cellular DNA for a 
"Southern cross" hybridization experiment was labelled 
by nick translation at endogenous nicks only; DNase 1 
was omitted from the reaction mixture. A fragment of 
pDHFR 21 labelled with 125i by nick translation was 
a gift from C.J.Bostock. Subfragments of pDHFR 11 
used as probes in one gene mapping experiment were 
prepared as follows. DNA was digested either with both 
Pst I and Hae III, or with Bgl II alone, ethanol 
precipitated and redissolved in distilled water. 
500ng of the mixture of restriction fragments was 
nick translated for 15 minutes, and the entire reaction 
mixture applied to the top of a 6% polyacrylamide gel. 
After electrophoresis for two hours, the wet gel was 
covered with cling film (Snappies snap-wrap), and 
autoradiographed at room temperature for 10 minutes. 
The appropriate band was excised from the gel with a 
scalpel blade, cut into small fragments, and the 
polyacrylamide-DNA mixture boiled and added to a 
hybridization mix (see section 27.7.). - 
2.7.7. Prehybridization, hybridization and washing 
of filters 
Filters were wetted in 2SC and inserted into 
cylindrical glass tubes about 25cm long and 5cm in 
diameter. Air bubbles between the filter and the 
glass were squeezed out and about 20ml of prehybridization 
4- 	,(s'c -cAq 
mix added. This was/4 to 6 X Denhard€'s solution (111). 
The tube was sealed and placed horizontally in a rotating 
aparatus in a 650C oven. After two to five hours, the 
prehybridization mix was poured out and replaced by lOml 
of hybridization mix. This was 	6 x SSC containing 
6 x Denhardt's solution, 0.5 SDS, a labelled probe, 
50 ug/ml sonicated sea urchin or E coli DNA, 50 ug/ml 
yeast RNA and sometimes 10 ug/ml poly A and 10 ug/ml poly C. 
Probe and competitor nucleic acids were boiled for five 
minutes before being added. In later experiments 10% 
dextran sulphate was included (112). Hybridization 
time in the absence of dextran sulphate was overnight 
when multiple copy genes were being sought, and over 
two nights for single copy genes. In the presence of 
dextran sulphate, a period of three to five hours 
was generally used; occasionally hybridizations were 
left overnight. 
After hybridization, filters were washed in a flat 
glass dish containing about 200m1 of solution. The 
standard conditions used for a homologous probe were 
0 	 0 0.1 x SSC, 0.1/a SDS at 52 C. For a non-homologous 
probe the SSC concentration was increased to 1 x or 3 x 
in order to retain poorly matched DNA duplexes. The 
wash mix was exchanged and the filters blotted dry each 
20 minutes until the background on the filter was 
reduced to an acceptably low level, a/i'stng a radiation 
monitor. The time required was usually one to two hours. 
2.7.8. Visualization of bands 
After washing, the filters were dried in a 650C 
oven for 10 minutes, put in X-ray film cassetes and 
covered by a layer of cling-film. A sheet of X-ray film, 
usually Fuji Rx but sometimes Kodak XR1 or XH1, was pre-
-flashed such that it would give a background optical 
density of about 0.15 after development, and put in 
contact with the cling film. Ilford fast tungstate 
WA 
intensifying screens were used. Casettes were stored 
in a -700C deep freeze for periods varying from half 
an hour to one month. Occasionally pref lashing and 
intensifying screens were omitted and exposure was at 
room temperature. Film was developed in Kodak DX-80 
for five to 20 minutes and fixed in Kodak FX-40. 
2.7.9. Estimation of DHFR gene number by blot cjuantitation 
pDHFRor pDHFR 21 was digested with Pst I and known 
amounts mixed with cellular DNA digested with Hind III. 
The mixtures were electrophoresed and transferred to 
nitrocellulose, and DHFR-containing DNA fragments were 
detected by hybridization to 32P labelled .pDHFR 11 or 
pDHFR 21 as described in sections 2.7.1. to 2.7.8. 
The hybridization was quantified in two ways. When the 
amount of hybridization was low, autoradiographs were 
scanned using a Joyce-Loebel microdensitometer. When 
the amount of hybridization was high, regions of the 
nitrocellulouse bearing bands were cut out, the 
accuracy of excision checked by autoracliography, and 
the radioactivity counted in 5m1 of toluene-based 
scintillant (5g PPO, 0.3g POPOP per litre of toluene) 
in a scintillation counter. 
The weight of hybridizing cellular DNA was determined 
by comparing the amount of radioactivity in cellular DNA 
bands with the amount in bands prodüc'ed by the known 
quantities of plasmid DNA on the same filter. The 
quantity of plasmid DNA was to be chosen such that it 
gave bands of similar intensity to the cellular DNA. 
The number of DHFR genes per haploid genome was 
calculated from the weight of cellular DNA hybridized. 
The cDNA insert sizes in the plasmids were known to be 
approximately 1600 base pairs (bp) for pDHFR 11 and 
lSOObp for pDHFR 21, and the haploid genome size of 
the mouse was assumed to be 3 x 109  bp. 
2.7.10 Estimation of DHFR gene number by spot hybridization 
DNA samples were adjusted to 60 ug/ml. 50u1 aliquots 
(3ug) were denatured by adding 5u1 of 0.5M NaOH, 1.5M NaCl, 
heated to 650C for 10 minutes and then neutralized by 
adding 5u1 of 0.5M Tris-HC1 pH 5.0, 3M NaCl. A 20 cm by 
20cm nitrocellulose sheet, ruled into 1.5cm by 1.5cm squares, 
was wetted in 2 x SSC, and a DNA sample was spotted onto 
each square. After rinsing in 2 x SSC, the filter was 
baked at 80 0C in a vacuum oven for two to five hours. 
Prehybridization, hybridization and washing were as 
described in section 2.7.6. The washed filter was dried 
and briefly autoradiographed to asess anomalous background. 
The 1.5cm by 1.5 cm squares were cut out and the radioactivity 
counted. Standards consisted of 3ug wild-type DNA mixed 
with known amounts of pDHFR 11 digested with Pst I. 
From the amount of hybridization the number of 
genes was estimated (section 2.7.9.). This method was 
only used to determine gene numbers in DNA samples from 
cells with amplified DHFR genes. The technique is similar 
to that of Kafatoand Velten et al (113)- 
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2.8. RNA PREPARATION 
Initially iwo methods of RNA preparation were 
tried. The method of Ross (103) gave RNA which was 
degraded, while the guanidine-HC1 method (115) gave 
very low yields because the guanidinium-nucleic 
acid precipitate failed to dissolve in the Na2EDTA 
at the cation exchange step
A
.ka 	tination of the 
two methods was developed. An unwashed cell pellet 
was rapidly lysed by adding 9ml 3M guanine-HC1, 
20mM Na acetate pH 5, 1mM DDT, or 8M guanine-HCI, 
20mM Na acetate pH 5, 10mM mercaptoethanol. The 
viscous mixture was layered over 2m1 5.7N CsC1, 
10mM Tris-HC1 pH 8, 1mMEDTA, and centrifuged at 
33,000 rpm overnight in an MSE 6 x 14 Ti swing out 
rotor. RNA formed a transparent pellet at the 
bottom of the tube. A similar combination of the 
two methods has been independently developed by 
Ruddle and coworkers (116). 
The RNA pellet was redisolved in lOOul 
distilled water, a one-tenth volume of 3M Na acetate, 
2mM EDTA was added and the RNA was precipitated by 
addition of two volumes of absolute ethanol. The 
precipitation step was repeated two more times, and 
the final RNA pellet was rediolved in distilled water. 
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2.9. RNA ANALYSIS 
Total cellular RNA was run on 20cm long agarose 
gels containing methyl mercuric hydroxide as a denaturing 
agent (117). The sample buffer contained 10mM NeHgOH 
and the gel 5mM MeHgOH. The agarose concentration varied 
between 0.5 and 2, and the voltage gradient was between 
2 V/cm and 5 V/cm. Ribosomal RNA species, visualized 
by staining with ethidium bromide, served as internal 
size markers. 
2.9.2.. Preparation of DBM paper and RNA transfer 
DBM paper was made by the procedure of Aiwine 
et al (118) as modified by Wahl et al (112), using 
Whatman 540 as the starting material and N-(3-
nitrobenzyloxymethy1)pyridjnium chloride from 
BDH Chemicals Ltd. (batch no. 6858662). Paper was 
stored as the NBM form and activated just before use. 
Transfer was carried out by blotting overnight at 40C. 
2.9.3. Detection of DHFR RNA species 
The procedure of Wahl et al (112) was followed. 
The probe used was 32P labelled pDHFR 21, prehybridization 
was for two hours in a rotating tube and hybridization 
was for four hours. Washing and detection of hybrids 
was as described in sections 2.6.7 and 2.6.8. 
. 10.cDNA SYNTHESIS 
cDNA was synthesized by A.T.H.Burns using a 
published protocol (119), with the following modifications. 
The template was total cellular RNA at a concentration 
of about 1mg/mi, and the RNase inhibitor was from 
Searle and was used at 182 units/ml. 
2.11 .PROTEIN ANALYSIS 
2.11.1. Preparation of protein samples 
Samples of total cellular protein were prepared for 
electrophoresis as described previously (94). Briefly, 
a washed cell pellet was resuspended in distilled water 
and taken through cycles of freezing and thawing to ensure 
complete lysis. DNase I was added and the mixture was 
incubated at 370C to degrade DNA. 
2.11.12. SDS polyacrylamide gel electrophoresis 
Gels were run according to the method of Laemrnli 
(120) using a 1 	polyacrylamide resolving gel and a 5 
polyacrylamide stacking gel. An electrophoresis apparatus 
was constructed it consisted of two 20cm by 20cm sheets 
of window gss separated by 0.7mm thick strips of plastic 
and connected to the buffer reservoirs at top and bottom. 
The plastic, purchased from a local toy shop, was a gift 
from E.N.Southern. The edges were sealed by a trace of 
vacuunigreàse (Edwards) and the apparatus was held together 
by 	foidhack 1414 clips (Myers). After the resolving 
out and equilibrated with 125mM Tris-HCl pH 6.8, 0.1.JDS, 
and then stored frozen at -20°C. Degradation was by 
Staphylococcus aureus V8 protease (Miles Laboratories) 
according to the method of Cleveland et al (122). 
Peptide fragments were separated on a 17f. SDS-polyacrylamide 
gel and visualised by staining with Coomassie blue. 
2.11.4. DHFR enzyme activity measurement 
DHFR enzyme activity was assayed spectrophotometrically 
as described previously (94). Cells were grown in medium 
lacking MTX and samples 	DHFR assay were taken every 
two to three days for two weeks. Measured activity 
increased for six to eight days and then remained 
constant in some cell lines and fell in others. If 
measured activity fell, measurements were extrapolated 
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3.1. DHFR ENZYME ACTIVITY IS HIGHER IN CRUDE EXTRACTS 
OF MTX-RESISTANT CELLS THAN IN CRUDE EXTRACTS OF 
SENSITIVE CELLS. 
The specific activity measurements of DHFR in crude 
S171j/CJ{-O 
extracts of EL4/WILD, LBI. trans/WILD,&cells are shown in 
table 3.1. No L1210/WILD cells were available for assay. 
DHFR specific activity measurements for MTX-resistant 
cells are plotted in fig.3.1. as a function of the number 
of days growth in the absence of MIX. It can be seen 
that in each case the measured DHFR activity increased 
for six to eight days as MIX was diluted out of the cells 
and fresh DHFR was synthesised. Measured activity then 
fell, at different rates in different cell lines. In 
order to estimate the activity on day 0, an extrapolation 
of the data has been made on the assumption that the amount 
of enzyme throughout the entire period decreased in an 
exponential fashion as it did after day 8, and that the 
MIX concentration was negligible after day 8. These 
estimated values, and the increase over wild-type 
specific activity, are shown in table 3.1. Also included 
in this table are the data on PG19 cells (94) and three 
other MTX-resistant EL4 cell lines (C.J.Bostock, personal 
communication). It can be seen that, in every MTX-
resistant cell line, there is an increase in DHFR specific 
activity over the parental cell line. 
In fig.3.2a. the DHFR specific activity of NTX-
resistant cells is shown as a function of the MIX concen-










PG19 0 2.8 - 
PG19 (Si) 10 4  2 100 750 
EL4 0 6.7 - 
EL4/3 2.2x10 3  38 000 5 600 
EL4/8 l.1x10 3  1 980 
EL4/11 1.1x10 3  890 
EL4/12 l.1x10 3  1 280 
LB1 trans 0 2.0 - 
LB1 trans 4.4x10 3  850 425 
L1210 1 000 unknown 
L5178Y 0 3.9 - 
L5178Y 4.4x10 3  8 000 2 050 
Table 3.1. DHFR specific activity estimates in crude extracts of 
wild-tvne and MTX-resistant cell lines. 
1the level of MTX used routinely for maintenence. 
2 i units: 1 unit oxidizes 1 ninole of NADPH/15min/mg.,t 
3ref 94. 
4CJ Bostock, personal communication. 
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Fj. 3.1. DHFR enzyme specific activity measured in crude extracts of 
MTX-resistant cells during growth in the absence of MTX. 
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Fig. 32. Comparison of DHFR enzyme activity and MTX resistance level 
in independently selected MTX-resistant cell lines. 
DHFR specific activity estimated for 'day 0' (y axis) is plotted 
against the MTX concentration (x axis). 
DHFR overproduction, the DHFR specific activity estimated in crude 
extracts of MTX-resistant cells divided by the DHFR specific activity 
measured in crude extracts of the parental cells, (y axis) is 
plotted against the MTX concentration (x axis). 
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specific activity ( relative specific activity) is shown 
as a function of the MTX concentration. There is no 
simple relationship between MTX concentration and either 
DHFR specific activity or DHFR relative specific activity. 
of the different cell lines. For a discussion, see 
section 4.2. 
3.2. MTX INHIBITION CURVES OF DHFR ACTIVITY IN WILD AND 
RESISTANT CELLS ARE SIMILAR 
DHFR activity in crude extracts of cells has been 
measured as a function of the concentration of MTX 
added to the assay mix, and fig.3.3. shows the measured 
activity expressed as a percentage of the activity 
measured in the absence of MTX and plotted against MTX 
concentration. In each case DHFR activity is inhibited 
by MTX, and the inhibition curve is similar in shape 
in wild and resistant cells. If a mutant DHFR, which 
was resistant to MTX inhibition because of decreased MTX 
binding, had been selected, the inhibition curves of 
wild and resistant cells would be different. Thus it 
seems that, in these cells, a structural alteration in the 
DHFR protein does not contribute to resistance. 
The results presented in sections 3.1. and 3.2. 
lead to the conclusion that a structurally unaltered 
DHFR has been overproduced in these MTX-resistant cell 
lines. This is tested in sections 3.3. and 3.4. by 
examining and characterizing total cellular polypeptides 
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Fig. 3.3. Inhibition of DHFR enzyme activity by MTX in vitro in 
affisigiW-U 
'crude cell extracts. In each of a - c, the concentration of MTX 
(in M) in the assay mix is shown on the x axis, and the % of the 
DHFR enzyme activity measured in the absence of MTX is shown on 
the y axis. -.---o---- = wild type, 	• = MTX-resistant. 
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3.3. SDS-POLYACRYLAMJJ)E GEL ELECTROPHORESIS OF TOTAL 
CELLULAR PROTEIN SHOWS THAT ONE POLYPEPTIDE IS OVER-
-PRODUCED IN MTX-RESISTANT CELLS. 
Washed cells have been lysed, treated with DNase I 
to degrade cellular DNA, and the proteins analysed by 
polyacrylamide gel electrophoresis. Fig.3.4. shows the 
patterns seen when successive stages c4- the PG 
1is 	PçI&g114)ttbMg aJA yAA O t.*ij.)  c* 	LCLJ 	l)t 6 
selection were analysed.] In the PG19T3:MTXR342'1° Msi 'I 
bc 
protein it is clearly visible, and it becomes more prominent 
in protein samples from cells resistant to higher levels 
of MTX until, in the PG19T3:MTXR 
 04M
SI protein, it is 
the most abundant polypeptide in the cell, and accounts 
for between 3 and 4% of the total cellular protein as 
judged by quantitation of a scan of the stained gel. This 
polypeptide migrates at a similar rate to DHFR purified 
from PG19T3:MTXR10 MS1 grown as tums (a gift from 
M.Mader and C.J.Bostock) and analysed in a parallel 
I 
track. Purified DHFR and PG19T3:MTXR' 	M51 cell 
protein were mixed, and it can be seen that the DHFR and 
overproduced polypeptide do indeed co-migrate in the 
mixture, thus providing evidence that the protein that 
is overproduced in the NTX-resistant cells is DHFR. 
Fig.3.5. shows a similar analysis of protein from 
wild-type and MTX-resistant EL4, LB1 trans, L1210 and 
L5178Y cells. In each case, an extra band is seen in 
the polypeptides from MTX-resistant cells which migrates 
at approximately the same rate as DHFR. The intensity 
of. this extra band, as a proportion of total cellular 
77 
12  
Fig. 3.4. SDS-polvacrviamide gel electronhoresis of total cellular 
nrotein from successive stages in the selection of the PG19 Si cells. 
The level of MTX used for selection is shown at the top of each 
track. The sizes of the marker proteins (in kilodaltons) are shown 
on the left-hand side. 
10 
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Fig. 3.5. SDS-tolvacrvlamide gel electrophoresis of total cellular 
protein from wild-type and NTX-resistant cells. Samples are 
identified at the top of each track ( W = wild-type, R = MTX-
resistant ). The sizes (in kilodaltons) of the marker proteins 
are shown on the left-hand side. 
protein, does not oorrelate well with the MTX resistance 
level. For example, it is only just visible in the 
4 
LB1 trans:MTXR 4 . x 
	M cell protein although these 
cells grow at the highest MTX level used, while in the 
EL4/3MTXR22X 	M cell protein, growing at half this 
MTX concentration, the polypeptide is so abundant that 
it is barely possible to visualise other cellular proteins 
without grossly overloading the gel in the DHFR region. 
Mixing experiments have shown that the migration 
rates of purified PG19 DHFR and the overproduced 
polypeptide in all except one of the resistant cell 
lines are indistinguishable. The exception is the 
-4 
polypeptide L12I0:MTXR 10  M cell protein, which migrates 
slightly, but significantly, faster than PG19 DHFR 
(fig. 3.6.) 
or  
3.4. PEPTIDE NAPPING BY PARTIAL PROLYSIS SHOWS THAT 
Ift 
THE OVERPRODUCED POLYPEPTIDE IS DHFR 
Purified PG19 DHFR has been mixed with varying 
amounts of Staphylococcus aureus V8 protease and the 
peptide fragments have been analysed by SDS polyacrylamide 
gel electrophoresis. Fig.3.7a. shows that specific 
degradation products are observed, and that 0.5 ug 
of protease generates a suitable series of 10 to 15 
bands. Fig.3.7b. shows that degradation occurs to the 
same extent when the source of the DHFR is a band 




Fig. 3.6. Demonstration of a difference in el mobility between 
L1210 DHFR anq PG19 DHFR. Total cellular protein from 
L1210:MTXR
1 0 
M cells (L1210), or DHFR purified from PG19 cells (DHFR), 
or a mixture of the two were electrophoresed in a 12% 
polyacrylamide gel containing SDS. Note that L1210 DHFR runs 
slightly faster than PG19 DHFR, and that the DHFR band appears 
as a doublet in the mixture. The sizes (in kilodaltons) of the 
marker proteins are shown on the right-hand side. 
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Fig. 3.7. Partial Droteolvsis of DHFR by Staohvlococcus aureus V8 
protease. 
About lOug of purified PG19 DHFR was mixed with the amount of 
protease shown at the top of each track and the polypeptides 
were separated byelectrophoresis in a 17% polyacrylamide gel 
containing SDS. The right-hand track shows the peptide pattern 
produced by the highest amount of protease alone. 
About lOug of purified PG19 DHFR (PG19) or a gl slice 
containing putative DHFR from EL4/3:1,ITXR22xlO  
N 
 cells (EL4) 
was mixed with 0.5ug or 5ug of protease and the polypeptides 
were separated by electrophoresis in a 17% polyacrylainide gel 
containing SDS. 
M = marker proteins with sizes (from top to bottom) 27Kd, 2lKd, 12Kd. 
-4 
The polypeptide overproduced in PG19T3:MTX 10 Msi 




	cells has been excised from a 
gel and subjected to proteolysis by 0.5 ug S. aureus 
V8 protease. It can be seen from fig 3.8a. that the 
degradation products are similar in each case. This 
shows that: 
The overproduced polypeptide is similar in amino-
acid structure in each cell line 
it is DHFR. 
It seems, therefore, that the small difference in the 
mobility of the L1210:MTXR 	MDHFR shown in fig.3.6. 
is not due to a major alteration in the amino-acid 
sequence of this DHFR. Such a mobility difference 
could possibly be caused by a single amino-acid change 
leading to the polypeptide binding a different number 
of SDS molecules, or by a difference in a post-
translational modification such as addition of 
carbohydrate residues. This matter has not been 
pursued. 
When protein from LBI trans:MTXR4'4 	
-3
° N cells 
was analysed in the same way, the degradation polypeptides 
could not be seen. It was thought that this was because 
the small amount of protein present (fig.3.5.) made 
location of the band difficult and hence excision 
of the band inaccurate. Therefore a modification of 
the method of Cleveland et al (22-) was introduced: 
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Fig. 3.8. Comparison of the structure of DHFR from different MTX-
resistant cell lines using partial proteolysis by Staphylococcus 
aureus V8 protease. 
a. A putctive DHFR band was excised from a gel similar to that shown 
in fig. 3.5. and mixed with 0.5ug protease. The polypeptides were 
separated by electrophoresis in a 17% polyacrylainide gel 
containing SDS. The sizes (in kilodaltons) of the marker proteins 
are shown on the left-hand side. 
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2nd dimension 
 
Fig. 3.8. (continued). 
b. Total cellular protein from wild-type or MTX-resistant LB1 trans 
cells was separated in the first dimension by electrophoresis in 
a 12% SDS-polyacrylamide gel, as shown in fig. 3.5. A gel strip 
was then laid along the top of a 17% SDS-polyacrylamide gel, 
Staphylococcus aureus V8 protease was added, and electrophoresis 
was carried out In the second dimension. On the right-hand side 
of each gel is shown PG19 DHFR partially digested with the same 
protease. A series of spots which are present in the resistant 
cell protein but not in the wild-type cell protein and which co- 
migrate with the major degradation products of PG19 DIIFR are arrowed. 
separated in one dimension by polyacrylamide gel 
electrophoresis, as subjected to proteolysis. 
Fig.3.8b. shows the result of such an experiment. 
A two-dimensional array of spots is generated. Most 
of the spots seen when LB1 trans:MTXR S X 	cell 
protein was analysed could also be seen when LB1 
trans/WILD protein was analysed using the same 
method. The exceptions were the series of spots 
arrowed in fig.3.8b., which were generated only from 
4 
LB1 trans:MTXR 4 
. Xi 	cell protein. These spots co- 
migrate in the second dimension with the major bands 
produced by degradation of purified PG19 DHFR. 
Therefore it can be concluded that the polypeptide 
overproduced in LB1 trans:MTXR 4 5X 	 cells is DHFR. 
Thus sections 3.3. and 3.4. confirm the results 
found in sections 3.1. and 3.2. Together they show 
that all the MTX-resistant cell lines characterized 
here overproduce DHFR, and that no extensive alteration 
of the enzyme has taken place. It seems, however, 
that factors other than overproduction of DHFR must 
be contributing to MTX resistance. While one candidate 
for such a factor is MDC transport, the subject has 
not been investigated further. The next step was to 
investigate the basis of DHFR overproduction. 
9 
3.5. INCREASED AMOUNTS OF DHFR-SPECIFIC RNA ARE 
FOUND IN MTX-RESISTANT CELLS 
DHFR-specific RNA was examined in sensitive and 
MTX-resistant cells in order to determine whether 
DHFR RNA is overproduced in the resistant cells. 
Total cellular RNA was separated according to size 
by gel electrophoresis under denaturing conditions 
and transferred to DBM paper. DHFR-specific RNA 
was detected by hybridization to 32  P labelled pDHFR 21 
and autoradiography,and fig.3.9. shosthe result. From 
fig.3.9a. it can be seen that approximately the same 
amount of RNA has been applied to each track of gel; 
despite this, hybridization is seen only to RNA from 
MTX-resistant cells in fig 3.9b., showing that DHFR RNA 
is increased in amount in these cells and therefore that 
DHRF enzyme overproduction is associated with DHFR RNA 
overproduction. 
Multiple species of RNA are visible in all resistant 
cell RNA tracks, and the species are the same size in 
each track. There are four intense bands smaller than 
18S ribosomal RNA, and two feint bands intermediate 
in size between 18S and 28S rRNA. The origin and 
biological function of these species cannot be 
determined from fig.3.9. However, work done by others 
(123); R.T.Schimke, personal communication) has shown 
that all the four smaller sized molecules can be found 
in the polyadenylated fraction of polysomal RNA from 
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Fig. 3.9. Analysis of total cellular RNA from wild-tyne and MTX-
resistant cells. 
Aliquots of total cellular RNA were separated by electrophoresis 
in a 2% agarose gel containing methyl mercuric hydroxide as a 
denaturing agent. Th gel was stained with ethidium bromide, 
illuminated with u/v lamps, and the fluorescence was photographed. 
The source of each RNA sample is shown at the top of each gel 
track ( S = sensitive, R = resistant; EL4 R cells were EL4/3. 
M = marker DNA, which was A double digested with Eco RI and Hind 
III ). Note that approximately equal amounts of RNA have been 
loaded onto each track. The proininant RNA species are, from top 
to bottom, 28S rRNA, 18S rRNA and 4S RNA. 
The RNA shown in a was transfered to DBM-paper, hybridized with 
32P-labelled pDHFR 21 and autoradiographed. Shorter exposures of 
the EL4/R track showed the band pattern seen in the other R tracks. 
of these four are active in an in vitro protein 
synthesizing system. Thus it appears that the 
multiple species of DHFR rnRNA are naturally found 
in the mouse, and are not a feature peculiar either to 
in vitro cultured tumr cells or to NTX-resistant cells. 
Since these RNA species are presumably translated in 
mouse liver, the increased amounts in the NTX-resistant 
cells are likely to be translated to give increased 
amounts of DHFR. The nature of the two larger species 
is unknown, but it is possible that they are precursor 
froms of the mature mRNA. 
Taken together, this evidence suggests that DHFR 
overproduction in the cells described here is mediated 
by increased levels of a structurally unaltered rnRNA. 
3.6. DHFR GENES HAVE BEEN AMPLIFIED IN MTX-RESISTANT CELLS 
The DHFR gene numbers in MTX-resistant cells have 
been estimated using the methods described in chapter 2. 
Fig.3.10a. shows the standard curve obtained in a 
spot hybridization experiment when nick-translated pDHFR 11 
was hybridized to EL4/ WILD DNA to which 0-2.25 ng pDHFR 11 
had been added. It can be seen that within this range 
there was a linear relationship between the amount 
of pDHFR 11 applied to the filter and the amount of 
32P-labelled pDHFR 11 which hybridized. The amount of 
hybridization observed when 3 ug of DNA from MTX-resistant 
EL4 cells was applied to the same filter fell within 
this range, and hence the amount of DNA complementary 
I I 	 I- 
2 
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ng pDHFR11 standard applied to filter 
Fie. 3.10. Exanmies of the standard curves used in the estimation of 
DHFR gene numbers. 
Spot hybridization. 0 to 2.25 ng of pDHFR 11 DNA digested with Pst I 
was mixed with 3 ug of EL4/WILD DNA, denatured, neutralized and 
otted onto a nitrocellulose filter. After hybridization with 
P-labelled pDHFR 11 and washing,the radioactivity in each spot 
was counted in a scintillation counter. The amount of pDHFR 11 
standard applied to the filter is shown on the x axis, and the 
resulting radioactivity is shown on the y axis. 
Blot guantitation. 0.18 to 1.44 ng of pDHFR 11 DNA digested with 
Pst I was mixed with cell DNA digested with Hind III, and the 
mixture was electrophoresed in an agarose gel. The DN 2was transfered 
to nitrocellulose and the filter was hybridized with P-labelled 
pDHFR 11. Bands were located by autoradiography, cut out, and the 
radioactivity in each was counted in a scintillation counter. The 
amount of pDHFR 11 standard in each band is shown on the x axis, 
and the resulting radioactivity is shown on the y axis., The '0' 
value shown in this experiment is the background radioactivity on 
a part of the filter lacking DNA. 
0 
to pDHFR 11 in the 3 ug EL4 samples could be estimated. 
These estimates, converted into estimates of the number 
of DHFR genes per 3 x 106Kb of DNA,are included in 
table 3.2. 
Fig 3.10b. shows the standard curve obtained in 
one experiment when blot quantitation was used to 
estimate DHFR gene numbers. Again it can be seen that, 
over the range used, there was a linear relationship 
between the amount of pDHFR ii applied to the filter and 
the amount of 32Plabelled pDHFR 11 which hybridized. 
Thus, again, the amount of pDHFR 11-complementary DNA 
in cellular DNA samples on the same filter could be 
estimated, and the estimates of DHFR gene numbers 
included in table 3.2. were calculated. 
While the total amount of hybridization on 
different filters varied considerably, because of 
different specific activities of the probe, different 
sizes of probe DNA fragments, and different times of 
hybridization, a linear relationship between the amount 
of plasmid DNA applied and the amount of hybridization 
was always found on a given filter. Thus pDHFR 11 
acts as an internal standard. The results from a number 
of such experiments have been combined to give the data 
in table 3.2. 
It can be seen that the estimated number of DHFR 
genes per 3 x i06 Kb of DNA varies from less than a 
to over a thousand in different MTX-resistant 





Estimated number of DHFR genes 
per 3xlO 	Kb of DNA 
 
Spot hybridization Blot quantitation 
PG19 	(Si) . 90 
EL4/3 2.2xiO 3  1 120 750 
EL4/8 1.1x10 3  1 330 690 
EL4/11 l.lx10 3  825 600 
EL4/12 1.lxlO 3  i 360 650 
LB1 trans 4.4xl0 3  150 
Li2lO 70 
L5178Y 4.4x10 3  . 200 
Table 3.2. Estimates of number of DHFR genes per 3x106 Kb of DNA 
in independently selected MTX-resistant cell lines. 
ld-type DNA is difficult to estimate precicely. Spot 
ybridization is not a suitable method to use because 
,f the wide variation between different measurements 
Df the same value (fig.3.10a.). Blot quantitation is 
more precice f 	two major reasons. Firstly blot 
quantitation concentrates the DHFR gene sequences: 
total DNA was typically spread over 15-17cm by gel 
electrophoresis while the DHFR-hybridizing bands on the 
filter were each 1-2mm in width; thus there was an 
approximately 30-50 fold enrichment of DHFR sequences 
in those regions of the filter contributing to the 
estimate of DHFR gene number. Secondly, and probably 
more importantly, the geometry of a blot enables 
hybridization to DHFR bands to be distinguished from 
background hybridization, since each band was a narrow 
rectangle while the background consisted of irregular 
spots and blotches. This meant that those filters with 
low backgrounds could be selected for estimation of DHFR 
gene number; while in a spot hybridization experiment, 
signal could not easily be distinguished from background 
and consequently experiments where the background was 
low could not be chosen. Blot quantitation shows that 
mouse liver and wild-type cell DNA preparations have about 
the same number of DHFR genes and that tht. number is 
one to two (fig. 3.11a. and fig3.12.) 
Whatever the precje number of DHFR genes in wild-
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Fig. 3.1l.a. Estimation of the number of DHFR genes in mouse liver 
and wild-type cell line DNA. bug of nuclear DNA (cell lines) or 
total cellular DNA (liver) was digested with Hind III and mixed with 
various amounts of pDHFR 21 digested with Pst I. The mixture was 
electrophoresed in a 0.75% agarose gel and DNA was transfered to 
nitrocellulose. The filter was hybridized with 32P-labelled pDHFR 21 
and autoradiographed. The autoradiograph was scanned using a Joyce-
Loebel microdensitometer and the areas of peaks were quantitated by 
cutting out and weighing the paper. The weight of paper (the signal), 
in arbitrary units, is plotted against the gene equivalents of 
standard pDHFR 21 added. In addition, the summed weights of the 
three peaks from each cellular DNA sample are indicated. 
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Fig. 3.11.b. Comparison of DHFR gene number and DHFR enzyme 
overnroduction in independently selected MTX-resistant cell 
lines. DHFR gene number estimates from blot quantitation ( • ) 
or spot hybridization ( *) experiments are taken from table 
3.2. DHFR enzyme overproduction estimates are taken from 
table 3.1. 
factor associated with DHFR enzyme overproduction. 
Fig 3.11b. shows he estimated number of DHFR genes 
per 3 x i06 Kb of DNA plotted against the degree of 
DHFR overproduction. It can be seen from the wide 
scatter of points that there is no simple relationship 
between the two, suggesting that factors other than 
gene number can influence the level of DHFR enzyme 
production. This subject is discussed further in 
section 4.3. 
3.7. DNA BLOTS SHOW THAT UNALTERED DHFR GENES ARE 
PRESENT IN MTX-RESISTANT CELL DNA, BUT ALSO REVEAL 
SEVERAL NOVEL FEATURES 
The structure of the wild-type DNA gene has been 
characteried using the Southern blotting procedure. 
The patterns of restriction fragments of wild-type 
DNA which hybridize to pDHFR 21 have been determined. 
Fig 3.12a-c. shows the results obtained from the l&)eJ bt'k 
of two inbred mouse strains, 2G19T3/WILD, LB1 trans/ WILD, 
and L5178Y/WILD cells when Barn Hi, Eco RI and Pst I were 
used. It can be seen that each enzyme produced the same 
pattern in all the DNA samples analysed, and that •in 
each case the patterns consisted of multiple bands. The 
similarity of the patterns produced in different DNA 
samples by the same enzyme shows that the structure of 
the DHFR gene is the same in each sample, at least in the 
distribution of restriction sites. The multiple bands 
observed in genomic DNA cannot be generated by 
Fig. 3.12. Analysis of the DHFR band patterns in wild-type and 
MTX-resistant cell DNA. 
Mouse liver or wild-type cell line DNA (a,b,c), or MTX-resistant 
cell line DNA (d,e,f), was digested with Barn HI (a,d), Eco RI 
(b,e) or Pst I (c,f) and electrophoresed in a 0.75% agarose gel. 
DNA was transfered to nitrocellulose and the filter was 
hybridized with 32P-labelled pDHFR 21 and autoradiographed. In 
wild-type cell DNA samples, the different intensities in different 
samples of bands of the same size Is largely due to different 
amounts of DNA. In MTX-resistant cell DNA samples, different 
autoradiographic exposures giving approximately the same band 
Intensities have been combined in the figure. 
a,d.. The highest molecular weight Barn HI band (58 Kb), visible 
in three of the MTX-resistant cell DNA samples Is believed to be 
present in all samples but is not seen in other samples because 
of the small amount of hybridization of pDHFR 21 to it and its 
susceptibility (because of its large size) to non-specific 
degradation. Two bands seen only in EL4/3 DNA samples are 
arrowed () and the positions of some feint bands which appear 
in suitable exposures of all tracks (see figs. 3.15. and 3.16.) 
are marked (c) 
b,e. The positions of feint bands which appear in suitable 
exposures of all tracks are marked (p.). 
c,f. A band seen only in EL4/3 DNA is arrowed (p.). Some very 
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cleavage within the sequences represented in mRNA since 
the cDNA lacks sites for the three restriction enzymes 
used. Two explanations for the multiple bands can be 
suggested. The mouse could have several different, but 
cross-reacting, DHFR genes; alternatively there could 
be a single gene interrupted by introns which contain 
the restriction sites detected. Since subfragmentS of 
pDHFR ii hybridize to different fragments of gnomic DNA 
(section 3.10.) showing that no genomic fragment contains 
the entire coding sequence, the latter is likely to be 
the correct explanation. 
The structure of the DHFR gene in DNA from NTX-
resistant cells has been characterised in the same wa y, 
and the results are shown in fig.3.12d-f. It can be seen 
that all the bands visible in wild-type DNA are also visible 
here. In addition, other bands can be seen. These can 
be divided into two categories on the basis of their 
distribution between different DNA samples: 
Extra bands which are seen in suitable exposures of 
all NTX-resistant cell lines, 
Extra bands which are seen only in a single cell line. 
EL4/3:MTXR22X1O -3 
 N 
S the only cell line shown in 
fig.3.12. which has category 2 bands. They are indicated 
by solid arrows. 
Category 1 bands are thought to be of two types: 
I.A.-Bands which are thought to be present in wild- 
types as well as all MTX-resistant cell DNA samples 
but which, because of technical limitations of 
sensitivity, can only be seen when multiple copies 
of DHFR gene are present. Bands containing only 
sequences complementary to the 5' end of the 
DHFR mRNA fall into this subcategory; they are 
difficult to detect because the probes used lack 
subsequences from this region (section2.6.1.) 
and so only a small amount of hybridization 
resulting in feint bands is possible. 
I.B. Bands which are thought to be generated by endogenous 
DNase cleavage at hypersensitive sites within the 
DHFR chromatin. Category 2 bands are thought to 
result from DNA rearrangement. The evidence on 
which these categories are based is given in sections 
3.9. and 3.10. Before considering it, however, 
another phenomenon revealed by DNA blots will be 
presented. 
3.8. THE DHFR GENE IS EXTENSIVELY METHYLATED AT CpG SEQUENCES 
It was found that many of the restriction enzymes 
used to digest cellular DNA did not produce a pattern 
of discrete bands as expected, but, even after complete 
digestion as judged by cleavage of internalXDNA samples,, 
produced a smear which must be comprised of many different 
fragment sizes that are not resolved by the gel. Examples 
of such patterns are shown in fig.3.13. The enzymes Sma I 
and Ava I have been used and it can be seen that the 
overall patterns produced in both sensitive and resistant 
DNA are similar, although close inspection reveals many 
too 
SENSITIVE RESISTANT 
Aval 	 Smal 
Fig 3.13. Analysis of DHFR 
	s in sensitive and MTX-resistant cell 
DNA cleaved with Ava I or Sma I. DNA was digested to completion with 
the methyl-sensitive enzymes Ava I or Sma I and electrophoresed In a 
0.75% agarose gel. After transfer to nitrocellulose, the filters were 
hybridized with 32P-labelled pDHFR 21 and autoradiographed. Note that 
in every case a smear of hybridization is seen extending from the top 
of the gel downwards, and in some cases a few discrete bands are 
superimposed upon It. The DNA samples are identified at the top of 
each track. 
(ol 
minor differences. 	Table 3.3. lists the enzymes which 
have been found to produce such patterns. Several 
explanations for these patterns can be suggested. 
Digestion may be inhibited or absent because of 
unsuitable conditions in the digestion mix or a 
poor enzyme preparation. 
Cleavage sites in the DNA may be absent or blocked. 
There may be extensive DNA sequence heterogeneity 
within a cell or between the cells in the population., 
so that even complete cleavage would not produce 
a simple pattern of discrete bands. 
Explanation 1 can be eliminated because XDNA was used 
as an internal standard in these reactions and was found 
to be adequately digested. Explanation 3 can also be 
eliminated btcause, as shown in section 3.7., the DHFR 
gene structure revealed by other restriction enzymes is 
homogeneous (MTX-resistant EL4 cells form a partial 
exception: see section 3.10.). Explanation 2 is 
therefore the most likely. Since the size of the DHFR 
gene is large (123,124), it is expected on the basis of 
chance that many sites for most of the enzymes listed in 
table 3.3. will occur. Also, since part of the cDNA 
sequence is known (123), the presence of some sites can 
be predicted. However, it is possible that sites for 
infrequently-cutting sites such as Tac I are absent. If 
sites are present but blocked, DNA modification is likely 
to be the reason. The major form of modification of DNA 
found in mouse cells is methylation of C residues in 
Cç11 









Ava I CPyCGPuG ± + 
HaeII PuGCGCPy + + 
HhaI GCGC + + 
Hpa II CCGG + + 
Sal I GTCGAC . + 
Sma I CCCGGG + + 
Tad I CGCG . + 
Table 3.3. Restriction enzymes which fail to generate discrete 
bands after complete digestion of DNA samples and visualization 
of the DHFR gene sequences. 
Key: + = a smear generated, comparable to those seen in fig. 
3.13. 
= not determined. 
tos 
CpG doublets in their recognition sequence. Some have been 
shown to be incapable of cleavage when their sites are 
methylated; for others there has been no formal demonstration 
of methyl-sensitivity, but the possibility exists. 
In one case it has been possible to distinguish 
experimentally between the absence of sites and the 
presence of methylated sites. The patterns produced by 
cleavage at CCGG sites by the isoschizomers Msp I and 
Hpa II have been compared. Msp I cleaves both CCGG and 
C5mCGG (125); Hpa II cleaves only CCGG (126). Fig 3.14. 
shows that-many CCGG sites are in fact present in the 
vicinity of the DHFR gene. It should be noted that 
the Msp I patterns themselves differ in the different 
cell lines and are also more complex than those shown in 
fig.312. This could be due to a small but variable amount 
of methylation in the first C of the CCGG recognition 
sequences Msp I cannot cleave the sequence 5mCCGG (127). 
Such methylation is rare but not unknown in mammals (127). 
It can be seen from fig. s 3.13. and 3.14. that 
although there is not extensive cleavage of the DHFR gene 
by methyl-sensitive enzymes, feint bands can be detected 
(arrows). Each band must be produced by cleavage at a 
pair of sites in or near the DHFR gene. Endogenous 
DNase activity could contribute to this pattern to the 
extent of cleaving at one or the other end of the 
fragment (see next section), but cannot be the sole cause 
by cleaving at both ends, because different patterns are 
seen when the same DNA preparation is analysed using 
104 
Wild - type 
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Fig. 3.14. Comparison of DHFR gene sequences after digestion 
with either Msp I or Hpa II. DNA samples, identified at the top 
of each track, were digested to completion with either Msp I or 
lipa II, as indicated. DNA was electrophoresed in a 0.75% agarose 
gel (wild-type samples) or a 1% agarose gel (MTX-resistant 
samples) and transfered to nitrocellulose. The filters were then 
hybridized with 32P-labelled pDHFR 21 and autoradiographed. The 
different amounts of hybridization to different wild-type DNA 
samples are due to different amounts of DNA loaded onto the gel. 
I OS 
different restriction enzymes, and no bands are seen 
when no restricticin enzyme is used. Therefore there 
must be sites which are unmethylated in a proportion 
of the DNA molecules. 
3 9. SITES HYPERSENSITIVE TO CLEAVAGE BY ENDOGENOUS DNASE 
ARE FCUND WITHIN AND NEAR THE DHFR GENE. 
The feint bands common to all or most NTX-resistant 
cell DNA samples seen in 3.12d-f. must represent sequences 
which have been amplified in the NTX-resistant cells, 
since such bands are not seen in wild-type DNA samples. 
They have been detected using pDHFR 21, and could therefore 
be sequences homologous to any 	portion of the probes 
pBR322, the G-C linkers, or the DHFR cDNA insert. These 
possibilities have been distinguished by using as a sub-
-probe the DHFR cDNA insert + linkers excised from the 
complete plasmid by Pst I digestion and purified by gel 
electrophoresis, and by carrying out the hybridization 
in the presence of a vast excess of poly C. Fig 3.15. 
shows that thQ, hybridization patterns obtained under these 
conditions are similar to those obtained using complete 
pDHFR 21 as probe. Therefore all Of these bands contain 
sequences complementary to the DHFR portion of the probe. 
The experiment shown in fig. 3.15.a. was designed to 
investigate the degree of homology between these feint 
bands and DHFR. Two extremes are possiblet that the bands 
have a high degree of homology to DHFR but are present in 
only a few copies per haploid genome, or that they have a 
4 
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Fig. 3.15. Analysis of the multiple feint bands in MTX-resistant cell 
DNA which hybridize with PDHFR 21. 
EL4/3:MTX22XIO M cell DNA was digested with Barn HI and 
electrophoresed in a 1% agarose gel. After transfer to nitrocellulose 
and hybridization with the Pst I-excised DHFR eDNA insert from 
pDHFR 21 labelled with 125  by nick-translation, strips of filter 
were washed at 65°C in the concentration of SSC shown at the top of 
each track. On the left-hand side of the figure are shown part of 
the ethidiuin bomide-stained gel and the marker DNA  
PG19T3:1,ITXR
1 0 M Si DNA (PG19) or EL4/3:MTXR22'1 
0 M DNA (EL4/3) 
were digested with Barn HI from Boehringer-Mannheim (Boe) or Bethesda 
Research Laboratories (BRL) using either a 2-fold excess of enzyme 
(x2) or a 6-fold excess of enzyme (x6). Fragments were electrophoresed 
in a 1% agarose gel and transfered to nitrocellulose. The filter was 
hybridized with the '251-labelled Pst I-excised DHFR cDNA insert 
from pDHFR 21 and autoradiographed. Note that essentially the same 
minor bands can be seen in each EL4/3 track. 
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low degree of homology but are present in many copies per 
haploid genome. To distinguish between these possibilities, 
hybrids formed 1tween genomtc DNA bound to the nitrocellulose 
and the pDHFR 21 insert in solution were washed under 
different conditions of stringency. If the feint bands 
represent homologous hybrids, they should show the same 
proportional decrease in intensity as the authentic DHFR 
bands when stringency is increased. If they represent 
heterologous hybrids, they should show a larger proportional 
decrease in intensity when stringency is increased. So far 
as can be determined from fig. 3.15.a., both the authentic 
DHFR bands and the extra feint bands show the same 
proportional changes in intensity. To this conclusion must 
be added the proviso that the blackening of the X-ray film 
may not be directly proportional to radioactivity over 
such a large range of intensities. However, the most 
important observation is that the intensity of these feint 
bands is not enormously greater in strips of filter which 
have been washed in 1 x SSC than in strips given the 
standard wash of 0.1 x SSC. If the feint bands represented 
multiple copies of a sequence with a small degree of 
homology with DHFR they should be proportionally more 
intense after a lower stringency wash. Thus the feint bands 
appear to be genuine DHFR sequences. 
Fig. 3.15.b. shows an investigation of the possibility 
that the feint bands are an artefact generated by incomplete 
specificity of the restriction enzyme preparation. Such 
decreased specificity could arise in two ways. A Barn 
IM 
HI activity could be present, analagous to the Eco RI* 
activity observed under suitable salt conditions, where 
the specificity of Eco RI cleavage decreases from GAATTC 
to NAATTN. Alternatively it could be that Bacillus 
arnyloliguefaciens H contains other, previously undetected, 
restriction enzymes: a hypothetical Barn Hil. A small 
amount of either contaminating activity could produce a 
series of minor bands such as those observed. If such 
contaminating activity is responsible for the feint bands 
then it should be manifested on overdigestion. Increasing 
digestion beyond that necessary to cleave at all Barn HI 
sites should not alter the Barn HI pattern, but it should 
increase the amount of any contaminating cleavage. Fig. 
3.15b. shows that overdigestion does not lead to an increase 
in the intensity of the feint bands. Therefore they are 
not artefacts generated by additional restriction enzyme 
cleavage within the DHFR bands. 
It therefore appears that the amplified DHFR genes 
in MTX-resistant cell DNA are present in the restriction 
fragments characteristic of wild-type cells, but also in 
an additional heterogeneous set of fragments. The true 
origin of these heterogeneous feint bands became clear 
when endogenous DNase activity in the NTX-resistant cell 
i nuclei was examined. Isolated nuclei from PG19T3s NTXR'o4  M Si 
cells were incubated at 37°C in 10mM Tris-HC1 pH 7.4, 
10mM NaCl, 3mM MgCl2 for varying times before DNA was 
prepared and digested with Barn HI. The patterns of fragments 
in total DNA and those containing DHFR genes in these 
samples are shown in fig.3.16. It can be seen from fig. 
3.16a. that the state of overall DNA degradation in these 
nuclei is small; hardly any difference can be detected 
between the size distribution of total DNA visualised by 
staining with ethidium bromide in the '0 mm' and '30 mm' 
samples. In contrast fig.3.16b. shows that considerable 
degradation of the DHFR gene has occurred in this time. 
Of the three bands represented in undegraded DNA, the 
largest is undetectable in DNA after 30 minutes incubation 
at 370C and the smaller two have decreased considerably 
in intensity. In addition, hybridization is seen to 
several discrete bands of new sizes and,there is an increase 
in overall background in the track. The most prominent 
new bands form two clusters at about 8.5Kb and 7Kb; each 
cluster can be seen to be made up of at least three bands 
of similar size. Discrete bands are not seen when no 
restriction enzyme is used; therefore each of the fragments 
in these new bands must be bounded at one end by a Barn HI 
site and at the other by a DNase site. 
Overexposure of the autoradiograph ( fig.3.16c.) 
shows that the new bands seen clearly in the 30 minute 
lane in fig.3.16b. can just be detected in the 0 minute 
lane in fig.3.16c. It therefore appears that, even in 
a DNA preparation fron nuclei which have not been incubated 
under conditions in which endogenous nucleases might be 
activated, a small amount of degradation has occurred, 
which results in the appearance of additional bands 
upon subsequent digestion with restriction endonucleases. 
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Fig. 3.16. Origin of the heterogeneous feint DHFR bands in MTX-resistant 
PG19T3:MTXR
10 
Si cell nuclei were incubated at 37°C in 10 mM 
Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl  for the times shown ( in 
minutes ) at the top of each track. DNA was prepared, digested with 
Barn HI, and electrophoresed in a 0.75% agarose gel. 
The gel was stained with ethidium bromide, illuminated with u/v 
lamps, and the fluorescence was photographed. 
DNA was transfered to nitrocellulose, the filter was hybridized 
with 32P-labelled pDHFR 21,and autoradiographed for about 14 hours. 
The same filter was autoradiographed for about 150 hours. 
(U 
A comparison of fig. 3.16. with fig.3.12d. shows that 
the bands generated by nuclease cleavage at such sites 
in chromatin accounts for some of the aberant new bands 
which are seen in resistant cell DNA. Other bands, 
however, cannot have arisen by such cleavage. It can 
be seen in fig.3.16b. that DNase degradation of the 
highest molecular weight Barn HI band (measured as 58Kb 
on other gels) never produces another high molecular 
2.2x10- ) weight band (about 33Kb) as seen in the EL4/3:MTXR'" x u M 
DNA track in fig.3.12d., either when about half the 58Kb 
band is degraded (10 minutes incubation) or when essentially 
all of it is degraded (30 minutes incubation). Similarly, 
DNase degradation for any length of time does not generate 
a prominent band at about 13Kb; a band of this size and 
almost equal in intensity to the 17Kb band common to all 
cell lines can be seen in the EL4/3:NTXR 2.2x10-  M DNA 
track in fig.3.12d. 
Thus, in addition to the new bands generated by 
endogenous DNase cleavage, there appears to be another 
class of extra band, for which the 33Kb and 13Kb Barn HI 
-3 
bands in EL4/3:MTXR2'20 N DNA are the prototypes. 
This class is distinguished from the DNase generated 
bands by some or all of the following characteristics. 
Bands do not increase in intensity when nuclei are 
incubated at 370C before DNA is isolated. 
Bands are unique to a cell line; whereas the 
DNase generated bands can be seen in suitable 
exposures of all cell lines. 
3. 	Bands are, when some restriction enzymes are used, 
larger than other DHFR hybridizing bands; DNase 
degradation must necessarily produce smaller bands. 
..10. EXTENSIVE DNA REARRANGEMENT HAS OCCURRED NEAR THE 
ENDS OF SOME OF THE DHFR GENES IN THREE OUT OF FOUR 
MTX-RESISTANT EL4 CELL LINES 
Category 2 bands can be seen in EL4/3:MTXR22X -3  M
DNA digested with Barn HI, with Pst I, and possibly with 
Eco RI (fig 3.12d-f). In the last case the band is feint 
and is situated close to an intense band, but is 
reproducibly present in replicate digests of the same or 
independent DNA preparations from this cell line. In 
addition, new bands can be seen in Hind III and Acc I 
digests (fig.3.17.) A single base change is sufficient 
to create or destroy a restriction enzyme site, but the 
finding of new restriction fragments with several enzymes 
would, if they were all generated by single base changes, 
imply a very high frequency of point mutation in this cell 
line. A more likely explanation is that DNA rearrangement 
has led to the replacement of a stretch of wild-type DNA, 
containing the restriction sites observed in EL4/WILD 
digests and most NTX-resistant cell lines, with a new 
stretch of DNA containing the new restriction sites seen 
only in EL4/3:MTXR2I2X1O_ 
3M 
 DNA. Such a rearrangement 
must affect only a proportion of the DHFR genes in the 
cell, or only a proportion of the cells in the population, 





Fig. 3.17. Analysis of the DHFR band pattern in EL4/3 cells usin 
Hind III and Ac I. DNA from EL4/3:MTXR 	
M  cells or from 
PG19T3:MTXR10 M81 cells (representing the wild-type pattern) was 
digested with the enzyme shown at the top of the track, electrophoresed 
in a 0.75% agarose gel and transfered to nitrocellulose. The filter 
was hybridized with pDHFR 21 and autoradiographed. Bands seen in 
EL4/3 DNA but not in PG19 or any other sample are arrowed. 
Itt 
any new bands. 
Fig.3.18. shows the patterns of DHFR-containing 
2 
fragments in EL4/3IMTXR'' 
X 	DNA digested with Hae T1 
and Taq I, and compared with the wild-type pattern which 
is represented here by PG19T3 MTXR 	DNA. The patterns 
seen seen in the two cell lines are identical. This 
shows that the DNA rearrangement which has given rise 
to the new restriction fragments seen in figs. 3.12 and 
3.17. can be separated from the sequences detected by 
hybridization with pDHFR 21 detects only the exon sequences 
of the DHFR gene; therefore the rearrangement has occurred 
outside the exon regions and is either in the introns or 
in the sequences which flank the DHFR gene. 
In order to investigate whether DNA rearrangement 
is a common feature of MTX-resistant EL4 cell lines, or 
is peculiar to EL4/3 cells, DNA from three independently 
selected MTX-resistant EL4 lines has been examined and 
the results shown in figs.3.19. and 3.20. In fig.319. 
it can be seen that one novel band is visible in each of 
the Eco RI digests of DNA from EL4/8:MTX l.lxlu H cells 
and EL4/11:MTX 1.1x1O 	cells. These novel bands are R 	
. 	xl 3  M analogous to the EL4/3:MTXR 
	cell extra bands 
in that new bands are detected with more than one enzyme 
(fig.3.20.), suggesting that DNA rearrangement, rather than 
point mutation, is the cause, and in that only a proportion 
of the DHFR genes in each cell line have been affected. 
The DNA rearrangement is different in each of the three 
cell lines. The fourth of these MTX-resistant cell lines, 
1(5 
EL4/12:MTXR1 .1x1O3M shows only the wild-type DHFR gene 
1 .1x1O 3M pattern with all enzymes tested. In EL4/8:MTXR 
DNA double-digested with both Eco RI and Barn HI, the 
extra band is different in size to those seen in* either of 
the Eco RI or Barn HI single digests of this DNA, thus showing 
that, at least in this cell line, the same region of 
rearranged DNA is being detected by both enzymes. 
The rearranged DNA has been localised to subregions 
of the DHFR gene by using fragments of pDHFR 11 as probes 
(fig.3.20.). A Pst I-Hae III fragment from the 5' end of 




DNA. A Bgl II fragment from the 3' end 
of the gene detects extra fragments in Barn HI digests of 
EL4/3:NTXR2S 2X1OM DNA,... EL4/8:MDc151X13M DNA and 
EL4/11:MTX 1.1x10 N DNA, and extra fragments in Eco RI 
digests of EL4/8ZMTXRI1x10 NDNA  and EL4/11:MTXRllX10 MDNA. 
These two subprobes together account for all the extra 
bands seen in fig.3.20. when complete pDHFR 21 was used 
as probe; no additional-bands were seen when Rae III 
fragments from the middle of pDHFR 11 were used (results 
3 
not shown). The feint Eco RI band in the EL4/3:MTXR S X 	DNA 
was not detected in this experiment. Thus DNA rearrangement 
in these three EL4 cell lines is located near the ends 
of the DHFR gene. From the results shown in fig.3.20. 
it is not possible to determine whether the rearrangement 
has occurred in the introns nearest to the 5' or 3' ends, 
or in the sequences which flank the gene. 
tI'4 
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Fig. 3.18. Analysis of the DHFR band pattern in EL4/3 cells using 
Hae III and Tag I. A procedure identical to that described in the 
legend to fig. 3.17. was followed, except that a 1% agarose gel 
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Fig. 3.19. Analysis of the DHFR band patterns in EL4 cell DNA. 
DNA samples were digested with Eco RI and fractionated in a 0.75% 
agarose gel. DNA was transfered to nitrocellulose, the filter was 
hybridized with pDHFR 11 in the presence of 10% dextran sulphate, 
and autoradiographed for lhr or 50hrs as indicated. Open arrows () 
mark the positions of bands thought to be generated by cleavage at 
hypersensitive sites in chromatin by an endogenous DNase and present 
in all samples. Closed arrows () indicate the positions of bands 
thought to result from DNA rearrangement and unique to a sample. 
M. 
Fig. 3.20. Mapping of the DHFR restriction fragments in EL4 cells. 
Partial restriction map of pDHFR 11 drawn using data in ref I&S 
The thick line represents part of the pBR322 plasmid vector, the 
open bar represents the coding portion of the DHFR cDNA and the 
thin line represents the 5' and 3' non-coding portions of the cDNA. 
Location of the Pst I - Hae III fragment used to p±obe the 5' 
end of the gene and the Bgl II fragment used to probe the 3' end 
of the gene. 
DNA samples were digested with restriction enzymes as indicated, 
electrophoresed in a 1% agarose gel and transfered to nitrocellulose. 
The filter was hybridized with the 32P-labelled probe shown in 
part B and autoradiographed. Open arrows (c) indicate bands thought 
to be generated by cleavage at hypersensitive sites in chromatin 
by an endogenous DNase. Closed arrows () indicate bands thought 
to result from DNA rearrangement. The DNA samples are identified 
as follows: 
PG19 = PG19T3:MTXR M 
3 	= EL4/3:MTXR  
8 	= EL4/8:MTXX10 M 
11 	= EL4/ll:MTXlX101 
12 	= EL4/12:Xl0 M 
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DISCUSSION PART I 
L2i 
4.  1. SCOPE OF THIS DISCUSSION 
In chapter 3 it was found that the MTX-resistant cell 
lines characterized showed considerable overproduction of 
DHFR enzyme, and that the basis for this overproduction was 
the increase in DHFR RNA associated with DHFR gene arnjlification. 
However, the numerology was not straightforward; that is, 
a cell line which was 1000-fold resistant to MTX did not 
show 1000-fold overproduction of DHFR enzyme and 1000-fold 
amplification of the DHFR gene. A discussion of possible 
reasons for the more complex relationships which were 
observed forms the first half of this chapter. The second 
half is devoted to a discussion of the DNA rearrangement 
which has accompanied DHFR gene amplification in some EL4 
cell lines. Specifically omitted from this chapter, however, 
is a general discussion of the amplification process; this 
can be found in chapter 6. 
4.2. MTX RESISTANCE LEVEL AND DHFR 	OVERPRODUCTION 
The results shown in fig.3.2. indicate that there is 
not a simple linear relationship between MTX resistance 
level and DHFR overproduction. The factors which might be 
expected to influence the relationship fall into several 
categories. There are, in addition to DHFR overproduction, 
other mechanisms by which cells become resistant to MTX. 
These were described in section 1.4. and their possible 
occurrence in the cell lines characterized in chapter 3 
will be discussed at the end of this section. However, 
even if alterations in MTX transport and changes in 
DHFR structure have not contributed to NTX resistance in 
IhL 
these cells, there are additiorreasons for expectijig a ,  
non-linear relationship between MTX resistance level and 
DHFR overproduction. 
It is important to distinguish between comparisons of 
absolute values for different MTX resistant cell lines 
and comparisons of resistant cells relative to their 
sensitive counterparts; that is, between the absolute 
DHFR specific activity and MTX concentration, and the 
relative DHFR overproduction and increase u& 
MTX resistance. Absolute DHFR specific activities have been 
listed in table 3.1. It can be seen that 
there is considerable variation between the specific 
activities measured in different wild-type cell lines. This 
variation could reflect either different numbers of DHFR 
molecules per cell, or different amounts of total protein 
per cell, or both. The cell lines have been derived from 
different tissues in different mouse strains. It is not 
known whether one DHFR gene always produces the same number 
of DHFR molecules, or whether expression depends on the 
environment. In the former case, variation in expression 
of other genes, leading to different amounts of protein 
per cell, would be the explanation for the variation in 
specific activity; in the latter case, variation in DHFR 
gene expressionwould also contribute. "Induction" of 
human DHFR has been reported (81,82), but it is not known 
whether a similar phenomenon occurs in the mouse. 
ITt 
DHFR specific activities for MTX-resistant cell 
lines are listed in table 3.1. Because instability in 
some cell lines makes extrapolation of the data back to day 
o necessary, there may be considerable errors in these 
estimates. The increase in DHFR specific activity (DHFR 
overproduction) has been calculated by dividing the specific 
activity estimated in resistant cell extracts by the specific 
activity measured in wild-type cell extracts. Therefore it 
does not necessarily reflect the increase in the cells' 
capacity to produce DHFR, since it do$ not allow for any 
increase which might occur on "induction" of wild-type cells. 
In order to obtain a true measure of the increase in the 
cells' capacity to produce DHFR, the DHFR activity of 
resistant cells grown in that concentration of MTX which 
cjzL& 	i. __ cdQ 	 ttk c1-& 1*Rt 	 4 	Wk%C_ 	4- - ('z:;L !ç&PJ 
just does not inhibit their growth.k It is impossible to 
obtain these measurëments.because.DHFR activity must be 
measured in eells which have been grown in the absence of 
MTX; nevertheless, it is a limitation on the interpretation 
of DHFR overproduction estimates. 
The absolute MTX concentrations in which the MTX-
resistant cell lines are routinely grown are shown in table 
3.1. The degree of MIX resistance is assessed by comparing 
the concentrations of MTX which halve the cloning efficiencies 
(relative to those in non-selective medium) of resistant 
and sensitive cells. It is this measurement of resistance 
which should be compared with the increase in the cells' 
DHFR activity. Data on the plating efficiency of sensitive 
and resistant PG19 cells in medium containing MTX is 
available (94) but measurements for the other cell lines 
have not been mad. In the case of the PG19 cells, an 
approximately 30,000-fold increase in MTX resistance was 
accompanied by an approximately 1,000-fold increase in 
DHFR specific activity. When the DHFR specific activity 
measured at successive stages in the selection was 
compared with the MTX concentration in the selective 
medium, a relationship of the form 
DHFR specific activity or, 4T 	0.65 
was found. The fact that this relationship was observed 
at all stages in selection suggested that no change in the 
mechanism of resistance had occurred during selection. 
Several explanations for the fact that the exponent is less 
that one are possible: more than one MTX molecule may be 
necessary to inhibit DHFR in vivo (cf in vitro), or the 
MTX concentration inside the cell may be less than the 
concentration outside because of decreased influx or 
increased efflux, or the concentration of DHF may have 
increased, thus competing more effectively with the MTX. 
For the other cell lines, where the increase in MTX 
resistance over wild-type is unknown, the most meaningful 
comparison which can be made is that of the absolute DHFR 
specific activity with the absolute MTX concentration 
(fig.3.2a.). Since these are not related in a simple 
fashion, factors other than DHFR activity, such as alterations 
in MTX transport or DHFR structure (see chapter 1),  must 
be important in determining resistance. No DHFR protein 
with altered structure and MTX-binding properties has been 
"is 
reported from mouse cells (sectionl.4.). While it is 
-4 
possible that L1210:MTXR 	N cell DHFR characterized 
here (sections 3.3. and 3.4.) may represent the first 
example of such an alteration, this could not be 
confirmed by comparing MIX inhibition of DHFR in vitro 
in extracts of sensitive and resistant L1210 cells since 
no sensitive L1210 cells were available for study. No 
differences in the DHFR characteristics studied were 
found in the other NTX-resistant cell lines. 
If the DHFR enzyme properties are the same in 
sensitive and resistant cells, it is likely that the 
differences in NIX transport between different NIX- 
resistant cell lines contribute to the scatter of points 
seen in fig.3.2a. In one case it has been shown by Courtenay 
and Robbins (75) that the L5178Y:MTX 
I 	
N cell line, 
from which the L5178Y: NTXR • X 	 cell line was derived, 
has reduced MIX uptake. In other cases this has not been 
demonstrated. However, in particular, the low DHFR specific 
bF Lva f1.J 
activity and high NIX resistance leve1 suggests that these 
cells have reduced transport. 
It is instructive to compare the results reported here 
with those in the literature. Some examples of the relationship 
between NTX resistance level and DHFR specific activity have 
been given in chapter 1. In addition, the results of Biedler, 
Spengler and co-workers on anti-folate resistant Chinese 
hamster cells (68-71) have been collected and displayed 
in a form similar to fig 3.2a. in a more recent publication. (1 
They have included data on 22 resistant cell lines derived 
lu 
from a single starting line, 20 of which were selected 
independently. There is such a wide scatter of points 
in their fig 1 that no clear relationship between NTX 
resistance level and DHFR activity can be seen, although 
Biedler et al discern three groups of points, of which 
one has an increase in MTX resistance relative to DHFR 
overproduction of 1.6;a second, a relative increase of 
about 46, and a third a relative increase of about 520. 
The molecular basis for these classes is unknown, but 
the wide scatter of points suggests that the kind of 
variation illustrated in fig.3.2a. will generally be 
found when different MTX-resistant cell lines are 
compared. 
4.3. DHFR ENZYME OVERPRODUCTION AND DHFR GENE AMPLIFICATION 
Fig.3.(L shows a plot of DHFR enzyme overproduction 
against estimated DHFR gene number per 3 x 10  Kb of DNA. 
For some cell lines, two estimates of gene number have 
been included; that obtained by spot hybridization, and 
that obtained by blot quantitation. It can be seen that 
in each case the two estimates for the same cell line are 
different, and that blot quantitation always gives the 
lower figure. 
The first question to be considered in this section 
is therefore why the two estimates should differ. The 
answer is likely to be that the two methods measure 
different things: spot hybridization measures the total 
amount of DNA which cross-hybridizes with the probe, whereas 
blot quantitation measures only that proportion of the 
total hybridization which is contributed by specific 
restriction fragments. Part of the difference between 
the estimates can be accounted for by the imprecision 
inherent in the techniques, but part is likely to be real. 
Cross-hybridization of the probe to non-DHFR sequences 
could contribute to spot hybridization estimates: for 
example, mouse satellite DNA cross-reacts with pDHFR 21 
to a very small extent (Noel Ellis, personal communication). 
However, the most important factor is probably cleavage 
of the DHFR gene by endogenous DNase (section3.9.). This 
would lead to loss of hybridization from the specific bands 
and to an increase in the background in the remainder 
of the gel track. This would not be included in blot 
hybridization, but would contribute to estimates based on 
spot hybridization. what is the reason for this DNase 
cleavage? 
It is known that NIX resistance in some cell lines is 
unstable (75, 129), such that, after growth in the absence 
of MDC, cells can no longer survive in the original MTX 
concentration, By this criterion, some of the cell lines 
characterized here are highly unstable (see chapter 5). 
In addition, during growth under selective conditions, 
cells which have lost the ability to exclude vital stains 
are readily detected in these lines. It would seem that, 
even under constant selection, cells which have lost the 
ability to grow in MIX are continually being generated. 
DNA degradation will eventually occur in such cells. 
Living and dead cells are not readily separated from 
each other in the suspensions of EL4 cells, so that 
when DNA is prepared from the population it is found 
to consist of an intact fraction derived from living 
cells and a degraded fraction from dead and dying 
cells. 
Some support for this hypothesis comes from a 
comparison of the different MIX-resistant EL4 cell 
lines. Resistance in EL4/11:MTXR 	
x cells  i  
stable as judged by DHFR enzyme activity measurements 
(C.J.Bostock, personal communication) and estimation 
,-L cø-L 	.9rLJi 	dQJ rt- 	iZ 
of DHFR gene number (section5.5.while resistance 
in the other three EL4 lines is unstable as judged 
by the same criteria (C.J.Bostock and section 5.5.). 
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The two estimates of gene number for the EL4/11:M' 	
. x v N 
cells differ by only a few per cent, a difference which 
can be accounted for by technical limitations on accuracy. 
In contrast, the estimates for the other three lines 
differ by two- to three-fold, which is significantly 
more than the error in these measurements. 
Which of the two measurements more accurately 
reflects the number of DHFR genes? For a cell line 
in which resistance is stable, it does not matter, 
because they are essentially the same. For an unstable 
cell line, blot quantitation estimates the number of 
intact and therefore potentially functional, DHFR genes. 
However, in blot quantitation experiments, only the total 
amount of DNA is known, and not that proportion of the 
t2 
DNA which gives rise to intact gene bands. Therefore 
blot quantitatioñ will tend to underestimate the number 
of DHFR genes, while spot hybridization will give a 
better estimate of the total number. The two estimates 
will be useful for different purposes. 
Using such estirnates,it is now possible to turn 
to a discussion of the relationship between DHFR gene 
number and DHFR enzyme overproduction, as shown in 
fig.3.11 	It can be seen that there is no simple 
linear relationship between the two measurements. 
In general, the cell lines in which MTX resistance 
is unstable (EL4/3, 8, 12) have the highest numbers 
of DHFR genes. A possible reason for this is that 
in these cells many of the DHFR genes may not be 
located in the nucleus and may therefore bp transcribed, 
or the RNA processed or exported, at a lower rate than 
the nuclear genes, although there is no direct evidence 
for such differential expression. The evidence that 
some DHFR genes are extra-nuclear is indirect and 
depends on interpretation of the following cytological 
data. In the unstable cell lines, many micronuclei 
can readily be observed in interphase cells (C.J.Bostock, 
personal communication). These are thought to arise 
from chromatin fragments which lack functioning 
centromeres and therefore do not segregate normally 
and equally at mitosis. When the nuclear membrane 
reforms at the end of telophase, some of these fragments 
can be left in the cytoplasm and give rise to the 
LIM 
micronuclei during interphase. Evidence that some 
DHFR genes are associated with such chromosomes i 
presented in section 5.5. However, nothing is known 
about gene expression in such micronuclei (and see 
the discussion on DHFR gene activity below). 
A second factor which might account for the very 
high number of DHFR genes found in the NTX-resistant 
EL4 cell lines is that the DNA rearrangement observed 
in three of the cell lines near the DHFR gene has led 
to the formation of a non-functional DHFR gene, or 
one with a lower rate of transcription. These rearranged 
genes will contribute to estimates of gene number, but 
may not contribute to DHFR enzyme activity. However, the 
high number of DHFR genes in EL4/12:MD(R11X1O 3M cells, 
which do not have detectabl rearranged DNA near the 
DHFR gene but are unstably resistant,.- and the lower 
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number of DHFR genes in the EL4/11:NTXR 1.1x10 N cells 
which do have rearranged DNA but are stably resistant, 
suggests that stability ip the mote important factor in 
producing NTX resistance. The high number of genes 
asociated with unstably resistant cells may arise 
in the following way. If DHFR genes segregate unequally, 
then one daughter cell will tend to have more genes 
than the number required for survival in a given NTX 
concentration, and the other daughter cell will tend 
to have less. Any cell with too few genes will be 
killed, and consequently there will tend to be an 
excess of genes in the population. 
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Even amongst the non-EL4 cell lines, however, 
the relationship between DHFR gene number and DHFR 
enzyme overproduction is not simple. One-complication 
arises because estimates of the DHFR gene number have 
been calculated using a nominal haploid genome size 
of 3 x 10  Kb. The real amount of DNA per cell may 
not be 6 x 10  Kb, and may differ in different cell 
lines because of aneuploidy and amplification of a 
different sized unit. Thus, the estimated number of 
DHFR genes may not be the true number, Also, in these 
cell lines additional factors such as the rate of 
transcription, or the rnRNA stability or rate of 
translation, or enzyme stability, may be different. 
While some Pvidence suggests that sequences in the 
amplified unit differ from cell line to cell line 
(section 5.2.) and therefore could produce different 
rates of transcription, nothing is known about the 
other factors. 
DHFR gene numbers have only been estimated for 
a few other cell lines, and published data are summarised 
in table 4.1. It can be seen that, while in some 
of these cell lines there is a one-to-one correlation 
between DHFR overproduction and increase in DHFR gene 
number, in others, as in the cell lines described 
in this thesis, there is not such a simple relationship. 
Strictly, there is no evidence from any cell line 
described here or elsewhere that more than one DHFR 
gene per cell is active. DHFR overproduction could 






Mouse S-180 200 200 87 
180 250 236 
L1210 45 35 87 
L5178Y "several 100" 300 140 
400 350-400 236 
3T6-R1 35 33 237 
3T6-R2 100 100 237 
3T6 75 50-100 236 
Hamster BHK 200 140 236 
CHO 160 150 236 
DC-3F/MQ19 120 150 238 
DC-35/A3 53 170 238 
DC-35/MQ20 20 49 238 
A3-P-U 7 18 238 
Table 4.1. Published reports of DHFR gene number and correspondi 
DHFR enzyme overproduction in MTX-resistant cell lines. 
be due to an increased rate of expression of a single 
gene in the resistant cell, rather than expression of many 
genes at the wild-type rate. The amplified copies of the 
DHFR gene which are associated with overproduction could 
mediate the increase in DHFR synthesis by increasing the 
rate of expression of the one gene, for example, by binding 
a (hypothetical) DHFR gene repressor molecule. 
Two measureable properties of DNA sequences, which 
have been widely studied in the hope of elucidating gene 
expression, are methylation and DNase sensitivity. Such 
work on gene expression in mammals has concentrated exclu- 
-sively on the few developmentally regulated genes which 
code for major cell proteins and for which nucleuc acid 
probes have been available. The relevance of results 
obtained in such systems to the expression of a "housekeeping" 
gene such as DHFR is questionable. Despite this reservation 
it can be asked whether the results described in sections, 
3.8. and 3,9. throw any light upon DHFR gene activity. In 
general, a correlation has been found between demethylation 
and transcription or transcribability. This has been 
established for f3-type globin genes in rabbit (130), 
chicken (131) and man (132), and for ovalbumin, conal- 
-bumin and ovmucoid genes in the chicken (133,134,). In 
all cases only a proportion of the 5mC residues in the 
region of the gene become deméthylated when the gene is 
activated, and often dernethylation at an affected site is 
only partial. Thus, although the DHFR genes in both 
MTX-resistant and wild-type cells are extensively methylated 
it is possible that this observation does not conflict 
with the established dogma that active genes are 
demethylated. Firstly, only some of the CpG sequences 
have been examined - those which occur in the restriction 
sites of the enzymes used - and these may not be the ones 
important for expression; secondly, some demethylated sites 
were found, and it is possible that this small observed 
degree of dernethylation, or that which may exist in the 
sites not examined, may be sufficient for transcription. 
A second kind of correlation has been found in 
several systems: that between the DNase I sensitivity of 
a gene and its transcribability (135,134). DNase sensitivity 
in this sense has not been examined in the DHFR gene. 
The phenomenon discovered here, hypersensitivity to 
cleavage by an endogenous DNase, is analagous rather to 
DNase I hypersensitivity. DNase hypersensitivity was 
first found near the heat-shock genes of Drosophil a 
melanogester (136, 137, 138) and has since been observed 
near chicken conalburnin (134) and chicken globin (139) 
genes. While the early evidence from the heat-shock genes 
of the fly seemed to show a correlation between the presence 
of the hypersensitive sites and inactivity, and between 
their disappearance and activation (137) 9 the site which 
was found about 1 Kb downstream from the 3' end of the 
chicken conalbumir4ene was present whether the gene was 
active or not (134), and different hypersensitive sites 
were found near chicken 	globin genes in different 
states of activity in embryos and adults (139). Thus the 
relationship of such sites to gene expression is at 
present unclear. The molecular basis for these sites is 
also unclear. They could be due to peculiarities of the 
DNA structure, such as a particular sequence or a single-
stranded nick, or they could be due to the presence of 
specific protein species or configurations in the 
chromatin. These possibilities can be distinguished 
experimentally, but no results from such experiments have 
yet been published. 
In conclusion, it can be said that while the DHFR 
gene appears to have some properties of inactive genes - 
extensive methylation and DNase hypersensitivity - too 
little is known at present about gene expression to decide 
whether or not most of the amplified DHFR genes are 
expressed. 
4.4. DNA REARRANGEMENT NEAR THE DHFR GENE 
It was shown in section 3.10. that DNA rearrangement 
had taken place in three out of four MTX-resistant EL4 
cell lines, and that this rearrangement was located 
near the ends of the genes either in the 5' and 3'-most 
introns or in the sequences which flank the gene. This 
result was striking because none of the other MTX-resistant 
cell lines described in section 3 or by others (123) 
showed evidence of DHFR gene rearrangement, although there 
was some ambiguity over the size and position of Barn HI 
fragments in MTX-resistant S-.180 cells (123, see note added 
in proof). Thus DNA rearrangement in the vicinity of the 
0' 
DHFR gene does not appear to be a general feature of 
gene amplification. 
It was not known at which stage in the selection 
of the EL4 cells the rearrangement took place. Cells 
resistant to intermediate levels of MTX were not frozen 
down, and so this question could not be investigated 
experimentally by examining DNA from such cells. 
However,analysis of DNA from the final stage of resistance 
shows that the amount of hy bridization to the rearranged 
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fragments is relatively high: ilk EL4/8:NTx . x 	M cells 
it is about 33% of the hybridization to the wild-type 
sized DNA fragment in these cells which hybridizes 
to the same subportion of the probe; in EL4/11:MTXR . x 
cells the corresponding figure is about 23.This indicates 
that there are multiple copies of the rearranged fragment, 
suggesting that rearrangement occurred at an early stage in 
selection and that the rearranged DNA was subsequently 
amplified. It is therefore pertinent to ask whether the 
rearrangements occurred as a direct consequence of gene 
amplification, or whether three out of four cells in the 
original EL4/WILD population had one of a variety of DNA 
rearrangements near the DHFR gene before HTX selection was 
applied. While these two possibilities have not been distin-
guished in a direct way by examining cloned EL4/WILD cells 
which have not been selected for MDC resistance, two factors 
favour the former possibility. Firstly, although the EL4/WILD 
cell population used has not, so far as is known, been 
cloned since its origin in a C57Black mouse in 1945 (96), 
the structure of the DHFR gene visualized on a Southern blot 
is identical to that seen in C57Black liver DNA ( fig. 3.12. 
a-c. ). If extensive DNA rearrangements had occurred in the 
EL4/WILD population, it would be expected to produce a more 
complex pattern in EL4/WILD DNA than in C57Black liver DNA. 
Secondly, extensive rearrangement has occurred in other 
amplified DNA in MTh-resistant EL4 cells, but no rearrangement 
in sequences which are not amplified in these cells has been 
found ( chapter 5 ). 
Gene amplification of a unique sequence involving a 
unit of less than a whole chromosome, even in the simplest 
models imaginable, necessarily involves some DNA rearrangement 
of the kind that could be visualized on a Southern blot as 
the change in size of a restriction fragment detected with 
a suitable probes for example, multiplication of an intact 
block of chromosome either as an episome or as part of a 
chromosome would produce changes in the restriction fragments 
derived from sequences at either end of the amplified unit. 
None of the MTh-resistant cells described here ( or elsewhere ) 
contains hundreds of extra copies of a whole chromosome 
( section 5.1.). Thus it might seem that the a priori problem 
is to explain why DNA rearrangement is not observed in most 
cell lines, rather than why it is observed in some EL4 cell 
lines. However, when it has been possible to estimate the 
size of the amplified unit, this has been found to be in 
the range 500-3000 Kb (140,141,92) in contrast, the 
sequences detected by a DHFR cDNA probe have been estimated 
to be spread over 42 Kb (123) or, more recently, 32 Kb (124) 
in the genome. Thus it has been thought that the block of 
DHFR sequences is located away from the ends of the amplified 
unit and therefore remains unchanged during the amplification 
process. This suggests one possible explanation for the 
rearrangement observed in the EL4 cellsz that an 
amplification unit with one end very close to the DHFR gene 
has been chosen. This explanation cannot be conclusively 
ruled out for the EL4/8iMTX 1.1x10 3M cells or for the 
EL4/1IsMTX 1.1x10 	cells, but it can be excluded for the 
EL4/3sMTXR22XlO- 
3M 
 cells and thus appears unlikely for any 
of the EL4 cells. The EL4/3ZMTXR •2 
X0 cells have DNA 
rearrangements near both 5' and 3' ends of the gene, yet the 
size of the amplified unit is far larger than the 30 or 40 
Kb which separates these ( section 5.3.). Therefore DNA 
rearrangement must have occurred within the amplified unit. 
During the last few years, many examples of DNA 
rearrangement have been detected in eukaryotic cells. These 
will be divided here into two categoriess sequence-specific 
rearrangements, which involve specific DNA sequences and 
which may occur at a defined stage in development or 
seemingly at random times; and sequence non-specific 
rearrangements, which appear to involve any sequence that 
is in the right place at the right time. The best-character-
ized types of rearrangement fall into the first category, 
and include imrnunoglobulin genes, trypanosome surface antigen 
genes, copia-like sequences in Drosophila, and transposons 
and mating-type bet in yeast. The second category consists 
of those rearrangements which accompany DNA integration in 
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DNA-mediated gene transfer experiments. Each of these examples 
will be discussed briefly. 
Mouse immunoglobulin gene rearrangement. At least two 
kinds of DNA rearrangement are involved in immunoglobulin 
gene expression, and have been characterized in the mouse. 
One is the assembly of active or abortive light chain and 
heavy chain genes. In the case of the light chain gene, the 
active configuration is produced by somatic recombination 
between the 3' end of one of several hundred V   regions and 
the 5' end of one of 5 or so J L  regions on the same chromosome, 
probably with deletion of the DNA between these sites (142). 
Assembly of an active heavy chain gene is a similar kind of 
process except that there is an additional D region between 
the V   and J H  regions (143). A short conserved sequence is 
found at the joining regions and may be involved in the 
recombination (143). Although in some of the myelomas studied 
only one of the chromosomes has undergone rearrangement and 
the other retains the germ-line configuration, in about 
half of the tumours both chromosomes have undergone 
rearrangement. In these cells the second rearrangement is 
abortive: that is, it does not lead to the production of a 
second functional immunoglobulin. There are multiple ways in 
which this has happened: recombination can occur in such a 
way as to produce an out-of-phase reading frame in the J 
region (144), or may lead to joining of the V region with a 
pseudo-J sequence situated between the J and C regions,thus 
deleting the J region (145). Other forms of abortive 
recombination may be found. Thus it appears that the mechanism 
(4.0 
of ,recombination must allow considerable flexibility of 
joining points. 
The second kind of rearrangement involved in imrnuno-
globulin gene expression is the heavy chain class switch. The 
assembled VHDJH  region is expressed at one stage of 
development with a CHP  region to produce an 1gM molecule but 
at a later stage with a CHY  region to produce IgG, and may be 
followed by a CHO  or  CRC  to produce IgA or IgE. The mechanism 
proposed for such a switch again involves site-specific 
recombination between homologous sequences on different parts 
of the same chromosome with deletion of the DNA region in 
between (146). 
Immunoglobulin gene expression has also been detected 
in T cells: Vcontaining receptors have been found on the 
cell surface although CH  regions and light chains are 
probably not expressed as proteins (147). Nevertheless, 
rearrangement of CHI  region gene sequences has been detected 
in T cell lymphomas (148,149) and may be associated with 
transcription but not translation of these regions. If so, 
the kind of rearrangement must differ from those found in B 
cells since only the heavy-chain gene is involved. 
Trypanosome coat protein gene rearrangement. Information 
on Trypanosoma brucei surface antigen gene rearrangement is 
more limited. Two groups have carried out the experiment of 
hybridizing a eDNA clone of the surface antigen to a Southern 
blot of genomic DNA from several strains of trypanosomes 
(150,151). Both groups found evidence for DNA rearrangement; 
in one case rearrangement of the cloned sequence only in the 
trypanosome strain which was expressing that sequence (151), 
while in the other case rearrangement of the sequence 
investigated had occurred in all strains, whether or not they 
were expressing it (150). The first-mentioned result fits 
better with current ideas about expression in this system 
(152), but the discrepency remains to be resolved and details 
of the rearrangement are unknown. 
Transposable mating type loci in yeast. Two loci in 
Saccharomyces cerevisiae, HML and HMR, contain silent copies 
of the mating type gene, each of which can be either a or Q. 
Expression of the mating type gene occurrs at a third locus, 
MAT, and the expression has been shown to be associated with 
transposition of DNA from HML or HMR to MAT (153,154). The 
mechanism of transposition leaves an unaltered a or ci gene 
at the HML or HMR locus while changing the mating type gene 
at MAT. It does not appear to involve generation of an 
extrachromosomal copy of a or a , but the details of the 
process are unknown. 
Transposable elements in Drosophila. Families of 
repeated sequences thought to be capable of transposition 
have been known in Drosophila melanogaster.f or several years 
and three such families, copia, 412 and 297 have been studied 
in some detail (155-158). Evidence that these sequences are 
mobile is that in different fly strains (156) or cultured 
cell lines (157) different numbers of the sequences are found 
In different sized restriction fragments on Southern blots, 
or at different sites in polytene chromosomes; it is not 
thought that DNA rearrangement is linked with the normal 
developmental processes as in the examples described above. 
Other evidence is consistent with mobility: members of a 
family are highly conserved but the different families are 
different. Detailed structural analysis has been carried out 
on copia. It is about 5 Kb long and contains perfect direct 
terminal repeats of 267 bp (158); at the end of this direct 
repeat a short imperfect inverted repeat is found. There are 
differences of one or two bp between the direct terminal 
repeats of different members of the copia family. At supposed 
sites of integration into the Drosophila genome a duplication 
of a 5 bp sequence present once in the target DNA has been 
founds this sequence is different at different integration 
sites (159). It has been suggested that the identity of the 
terminal repeats of a single copia element, contrasting with 
the difference found between elements, arises because 
transposition carries the information for only one of the 
repeats, and an excision-replication model has been proposed 
(158). 
Transposition elements in yeast. The Tyl element in 
Saccharomyces cerevisiae is present in about 35 copies per 
haploid genome, hybridizes to different sized restriction 
fragments in different strains, and has been found to 
hybridize to a new fragment in two out of five subclones of 
a yeast clone maintained independently for 30 days (160)s 
it is therefore mobile. It is about 5.6 Kb long and is flanked 
by 334 bp direct repeats called ô. Insertion of Tyl is 
associated with duplication of a 5 bp sequence present once 
before insertion (161,162); excision commonly leaves one 
copy of 8 at the integration site, and may therefore occur 
1+3 
by homologous recombination (161,162). At least 30 copies 
per haploid genome of solo 8 are found (160). The similarity 
with copia-like elements in Drosophila is striking; one 
bMMMMMMMM 
difference is the presence of solo 8 elements in yeast. 
DNA rearrangement following DNA-mediated gene transfer. 
Although attempts to transfer genes to mammalian cells 
using purified DNA as a donor have been made for many years, 
it was only with the introduetion of the system using Herpes 
Simplex Virus thymidine kinase (HSV-TK) gene as donor, mouse 
LMTK cells as recipient, and HAT medium as the selective 
agent (163,164) that unequivocal success was obtained and it 
became possible to study the molecular events accompanying 
gene transfer. It was found that the donor DNA becomes 
integrated into high molecular weight cellular DNA in 
successful transformants (165,166), and more recently it has 
been shown by chromosome-mediated gene transfer experiments 
(167) and in situ hybridization (168) that there is a single 
major site of integration of donor DNA into a recipient cell 
chromosome. The aspect which is significant to the work 
described in this thesis is that integration, which must 
involve DNA rearrangement, is non-specific with respect both 
to the site in the donor DNA and the site in the recipient 
chromosome. Furthermore, DNA present in the gene transfer 
mixture other than the HSV-TK.gene, such as the bacteriophage 
Øx174 or the plasmid pBR322, is also incorporated into the 
+ TK mouse cell DNA (166). Again, integration is not site- 
specific and the number of copies of the sequence which are 
incorporated can vary from one to several hundred in 
independently arising transformants (166). Two lines of 
evidence suggest that such non-selected DNA is integrated 
into the same region as the TK gene in a particular cell line. 
Firstly, when selection for the loss of the TK gene is applied, 
part or all of the co-transfered DNA is also lost (168). 
Secondly, in situ hybridization to Buffalo Rat liver cell 
line chromosomes from cells which have incorporated both the 
HSV-TK gene and a plasmid containing the human growth hormone 
gene shows hybridization to the same chromosomal region 
whether the TK gene or the human growth hormone gene is used 
as a probe ( J Jackson, personal communication ). Thus the 
scheme that emerges for the gene transfer process is that a 
cell takes up many foreign DNA molecules in a non-specific 
fashion. These may then be partially degraded and the ends 
ligated together, or ligation at internal sites may occur. 
In either case, the result is the assembly of a large unit 
of foreign DNA which can be hundreds if not thousands of Kb 
long. Subsequently the unit may be integrated into a recipient 
cell chromosome. Thus the outcome is extensive and sequence 
non-specific DNA rearrangement. 
Returning now to the DNA rearrangements which have 
occurred in the EL4 cells, it can be asked whether the 
examples listed throw any light on this process. Transposons 
of the Tyl or copia type have not been identified in 
vertebrates, although the proviral forms of some of the 
retroviruses show similarities of structure (169). If the 
observed changes in restriction fragment size in the EL4 
cells were due to the precise excision of a hypothetical 
transposon situated near the DHFR gene in the EL4/WILD cells, 
it would be expected that the new DNA fragment would be the 
same size in each case. All three rearrangements were found 
to be different in size. The same objection can be raised to 
rearrangement by the insertion of a transposon at a precise 
site. Also, the probability of three detectable insertion 
events near the 3' end of the gene and none in the middle is 
small if insertion is random. But perhaps the strongest 
objection to the involvement of a transposon is that the 
rearrangements occurred at an early stage in amplification 
and have since remained stable: if transposition were frequent 
enough in the early stages to generate observable changes in 
three out of four cell lines, it should also occur at later 
stages and give rise to far more complex patterns of DHFR 
gene restriction fragments than were observed. This will be 
called the 'rearrangement switch-off' problem. 
The DNA rearrangement involved in the yeast mating type 
switch is specific to this systems mating in mice is by a 
sexual process. DNA rearrangement in trypanosomes is too 
poorly characterized to serve as a useful model. Immunoglob-
ulin gene rearrangement, however, may be relevant. EL4 cells 
are T-cell derived ( section 2.2.4.). It is possible that 
the machinery for DNA rearrangement, which is switched on at 
some stage in normal T-cell development, remains active in 
the tumour cells in culture and can involve the DHFR gene. 
Too little is known about DNA rearrangement in T cells to 
decide whether this is a likely possibility. It is of interest 
that, in the case of myeloma lines, there is some evidence 
t4- 
that immunoglobulin gene rearrangement continues in the tumour 
cells. When B cells were isolated from blood by staining for 
Ig and selecting positive cells with a fluorescence activated 
cell sorter, it was found that the cell population retained 
an average of about one gene per diploid genome in the germ-
line configuration (170): therefore in most cells rearrangement 
of immunoglobulin genes can have occurred only on one 
chromosome per cell. However, of thirty myelorna lines 
examined in one study, about half had rearrangements on both 
chromosomes (171). Thus immunoglobulin type gene rearrange-
ment might be involved in DHFR gene amplification in the EL4 
cells. However, the rearrangement switch-off problem also 
arises here if such a mechanism is invoked. A further point 
is that the two MIX-resistant B cell lines studied show no 
evidence of DNA rearrangement near the DHFR gene, nor do MIX-
resistant L1210 and L5178Y cells examined by others (123). 
This could reflect a difference between B and I cells, or 
could be a matter of chance: five lymphoma lines is not a 
large sample. 
The second kind of process which might be involved is 
sequence non-specific DNA rearrangement. Such rearrangement 
clearly can occur to any DNA which has been introduced into 
cultured mouse cells. Whether it can also occur in the 
absence of DNA-mediated gene transfer, or whether gene 
transfer is involved in DHFR gene amplification, is unknown. 
If this kind of process has taken place, it might be expected 
that DNA rearrangement would have involved other sequences, 
and it is not clear why detectable rearrangement near the 
to 
DHFR gene should be restricted to the MIX-resistant EL4 cell 
lines. These questions lead to a general discussion of the 
amplification process and are pursued in chapter 6. 
4.5. CONCLUSIONS. 
The conclusion from sections 4.2. and 4.3. is that it 
Is very easy to suggest factors which may explain the 
complicated relationships between DHFR gene number, DHFR 
enzyme overproduction and MIX resistance level. A study 
aimed at elucidating the details of MIX resistance or DHFR 
gene expression should investigate these factors in detail. 
This thesis, however, is aimed at studying gene amplification. 
From this point of view, the important finding is that DHFR 
gene amplification has occurred in the MIX-resistant cell 
lines under investigation. Also important is the observation 
that the structure of the DHFR gene is similar to wild-type 
in most resistant lines, but that DNA rearrangement has 
accompanied amplification in a few lines. 
CHAPTER 5 












Fig. 5.1. Analysis of total nuclear DNA from wild-type and successive 
stages in selection of MTX-resistant PG19 cells. DNA samples were 
digested with Eco RI and electrophoresed in a 0.75% agarose gel. The 
gel was stained with ethidium bromide, illuminated with u/v lamps, 
and the fluorescence was photographed. M, the marker track, is a mixture 
of whole X DNA and a double digest of X DNA with Eco RI and Hind III; 
some feint bands are partial digestion products. 
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to this rule is the band marked A in the figure. In the 
DNA from cells resistant to 10- 
3 
 N and 3x10 4N MTX it is 
similar ri iintensity to the band in the same track marked 
B, while in the DNA from cells resistant to 10 4M MTX it 
is very much feinter than the band B in this track. 
Another exception is the very high molecular weight DNA 
at the top of the gel (marked C'); in this case, however, 
the apparent differences in intensity are probably due to 
artefactual differences in the size of the original DNA 
preparation and the amount of nonspecific DNA degradation 
during Eco RI digestion. These exceptions do not alter 
the general conclusion from fig.5.1., which is that DNA 
sequences, which are amplified in MTX-resistant cells, 
can be detected in total nuclear DNA, and that these 
sequences increase in amount but do not change much in 
structure during amplification. Comparable sequences 
have therefore been looked for in other MTX-resistant 
cell lines. 
5.2.2. A comparison of amplified DNA bands in independently-
selected cell lines 
Fig 5.2.a. shows at- comparison of PG19T3/WILD DNA with 
PG19T3:MTX 	Si DNA and PG19T3:MTXR 0 S2 DNA; fig. 
5.2b. shows a comparison of EL4/WILD DNA with DNA from the 
four resistant EL4 lines, and fig.5.2c. shows a comparison 
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Fig. 5.2. Analysis of total nuclear DNA from wild-type and MTX-resistant 
PG19 DNA samples were digested with Eco RI and electrophoresed in a 
0.75% agarose gel. 
EL4 DNA samples were digested with Eco RI and electrophoresed in a 
0.75% agarose gel. 
C. LB1 trans DNA samples were digested with Barn HI and electrophoresed 
in a 1% agarose gel. 
All gels were stained with ethidium bromide illuminated with u/v lamps, 
and the fluorescence was photographed. 
in PG19T3:MTXR1 	H S2 DNA but others are different. All 
four MTX-resistant EL4 cell lines show many clear new bands 
and again each cell line has a characteristic pattern. No 
-3 
new bands can be seen in the LBI. trans:MTXR 
• X 	
DNA, 
either in fig.5.2c. or on the original negative. A visual 
examination of the different patterns of extra bands 
suggests that each pattern is unique in that it shows both 
the presence of endemic bands (ie. ones found only in that 
cell line) and a characterjsjtc distribution of relative 
intensity among those bands which are common to several 
cell lines. Indeed, with such complex patterns, comigration 
in a one-dimensional DNA gel is not good evidence that two 
bands in different cell lines contain the'same sequence, 
because bands of similar size are expected to occur by 
chance alone. 
The band patterns from EL4 cells have been analysed 
in more detail. 	In this experiment Barn HI digests were 
used, and only the central portion of each gel track was 
analysed. 	This limitation was applied because the background 
subtraction method employed only separated background from 
signal if the signal was more variable than the background; 
such was not the case at the top and bottom of the gel 
track. 	The results are shown in figs.5.3. to 5.7. 	In 
each of figs.5.3, to 5.6., part A shows a photograph of 
the appropriate part of the gel track, part B shows the 
COSMOS scan of it, part C shows the calculated background 
and part D shows the total scan after background has been 
subtracted from it. 	Thus each peak in part D represents a 
band in the DNA, displayed with the continuum of unresolved 
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Fig. 5.3. Analysis of Barn HI digest of EL4/WILD DNA. 
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Fig. 5.5. Analysis of Barn HI digest of EL4/8:XR''° M DNA. 
(59 
5.3. to 5.6. Legend. 
Nuclear DNA was digested with Barn HI and electrophoresed in a 1% 
agarose gel. The gel was stained with ethidium bromide, illuminated 
with u/v lamps, and the fluorescence was photographed. The portion 
of the gel track analysed in detail is shown; the top and bottom 
are omitted. The numbers above A are the approximate sizes of the 
DNA molecules in Kb. 
COSMOS scan of the negative from which A was prepared: the 'raw data'. 
Calculated background to B. 
C subtracted from B: the 'baäkgrourid subtracted data'. 
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Fig. 5.7. Analysis of the amplified DNA in Barn HI digests of MTX-
resistant EL4 cell nuclear DNA. 
A.- C. Subtraction of the EL4/WILD peaks (fig. 5.3.D.) from the MTX-
resistant EL4 peaks (figs. 5.4.D., 5.5.D. and 5.6.D.) to show the 
amplified DNA patters. 
EL4/3:MTXR22''° M - EL4/WILD. 
EL4/8:MTXR''° 
M - EL4/WILD. 
1. lxlO 3M EL4/12:MTX. 	 - EL4/WILD. 
D.- E. Comparison of the amplified DNA pat erns. 
EL4/8:MTX1lXlOM EL4/3:MTXR22xlO M 
EL4/8:MTXRL lxlO 3M EL4/l2:L  lxlOM 
seen (fig.5.3.d.) corresponding to repeated sequences in 
the normal mouse genome. In each of the DNA samples from 
MTX-resistant cells, these two peaks can be seen, but in 
addition, many new peaks corresponding to amplified 
sequences are visible (figs. 5.4.D., 5.5.D., 5.6.D.). 
Thus the techniquedeveloped here allows a clearer view 
of the amplified DNA sequences than can be obtained from 
looking at the gel photograph alone. 
It does more than this, however; it enables extensive 
manipulation of the data to be carried out. This has 
been done in two stages. First, the EL4/WILD peaks have 
been subtracted from each of the MTX-resistant DNA patterns 
and the results displayed in fig 5.7., A to C. Secondly, 
these resulting patterns, each of which represents only 
amplified DNA, have been compared with one another, This 
. xl u M has been done by subtracting from the EL4i8:MTX i.i  
pattern either the EL4/3:MTX 2.2x10 M pattern or the 
EL4/12:MTXR
1 '1X10- 3   M pattern. The results are shown in 
fig.5.7.D. and E. In each case, the observation that there 
are both positive and negative peaks in the difference 
pattern shows that the two DNA samples compared each 
have sequences that the other lacks; and the lack of 	* 
similarity between the two difference patterns indicates 
that all three DNA samples differ. This analysis therefore 
confirms and extends the conclusion reached from visual 
inspection of the gel patterns: that different sequences 
have been amplified in each cell. 
h 
5.2.3. A comparison of amplified DNA bands in clones of 
the MTX-resistant cell populations 
With the exeption of the PG19T3:MTXR 	N Si cell 
DNA, all of the DNA samples used in subsections 5.3.1 and 
5.3.2. were derived from cell populations which had not 
been cloned since the initial selection stage. It is 
therefore unclear to what extent the complex patterns 
found reflect heterogeneity between cells in the populations 
or between amplified units within a cell, and to what extent 
they reflect the array of sequences found within a large 
amplification unit. 
Attempts to clone the MTX-resistant EL4 cells were 
unsuccessful, using either soft agar or a, microwell plate. 
It seems that their plating efficiency at low density is 
extremely low. However, the NTX-resistant PG19 cells 
have been successfully cloned, and fig.5.8. shows Eco RI 
digests of DNA from some of the resulting clones. In fig.5.8a. 
two separate clones resistant to 10N MDC which were derived 
from the PG19T3:NTX 3x10 
R 	N51 population are compared, and 
in fig.5.8b. four subclones of one of these, PG19T3:NTXR 
Si clone 15, are compared. It can be seen that the patterns 
of amplified DNA bands are very similar in all clones, and 
any slight differences are no more than would be expected 
Rc g3Ae db&e. Rj 	. sus &o a(-t - P'314 
from different preparations offG19T3:MTXR 	2 DNA 
made from the uncloned population. The first preparation 
was made as soon as about 10 cells resistant to 10 3M MTX 
had been obtained; the second was made after the population 
had been growing continuously under selection for about six 
weeks (30 to 40 generations). Fig 5.8c. also shows three 
separate clones of populatioru clones 4,7 and 8. 
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Fig. 5.8. Analysis of total nuclear DNA from cloned MTX-resistant 
PG19 cells. All DNA samples were digested with Eco RI and electrophoresed 
in a 0.75% agarose gel. The gels were stained with ethidium bromide, 
illuminated with u/v lamps, and the fluorescence was photographed. 
Clones of PG19 Si cells resstant to 10 4M MTX. 
Subclones of PG19T3:MTXR1
0 
M51 clone 15. 	
3 
Two different preparations of DNA from the PG19T3:MTX'° M52 
population and three cloned derivatives of this cell line. 
The patterns of amplified DNA bands in all five DNA samples 
are very similar. Thus the results in fig.5.8. show that 
most, if not all, cells in the population contain the 
same amplified DNA sequences. 
Fig 5.8. does not, however, indicate whether there 
is any heterogeneity between amplified units within a cell. 
It is difficult to think of an experiment in which this 
problem could be investigated. Nevertheless, purely by 
chance, a biological system arose which made it possible 
to characterize the DNA of what is probably a single 
amplified unit. Over a period of about two weeks during 
the summer of 1980, it was observed that in one subculture 
-3 
of EL4/8MTXR lxlO M cells maintained in 1.1 x 10 3M MTX, 
cells containing the dms and ring chromosomes described 
in section 5.1. were replaced by cells lacking these 
features but containing three new marker chromosomes. 
Examination of chromosome preparations made during this 
period suggested that the new roJ-kQf chromosomes had 
the following origin (C.J.Bostock, personal communication). 
A dm, possibly a submicroscopic ring itself, gave rise to 
a microscopically discernible acentric ring which, probably 
by crossing over an odd number of times, increased in size. 
Very large ring chromosomes generated in this way were 
unstable and broke to form linear chromosome fragments, 
and one such fragment gained a centromere. The cells 
possessing the resulting centric chromosome had a selective 
advantage over other cells in the population because they 
carried the amplified copies of the DHFR gene essential 
for survival in a stable form, whereas the other cells 
carried the DHFR gene in an unstable form (section5.5.). 
These cells outgrew the rest of the population, and came 
to replace them entirely. If this interpretation of events 
is correct, the process led to the DNA from a single dm 
becoming the major form of amplified DNA in the population. 
Thus a comparison of the amplified DNA in the cells 
containing dms with that in the cells containing the 
centriqciiarker chromosomes will allow the sequences in the 
population of aruiplified units to be compared with the 
sequences in a single dm, and hence probably those in a 
single (or at the most a few) amplified unit(s). Fig.5.9a. 
shows such a comparisons the sequences are very similar. 
Therefore most, if not all,' amplified units in the parent 
EL4/8:MTXR 	 cell line have the same structure. 
Fig.5.9b. re-enforces this conclusion: the DHFR sequences 
in the two EL4/8 DNA samples illustrated in fig 5.9a. 
have been visualized. In this cell line, DNA rearrangement 
has led to the appearance of a new restriction fragment - 
containing sequences from the 3' end of the DHFR gene 
(chapters 3 and 4). This new fragment (arrowed) is 
present in approximately the same proportion in both 
DNA samples. 
Thus the conclusion reached from section 5.2. is that 
the DNA sequences within the amplified units in a single 
cell line areLderived from the same parental wild-type 
cell. The structure of the amplified unit is stable 
during growth for many generations, and when selection 
(Cl 
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Fig. 5.9. Comparison of EL4/8:MTXR l.1X10M DNA from cells with dms 
..4 	 mi1-1 1ZPc 
Total nuclear DNA was digested with Eco RI and electrophoresed in 
a 0.75% agarose gel. The gel was stained with ethidiuin bromide, 
illuinunated with u/v lamps, and the fluorescence was photographed. 
The gel shown in a was transfered to nitrocellulose, the filter 
was hybridized with 32P-labelled pDHFR 11 and autoradiographed. 
The arrow indicates the band which has been generated by DNA 
rearrangement. 
for increased numbers of DHFR genes is applied, the 
amplified DNA increases in whole u.its without much 
change in structure. 
5.3. ESTIMATION OF THE SIZE OF THE AMPLIFIED UNIT 
Since total amplified DNA has been visualised using 
the two different techniques of metaphase chromosome 
spreads and DNA gel electrophoresis, the amount of 
amplified DNA, as a proportion of total DNA, can be 
estimated in two ways. Thus, since the approximate number 
of amplified DHFR genes has been determined, two independent 
estimates of the size of the amplified unit can be obtained. 
Estimation of the amount of additional chromosomal 
material present in MTX-resistant cell metaphase spreads 
is complicated by chromosomal heterogeneity between cells. 
The simplest case, because the chromosomes are the most 
homogeneous, is the EL4/11:MTXR11X1O N  cell line. Here 
there are on average seven normal-sized homogeneou3Cj 
staining chromosomes in addition to the EL4/WILD 
complement of 40- (section 5.1.). These extra chromosomes 
must contain at least 7/40 x 6 x 1O9 bp = 1.05 x109 of DNA. 
Since there are about 700 copies of the DHFR gene per haploid 
genome (table3.2.), the size of the amplified unit is 
about 7.5 x 10 bp. 
EL4/8NTXR11)d1OM cells contain on average 64 dms 
in addition to the 40 EL4/WILD chromosomes. If it is 
assumed that a dm in these' cells contains on average 
between one tenth and one twentieth of the DNA of a normal 
149 
mouse chromosome, this will correspond to about 5 x 10  bp 
of DNA. Since these cells contain about 700-1300 copies 
of the DHFR gene per haploid genome (table 3.2.), estimates 
for the size of the amplified unit vary from about 2 x 105bp 
to 8 x lO5bp. 
Estimates can be made in similar ways for EL4/3 and 
EL4/12 cells, and the figures are of the same order. However, 
it is very difficult to estimate the amount of chromosomal 
1 
material in the dms of the PG19T3:MTXR' 	S2 cells because 
they are so small. The size of the amplified unit estimated 
from the amount of additional chromosomal material will tend 
to be an underestimate, because not all copies of the 
amplified unit are present in recognizable chromosomal 
forms (see section 5.5.). Consequently, estimates obtained 
in this way must be regarded as imprecise 
In principle, DNA gel electrophoresis can give a 
more accurate figure, since the sizes of bands resulting 
from the amplified DNA can be measured accurately by comparing 
their rates of migration with those of standards, and the 
measurements added together to give the total. In practice, 
however, this accuracy cannot be achieved because of two 
major factors. First, it is difficult to distinguish every 
band in complex patterns such as those seen in fig s. 5.1. 
and 5.7. Second, not all sequences which are amplified will 
give rise to bands visible on these gels. For example, 
under the conditions used, a sequence which is present in 
600 copies per haploid genome would have to be approximately 
10Kb long in order to be detected. The feint bands 
which are larger than this size may thus be derived from 
sequences which arp present once per amplified unit. 
Intense large bands and all small bands must, however, 
be derived from sequences which are present more than once 
per amplified unit, or from the chance co-migration of 
fragments from several sequences present once per amplified 
unit. For these reasons, again only a minimum size for the 
ec4g. Ps'.ik Sb 6 (c* c4, 4 	tt' c- 
amplified DNA can be(counted in the MTX-resistant EL4 lines 
and the PG19S2 cells; if an average size of 5Kb is assumed 
for the bonds, this corresponds to 2.5 x 105bp to 5 x 105bp 
per amplified unit. Because each band has only been counted 
once, and because many bands must have been missed, this 
figure must be multiplied by at least a factor of two or 
three, and possibly by a factor of ten, to obtain the true 
size of the amplified unit. 
In conclusion, the size of the amplified unit can only 
be estimated very approximately in any cell line by either 
method, but the minimum size estimate is about 2 x 10 bp 
and the real size may be nearer 2 x lO6bp. 
5.4. BLOT HYBRIDIZATION EXPERIMENTS REVEAL AMPLIFICATION 
OF SPECIFIC SEQUENCES 
It is clear that, in MTX-resistant PG19 and EL4 cells 
described here, as in other 'cell lines (140, 92), the 
amplified unit is much larger that,., the stretch of DNA 
required to code for DHFR. This amplified DNA has been 
characterized in toto in sections 5.1. and 5.2.; in this 
section specific sequences which may occur in it are investigated. 
5.4.1. Hybridization of transcribed sequences 
cDNA has been synthesized from total sensitive or 
resistant cell RNA primed with oligo-dT and used as 
a probe against Southern blots of sensitive and 
resistant cell DNA. Fig.5.10a. shows an experiment where 
cr4  
the cDNA probes were from PG19T3/WILD and PG19T3:NTXR 	Si 
RNA, and the DNA attatched to the filter was from PG19T3/ 
WILD, PG 19T3:MTXR 	 or PG19T3:MTXR 	1S2 cells. 
It is expected that the cDNA synthesized from wild-type 
cells will be a complex mixture of species, and that the 
genomic DNA fragments from which they have been transcribed 
will fall into many size classes after digestion with . a 
restriction enzyme; consequently the result of hybridization 
will be a smear. This is what is seen in all tracks (fig. 
5.10.) although some bands can be seen superimposed upon 
thtackground in some of the tracks. Two ways in which 
such bands could be produced can be suggested: they could 
represent species which are particularly abundant in the 
mRNA, or they could be sequences which are repeated in 
the genome. Under the conditions of hybridization, it 
is likely that only sequences which are repeated in the 
genomic DNA will give rise to bands. The expected sizes 
of DHFR genomic DNA fragments are known (section3.7.) 
and also which fragments hybridize to the 3' end of the 
DHFR cDNA (fig.3.19.). It can be seen that bands at the 
- positions of the 3' DHFR fragments show up when MTX-
resistant cell genomic DNA is probed with MTX-resistant 
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Fie. 5.10. Hybridization of wild-tvne and MTX-resistant cell DNA 
with eDNA. 
a. PG19. Nuclear DNA from 4PGl9/WILD (WILD), PG19T3:MTX
0 
Si 
(R:S1), or PG19T3:MTXR10 M52 (R:S2) cells was digested with either 
Barn HI or Eco RI as indicated, and electrophoresed in a 0.5% 
agarose gel. After transfer to nitrocellulose, filters were 
hybridized either with 32P-labelled eDNA transcribed from PG19/WILD 
RNA (ScDNA), or with 32P-labelled cDNA transcribed from 
PG19T3:MTXR
1 0 
Msi RNA (RcDNA), and autoradiographed. 
P3 





Fig. 5.10. (continued). 	
2.2x'° -3 M b. EL4. Nuclear DNA from EL4/WILD (S) or EL4/3:MTXR 
	
(R) 
cells was digested with Barn HI and electrophoresed in a 1% agarose 
gel. After transfer to nitrocellulose, filter strips were 
hybridized with the Pst I - excised insert from pDHFR 21 labelled 
with 1251 by nick translation (pDHFR 21), or with 32P-labelled 
eDNA transcribed from EL4/WILD RNA (ScDA), or with 32P-labelled 
cDNA transcribed from EL4/3:MTXR22' 	M RNA (RcDNA), or with 
32 P end-labelled mouse 5.8S RNA (5.8S RNA) and autoradiographed. 
The hybridization with 5.8S RNA was carried out by E. Lund. 
hundred nucleotides long (data not shown) and therefore 
lacks sequences from the 5' ends of most rnRNA 5; for this 
reason other DHFR genomic DNA fragments are not seen. 
No DHFR bands can be seen in PG19T3/WILD DNA probed with 
MTX-resistant cell cDNA, suggesting that even an abundant 
cDNA species does not detect a unique gene under these 
conditions. In MTX-resistant cell genomic DNA probed 
with wild-type cDNA, the 3' DHFR gene fragments can 
again be seen, although less distinctly than when resistant 
cell cDNA was used; again these bands cannot be seen in 
wild-type genomic DNA. Thus even in wild-type cells the 
low amount of DHFR ITIRNA (fig.3.9.) is sufficient to 
generate enough cDNA to visualise genomic DHFR bands in 
MTX-resistant cell DNA: this shows that a genomic sequence 
which is present ir/nultiple copies can be detected in this 
experiment even if its transcripts are not very abundant. 
Fig.5.10b. shows that similar bands can. be  detected in 
EL4 cells. 
In both PG19- and EL4 cells, bands which do not 
correspond to DHFR fragments can also be seen. In Barn HI 
digests of all PG19 DNA samples there is a band at about 
2Kb, which must represent a sequence repeated in mouse 
DNA which is also complementary to transcribed sequence. 
This band is clearer in the DNA from the MTX-resistant 
cell lines; therefore some copies of it must be amplified. 
No other discrete bands can be seen in the ?G19T3/WILD DNA 
digested with either Barn HI or Eco RI and probed with 
cDNA from either sensitive or resistant cells. In Barn HI 
digests of both MTX-resistant PG19 cell lines, there 
is a band at about 34Kb which must represent a sequence 
which has been amplified in both these cell lines. In 
the Eco RI digest of PG19T3:MTXR' 	Si DNA there is 
a band at about 9 Kb, and in the Eco RI digest of 
PG19T3:MTXR 	S2 DNA there is a band just above the 
DI-IFR band in this track; both of these must represent 
sequences which have been amplified in only one cell 
line. Similarly, in the EL4/3:MTXR 2.2x10_ 	cell DNA, 
bands at about 3.0, 2.1 and a feint one at about 1 Kb 
can be seen representing transcribed sequences amplified 
in this cell line. 
Thus hybridization with cDNA probes' shows that in 
each NTX-resistant cell line there is DNA in the amplified 
unit which is complementary to transcribed sequences of 
both sensitive and resistant cells, and that each of the 
cell lines examined has sequences of this kind which are 
unique to it. However, it should be noted that these 
RNA species do not give rise to increased amounts of 
polypeptides (fig s.3.4. and 3.5.). 
5.4.2. Hybridization of specific probes 
"Satellite" DNA is the major-repeated sequence in the 
mouse and makes up about 107 of the genome. Originally 
defined by its distinctive density in caesium chloride 
density gradients (174), a large part of it consists of 
tandem repeats of variants of a 240 bp sequence, which 
.after digestion with enzymes such as Pst I, Hae III or 
t1' 
Taq I and separation according to size in an agarose gel, 
generate a'ladder'with "rungs" differing in size. by 240 bp. 
Fig.5.11. shows that such patterns are found in EL4 cell 
DNA. Since satellite DNA is so abundant it might be 
expected on the basis of chance that changes in the genome 
will involve it; but equally it may be difficult to detect 
such changes against the enormous background of unaltered 
satellite DNA. No significant differences between wild-
type and MTX-resistant cell DNA can be seen in fig.5.1, 
kow5 DNA digested with Barn HI, which cuts satellite DNA 
infrequently (T.H.N.Ellis, PhD thesis, University of 
Edinburgh, 1979). In all tracks a background smear of 
unresolved fragments is seen, and superimposed upon this 
are a few discrete bands. These are different in wild-type 
and MTX-resistant cell DNA samples, indicating either that 
a few previously undetected Barn HI repeats have been 
amplified or that rearrangement has generated new fragments. 
Few cloned probes were available when this work was 
carried out, but a fragment of the mouse genornic ribosomal 
repeat, rabbit a and P globin cDNA clones, and a sea urchin 
actin genomic clone have been used. No significant difference 
between sensitive and resistant cell DNA were seen when 
actin, a globin or ribosomal DNA were used as probes, 
thus showing that sequences which have homology with 
these probes are not amplified or rearranged. The 
result obtained with the ribosomal probe is shown in fig. 
5.13.z it is significant because it shows that the results 






Fig. 5.11. Analysis of satellite DNA in wild-type and MTX-resistant cells. 
DNA samples were digested with Taq I or Pst I and electrophoresed in 
a 1.5% agarose gel. The DNA was transfered to nitrocellulose, and the 
filter was hybridized with 32P-labelled mouse satellite DNA and 
autoradiographed. DNA samples are identified at the top of each track. 
09 
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Fig. 5.12. Analysis of satellite DNA in Barn HI digests of wild-type 
and MTX-resistant EL4 cells. DNA samples were digested with Barn HI 
and electrophoresed in a 1% agarose gel. The DNA was transfered to 
nitrocellulose, and the filter was hybridized with 32P-labelled 
mouse satellite DNA and autoradiographed. DNA samples are identified 
at the top of each track. The band marked with a star (*) derives 
from residual hybridization to DHFR from a previoui experiment; the 
broad bands near the bottom of the gel are a 'nucleosomal ladder' 
due to degredation of the DNA samples; other bands are satellite DNA. 
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Fig. 5.13. Analysis of ribosomal DNA in wild-type and MTX-resistant 
cells. DNA samples were digested with Eco RI and electrophoresed in a 
0.75% agarose gel. The DNA was transfered to nitrocellulose and the 
filter was hybridized with a 32P-labelled XgtWES.rDNA clone (lot) 
containing a 6.6 Kb insert of mouse ribosomal DNA and autoradiographed. 
A single band of approximately 6.6 Kb and approximately equal 
intensity can be seen in each track. 
0 
in section 5.4.1. are not due to contamination of the cDNA 
preparation with ribosomal sequences. 
The result obtained when the rabbit fi globin cDNA 
plasmid was used as a probe are shown in fig.5.14. It 
can be seen that there is an extra band in the EL4/3:MTXR212XlO  
DNA track which is not present in DNA from other cell lines. 
Its intensity in the EL4/3 track is not much greater than 
that expected for a single copy of the ft globin gene; 
therefore it cannot result from the presence of one intact 
3 globin gene in each amplified unit. 	Two explanations 
for the band can be suggested: 	it could represent a 
structurally rearranged 13 globin gene or homologous 
sequence which is present in only a few copies per cell; 
alternatively it could represent a non-rearranged sequence 
present in many copies per cell, perhaps once per amplified 
unit, but which has only a small degree of homology with 
the probe. 	it is known that many such sequences - the 
foetal, embryonic and pseudo- 	-globin genes, which cross- 
hybridize with rabbit 	3 globin cDNA - exist in the mouse 
genorne (175). 	These explanations have not been distinguished 
experimentally, although the latter would be the one 
predicted from the homogeneity of the sequences in the 
amplified units of a single cell line ( section 5.2.). 
Additional,very feint, bands could be seen on the original 
autoradiograph, and their positions are marked by arrows 
infig.5.14. 
While it is not possible to decide whether amplification 
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Fie. 5.14. Analysis of R-globin-like sequences in wild-type and 
MTX-resistant cells. DNA samples were digested with Eco RI and 
electrophoresed in a 0.75% agarose gel. The DNA was transfered to 
nitrocellulose, and the filter was hybridized with 32P_labelled 
pGl and autoradiographed. pG1 contains an insert of rabbit 
-globin cDNA (DT). Two bands, probably corresponding to the 
3-major and 13-minor globin genes,are seen in eachtracks In addition, 
a smaller band is clearly seen in the EL4/3:MTX,,22X10 	DNA track. 
This and some other feint bands are arrowed (). 
results showing amplification and/or rearrangement of a 
sequence which cross-hybridizes with rabbit 13 globin cDNA, 
and the results described earlier in-this section, re-enforce 
the conclusion that extensive DNA alteration has taken place 
during the development of resistance to MTX in these cells, 
and that this is different in different cell lines. 
5,5. SOME AMPLIFIED DNA IS LOCATED ON dms 
In the earlier sections of this chapter, DNA which 
has been amplified in the MTX-resistant cells was 
characterized, either directly by staining with ethidiurn 
bromide, or indirectly using specific radioactively... 
labelled sequences as probes, and the chromosomal changes 
which have occurred were described. While the two kinds of 
change are associated in that they occur within the same 
cells, it has not been shown whether they are physically 
linked: that is, whether the abnormal chromosomes are the 
carriers of the amplified DNA visualized by the other 
techniques. This question is investigated in this section. 
MTX resistance in the EL4/8:NTXR11dO M cells is 
unstable. Associated with the loss of resistance is a 
decrease in DHFR enzyme activity and a decrease in the mean 
number of dms per cell from about 64 under selective 
conditions to 30 after 1 day under non-selective conditions, 
14 after 3 days and 6 after 14 days ( C.J. Bostock, personal 
communication ). If the amplified DNA sequences are carried 
on the dms, they too should decrease in amount under non-
selective Conditions. DNA preparations made from the samples 
used for enzyme assays have been examined for the presence 
of the amplified DNA sequences visualized by ethidium 
bromide staining, and the number of DHFR genes in each has 
been estimated. Figs. 5.15. and 5.16. show the results. 
There is a notible decrease in the intensity of the 
ethidium bromide - visualized bands, although the amount 
is difficult to assess quantitatively by eye. The important 
point is that these bands are still easily detectable after 
14 days growth under non-selective conditions when there 
are only 10%  of the dms remaining in the cells. Therefore 
not all the amplified DNA is associated with dms. The 
number of DHFR genes decreases somewhat during growth under 
non-selective conditions, but again about 407. of copies of 
the gene remain when when there are very few dms. Therefore 
not all of the amplified copies of the DHFR gene are 
associated with dins. However, the fact that there was some 
decrease in both of the characteristics measured suggests 
that some ( very approximately a half ) of the amplified 
DNA is carried on the dms. These results can be compared 
with the results obtained with the stably resistant 
EL4/11:MTXR1IXIM 	cells, where no significant change in 
the ethidium bromide fluorescence pattern was seen and there 
was no overall decrease in the number of DHFR genes ( fig. 
5.16. ). 
If only about a half of the amplified DNA in 
-3 
EL4/8:NTXR 	M cells is carried on dms, where is the 
other half? Two answers can be suggested there could be 
WILD 	3 7 10 14 
1.x Fig. 5.15. Analysis of total cellular DNA from EL4/8:MTXR 
cells grown under non-selective conditions. DNA samples from cells 
on day 0, 3, 7, 10 or 14 of growth in the absence of ?TX were 
digested with Eco RI and electrophoresed in a 0.75% agarose gel. The 
gel was stained with ethidium bromide, illuminated with u/v lamps, 
and the fluorescence was photographed. The first two tracks are 
marker DNA and EL4/WILD DNA digested with Eco RI. 
Days growth without MTX 
Fig. 5.16. Stability of DFR gene number during growth in the absence 
of MTX. EL4/8:MTX .i•X1O M cells (_S ) or EL4/11:MTXR1 '° M cells 
(-o--) were resuspended in medium lacking MTX and cells were harvested 
after 0, 3, 7, 10 and 14 days growth. Samples of total cellular DNA 
were prepared, digested with Eco RI, and electrophoresed in a 0.75% 
agarose gel. The DNA was transfered to nitrocellulose and the filter 
was hybridized with 32P-labelled pDHFR 11. Bands of hybridization were 
located by autoradiography, cut out, and the radioactivity was measured 
in a scintillation counter. The amount of radioactivity from equal 
quantities of DNA, expressed as a % of the radioactivity in 'day 0' DNA 
of each cell line, Is plotted here against the number of days growth 
without MTX. 
smaller, submicroscopic, dm-like particles in these cells 
which are retained in a stable fashion when the cells are 
grown in non-selective medium, or the amplified DNA could 
be integrated into the visible chromosomes. These have 
been distinguished by separating chromosomes according 
to size on a sucrose gradient (carried out by C.J.Bostock) 
and analysing the fractions. If the amplified DNA is carried 
on very small particles 'and dms, it should be well separated 
from the bulk of the chromosomes and found at the top of the 
gradient; while if some amplified DNA is carried on the 
large chromosomes, it should be found all the way down the 
gradient. Fi 5.17. shows that both amplified DNA visualized. 
by ethidiurn bromide fluorescence and the DHFR gene are foud 
all the way down the gradient. Microscopic examination of 
fractions showed that there was good separation between 
different size classes of chromosomes,although a few dms 
were seen in every fraction probably because they "stick" 
to other chromosomes. Some amplified DNA would be expected 
in all fractions because ring chromosomes and mkrtnuclei 
of all sizes are present. However, the amount of DNA in 
these structures is far too small to account for the large 
amount of amplified DNA seen in all fractions. Mitochondrial 
DNA and cellular RNA served as internal markers: mitochondrial 
DNA was largely found in fraction 1 and RNA was concentrated 
in the topmost four or five fractions. Therefore the 
-3 
amplified DNA in the EL4/8:MTXR1 	M cells rcs a complex 
chromosomal location: about half of it is located on dms 














Fig. 5.17. Analysis of EL4/8:MTXR]lxl0 M chromosome fractions 
after separation according to size on a sucrose density gradient. 
Chromosomes were fractionated on a sucrose gradient and nucleic 
acids were prepared from each fraction. The top of the gradient 
was fraction 1 and the bottom was fraction 32. Even-numbered 
fractions were digested with Eco RI and electrophoresed in a 
0.75% agarose gel. 
The gel was stained with ethidium bromide, illuminated with 
u/v lamps, and the fluorescence was photographed. A large 
amount of RNA can be seen in fractions 2 and 4. 
DNA was transfered to nitrocellulose and the filter was 
hybridized with 32P-labelled pDHFR 21 and autoradiographed. 
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CHAPTER 6 
DISCUSSION PART II 
\ 
/ 
6.1. GENE AMPLIFICATION IN PERSPECTIVE 
Gene amplification is not a common mechanism by which 
mammals increase their capacity to synthesize a gene product 
(93). 	Perhaps the best counter-example is provided by the 
red blood cell which essentially contains only two polypeptides, 
a and 0 globin, but lacks a rucleus and consequently does 
not have even a single globin gene. Cells can produce large 
amounts of a protein by transcribing the gene at a high rate, 
making a stable and frequently translated mRNA molecule, and 
ensuring that the protein itself is stable. Organisms can 
synthesize large amounts of a product by selective prol. 
-iferation of a specialized cell type. Why then, if all 
these normal mechanisms for synthesizing large amounts of 
a gna6 product exist, has gene amplification ocicurred in 
the cells characterized in this thesis? Firstly, since 
the cells being selecetd are growing in culture, •inthe 
absence of alterations of MDC transport or DHFR structure, 
every cell must produce large amounts of DHFR itself in 
order to survive. Thus potential for survival of the 
population by selective proliferation of a specialized 
DHFR-producing cell in a manner similar to the selective 
proliferation of specialized cells in a whole organizm is 
removed. Secondly, by defining the conditions as selective, 
that is as those that kill most cells, any normal mechanisms 
of increasing DHFR production will be insufficient since 
they will be possessed by most members of the population. 
Thirdly, it is the DHFR level compared to synthesis of 
other proteins, RNA and DNA which must be increased. Thus, 
for example, a general increase in transcription rate or 
mRNA stability will be of no use. Fourthly, of all those 
mechanisms for increasing DHFR level which may be possible, 
only those which occur most frequently will actually 
be observed. 
Those few systems where gene amplification has been 
found to occur in whole organisms are all cases where the 
final gene product is an RNA molecule and so the potential 
"amplification" steps inherent in protein synthesis cannot 
be used. This is particularly striking in the amphibians 
where very rapid ribosorne:assembly takes place during one 
stage of developmant. Many copies of the ribosomal RNA 
gene are amplified from the few carried in the germ-line 
DNA (section 6.2.2.), but no amplification of the ribosomal 
protein genes has been detected, although the rRNA and 
protein products are used in equimolar amounts. 
6.2. ESTABLISHED EXAMPLES OF GENE AMPLIFICATION IN WHOLE 
ORGANISMS 
Although, strictly, any change in the relative amounts 
of different parts of the genome could be called amplification, 
examples such as polysomy or simple chromosomal transloca-
-tions, and the polyteny that occurs in some insect chromosomes 
will be ommitted from this discussion and only examples 
where amplification is specific and of high order will be 
included. Two recent reviews covering this field have 
appeared (93, 176). 
I 
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6.2.1, rDNA amplification in protozoa and sLime molds 
Several of the lower eukaryotes contain 'extra-chromosomal 
rDNA. The protozoon Tetrahyrnena pyriformis hà, in the 
vegetative phase , a micronucleus and a macronucleus. The 
diploid micronucleus has a single integrated copy per 
haploid genome of the gene for the ribosomal RNA 
precursor (177); in contrast, the polyploid macronucleus 
lacks this integrated copy but has about 200 copies per 
haploid genome of extra-chromosomal rDNA which is found 
as paired linear palindromic molecules about 10 Kb long. 
Since the macronucleus is derived from the micronucleus 
after the sexual phase, amplification of the rDNA must 
occur. The process involves excision of the integrated 
copy, generation of a palindrome and amplification of the 
palindrome, but the details are unknown. 
Extra-chromosomal rDNA has been found in the form 
of tandemly repeated units in linear and circular molecules 
in Paramecium tetraaurelia (178). It has also been found 
in Stylonochia (179, 180), but in this organism all the 
macronuclear DNA is found in the form of small "gene-sized" 
pieces. In slime molds, palindromic extra-chromosomal 
copies of rDNA have been found, —60 Kb long in Physaruin 
polycephalum and about 88 Kb long in Dictyosteljum 
discoideurn. It is thought that all these extra-chrornosoma]. 
DNA molecules arise by amplification. 
6.2.2. rDNA amplification during oogenesis, 
tDNA amplification is a widespread but not universal 
feature of oogenesis. In the insects Dytiscus and Acheta, 
circular extrachromosomal copies of rDNA have been detected 
(181-183); in clams and in the worm Urechis a low level of 
amplification has been reported (184,185) among vertebrates 
high levels of amplification have been found in fish and 
amphibians (186,184,187,188), and a low level in humans (189). 
Reports of low levels of amplification must be interpreted 
with caution because of possible errors in the measurements. 
The best-characterized system is Xenopus laevis (93). 
This frog carries about 500 slightly different copies of the, 
rDNA repeat integrated in the germ line. In the primordial 
germ cell, a single one, or a few, of these repeats give 
rise to circular extrachromosomal copies which constitute 
about 20 to 50 times the haploid amount of rDNA. This level 
is maintained during proliferation of the germ cells in the 
growing tadpole, probably by autonomous replication of the 
amplified rDNA circles. As the tadpole enters metamorphosis 
and the germ cells start to undergo meiosis, then in 
spermatocytes the amount of rDNA falls to the haploid level, 
but in oocytes a second round of amplification takes place 
leading to about 2 500 times the haploid amount. While little 
is known about the mechanism of amplification in the 
primordial germ cells, it is well established that meiotic 
amplification in the oocyte takes place by a rolling circle 
mechanism. 
6.3. DHFR GENE AMPLIFICATION 
The evidence presented in this thesis 
suggests that DHFR gene amplification is a quite 
different process from the well-characterized 
examples of amplification in whole organisms 
discussed in section 6.2. The most important 
disti—nction is that 1?HFR gene amplification is an 
imprecise process, differing in the sequences involved 
and the amount of DNA in each cell line, and at least sometimes 
involving extensive sequence rearrangement (see below). 
Amplification by a rolling circle mechanism would generate 
identical copies of an intact portion of the 3enome; unequal 
crossing over between integral numbers of units of a repeating 
structure would also a4ify a sequence intact, but if it 
occurred out-of-phase between non-integral numbers of repeat 
units it could generate sequence rearrangement. There are 
three reasons for thinking that unequal crossing over is not 
an important mechanism of amplification in these cells. 
Firstly, in those situations involving already tandeinly 
repeated genes where it has been implid on experimental or 
theoretical grounds (190-194), the size of the repeating unit 
and the distance of unequal crossover has been at least ten 
to one hundred times smaller than the amplified unit in 
MTX-resistant cells. Secondly, suitable arrays of units 
should be visible at the cytological level in cells resistant 
to high levels of MTX. dms are not candidates for such 
arraysj HSRs are more suitable. However, if unequal 
sister chromatid exchanges were sufficiently frequent to 
double the number of DHFR genes in a high proportion of cells 
in a very few generation& during selection for increased MIX 
resistance, they should also occur as frequently in cells 
growing at a fixed MTX concentration. Such unequal sister 
chromatid exchanges should then be visible cytologically 
as changes in the size of FJSRs. While the size of the HSR 
has been correlated with the level of resistance (128), 
variation in size at a given level of resistance has not 
been noted. Thirdly, if unequal crossing over is the 
mechanism of gene amplification, and sequence rearrangements 
are introduced by out-of-phase unequal crossovers, such 
rearrangements should continue to be produced throughout 
selection, this is the "rearrangement switch-off" problem 
(section 5.2.). In order to explain why rearrangement 
ceases after the early stages in amplification, the ad hoc 
assumption would hove to be made that alignment of repeat 
units is better in cells with multiple copies. 
DHFR gene amplification itself seems to consist 
of two distinct processes. In the later stages of amplification 
there is a homogeneous population of amplified units, and 
changes in the number of DHFR genes, either increase 
during selection for a higher level of MDC resistance 
( section 5.2.1.) or decrease during growth under non-
selective conditjons(sectjon 5.5.), take place in whole 
amplified units and do not involve change in the structure 
of the unit. In contrast, during the early stages of 
amplification, when the amplified unit is being generated, 
extensive DNA rearrangement takes place. In subsections 6.3.1 
and 6.3.2. each of these processes is discussed. 
6.3.1. Generation of the amplified unit 
Two kinds of evidence show that DNA rearrangement 
has taken place during the generation of the amplified 
unit. Firstly, there is the direct evidence from the 
DHFR gene restriction patterns in the EL4 cells (section 3.10.) 
and possibly in S-180 cells (123). This evidence is direct 
in the sense that both the patterns before and after 
amplification are known, and the two are different. Secondly, 
there is indirect evidence from the restriction patterns 
of total amplified DNA in EL4 and PG19 cells: the patterns all 
contain unique fragments (section 5.2.). 	How can these be 
generated? Consider the simple case of amplifying intact a 
piece of chromosome. If only one amplified pattern was 
examined, thnecessarily all the bands would be unique. If 
two were examined, then each would have some unique bands 
because overlapping but non-identical amplification units 
could have been chosen. However, if three patterns were 
examined, and no DNA rearrangement had taken place, then one 
of the three units must be the middle one and consequently 
can have no unique bands (see fig6.1.). The observation 
that unique bands can be seen in three or more patterns shows 
that rearrangement must have taken place. Even if the two 
homologous chromosomes carrying the DHFR gene should differ 
in the neighbouring sequences, an extensn of the above 
argument shows that only four unique patterns could be 
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Fig. 6.1. Model showing how not more than four unique amplification 
units containing the DHFR gene could be derived from two homologous 
( but non-identical ) chromosomes. Each of the amplification units 
numbered 1 - 4 could contain sequences which would give rise to 
unique bands 	Any fifth unit, however, could only contain 
sequences present in these four and therefore it could not give rise 
to unique bands. 
Key:. 	 -  chromosomal DNA containing DHFR gene. 
-V amplification unit. 
5.2.). The observation that extensive satellite DNA is 
io 4  
amplified in the PG19T3IMTXR' 	M Si cells suggests that 
DNA from this cell line contains a sixth set of sequences. 
An understanding of how this DNA rearrangement 
has taken place will be essential to the understanding of 
how the amplified unit has been generated. It was suggested 
in section 4.4. that DNA rearrangement in the vicinity of the 
DHFR gene was more similar to the sequence non-specific 
DNA rearrangement which takes place in DNA-transformed 
cells than to the sequence-specific DNA rearrangement 
systems which have been identified in eukaryotes. This 
also seems to be true of the general DNA rearrangement In 
the amplified unit. 
This suggests the possibility that the amplified 
unit really is generated by a spontaneous transformation 
event: that a cell can take up chromatin fragments from 
a neighbouring dying cell and express the DHFR gene. DNA- 
mediated transformation is carried out experimentally by 
forming a mixed precipitate of DNA and calcium phosphate 
(195) or DEAE dextran (196). It is not known precicely 
what the role of these carriers is: they may be important 
in protecting the DNA from nucleases in the serum contained in 
the cell culture medium or within the cell, or they may 
act on the cell membrane in such a way as to cause DNA uptake. 
In putative spontaneous transformation the first of these 
roles could be fulfilled by chromosomal proteins, and the 
second by the toxic effects of MIX leading to weakening 
or rupture of the cell membrane. 
This hypothesis is testables for example by 
examining MIX-resistant cells selected from a mixed 
culture of human and mouse cells for individuals with 
both types of DHFR gene. Such an experiment has not been 
done. However, it is perhaps significant that when mouse 
cells were transformed with DNA from hamster cells and 
selected 	 for increasing levels of MIX resistance, 
all the-four highly resistant clones examined contained 
amplified hamster DHFR gene and not amplified mouse DHFR 
genes (197). It seems that the incoming DNA was more 
easily formed into an amplifiable unit than the endogenous 
DNA. Even if transformation per se does not take place, 
that is, if the DNA which becomes the amplified unit comes from 
within the first resistant cell, possibly by some MIX-induced 
change,and not from the outside, the transformation experiments 
show that mouse cells are capable of ligating together and 
expressing many non-homologous DNA fragments. The explanation 
for the observed DNA rearrangement near the DHFR gene only in 
the MTX-resistant EL4 cells, could be that the DNA fragments 
contributing to the amplified units in these cells were 
smaller, possibly just because the endogenous nuclease 
levels in these cells are higher. 
6.3.2. Increase in number of amplified units 
Two major mechanisms seem to have been involved 
ink increase in the number of amplified units. Firstly, if 
the amplified DNA is carried on acentric chromatin fragments, 
as in some of the cells described in section 5.1. and unstably 
MTX-resistant S-180 cells (129), then it will not segregate 
using the mCtotic  apparatus at cell division, and may 
segregate unequally. It might be expected that, nevertheless, 
approximately equal numbers of dms would be found in each 
daughter cell; however, this simple view is probably wrong. 
A detailed study of mitosis in the dm-carrying MTX-resistant 
cells described here has not been carried out, but Levan and 
Levan (198) have made such a study in another mouse line, 
SEWARTC 13 clone 3R which has dms, although, so far as is 
known, these do not carry DHFR genes. In order to approximate 
as closely as possible to the natural conditions, all Levan 
and Levan's observations were made on cells which had not 
been treated with mitotic-arrest agents or given hypotonic 
swelling. They found that during prophase the dms were 
visible dispersed among the other chromosomes. When the 
nuclear membrane disintegrated, some of them spread into 
the cytoplasm. At metaphase, when the chromosomes were 
arranged in a ring in the equatorial plane with their 
centomeres pointing inwards, the dms were excluded from 
this assembly and were located at the periphery of the 
metaphase plate or in the cytoplasm. This was a charact-
-eristic peculiar to dms since small centric chromosomes 
were generally more centrally located than large ones, 
ME 
and SEWARTC 13 clone 3R cells had a centric marker chromosome 
which was only slightly larger than the dms but was regularly 
found inside the ring. During metaphase, nucleolar material 
was pushed towards the periphery of the nucleus and therefore 
became associated with the dms. During anaphase, the 
chromosomes were pulled towards the poles; nucleolar material 
remaining associated with their ends was pulled with them and 
also 
therefore a few of the dmsLmoved towards the poles. Many dms, 
however, remained separate from the main bodies of the chromosomes 
but associated with one another. At no stage in mitosis were 
sister dms specifically separated; generally they remained 
together. During interphase many dms appeared to form micro-
-nuclei; such micronuclei were seen in 14°!. of 500 cells 
examined. 
Another study of the behaviour of dms during mitosis 
has been carried out by Barker and Hsu (199) using the human 
breast tumor line SW-613. They also observed that sister dms 
did not separate, but some of the pairs or small clumps of pairs 
became associated with other chromosomes and hence moved to 
daughter cell nuclei, while other pairs or groups seemed to 
be excluded from both daughter nuclei. These two papers show 
that dms from different sources behave in similar ways at 
mitosis. 
The striking Conclusion from these cytological 
observations is that essentially all the dms from the parental 
cell line can go to one of the daughter cells; thus in MDC-
resistant lines, the number of DHFR genes carried on dms 
could almost be doubled in a single generation. This is 
therefore potentially a very powerful mechanism of gene 
amplification. Evidence that such unequal segregation can 
occur in some of the cell lines described in this thesis is 
that in some metaphase spreads, almost all the dms can be 
seen lying associated with one another and separate from 
the other chromosomes (C.J.Bostock, personal communication). 
The second major mechanism of increase in the 
number of amplified units depends on their having a circular 
structure. In such a case, any odd number of sister 
chromatid exchange events will generate a ring of twice the 
size. Such a ring can then go to only one of the daughter 
cells, increasing the number of DHFR genes in this cell, and 
thus its chance of survival, whereas the other daughter cell 
not receiving the ring will be selected against. This mechanism 
seems to have been important in the EL4 cells where acentric 
rings are very common, and rings of different sizes cr 
be found within a single cell (section 5.1.). It may also 
have been important in the PG19 Si cells where centric rings- 
were observed at some stages (94). A ring with two functioning 
centomeres generated in this way will generally be disadvantageous 
to the cell since it will tend to be pulled towards both daughter 
cells at rnitosjs. However, under the highly selective conditions 
in these cultures, the few cells which avoided death would be 
selected.. ---It has often been suggested that dms themselves 
are rings (200, 201), but this question cannot be answered by 
light microscopy and it remains a hypothesis. If true, it 
would suggest that this second mechanism of amplification 
could be involved in early as well as in late stages in 
selection. These two mechanisms are illustrated in 
fig.6.2. 
A third possible mechanism for increasing the 
number of amplified units is by replication more than once 
per cell generation. The fact that dms appear double at 
metaphase suggests that they generally replicate in pse 
with the other chromosomes, and "harlequin banding" studies 
confirm that this is true for most dms in the cells examined 
(202, 203). However, it is possible that DNA in micronuclei 
replicates out of phase with nuclear DNA. Evidence that 
such might be the case is tenuous: in some cells where 
the nuclear chromosomes have been examined at metaphase, 
the micronuclear chromosome has appeared to be at another 
stage in the replication cycle (204). There is no evidence that 
replication is more rapid rather than more slow in these 
cases, and only more rapid replication would lead to an 
increase in DNA amount; there is no evidence that this 
is a major mechanism of amplification. 
A change occurring in some of the cells which 
is not a mechanism of amplification, but which is nevertheless 
relevant to the process, is stabilization. As indicated 
in section 5.2.3., a cell which carries its DHFR gene3in 
a stable form has a selective advantage over a cell in 
which they are unstable, if cells are maintained in a 
constant MTh concentration. Stabilization can occur by 
acquisition of a functioning centomere. Centomeric 
acquisition is probably a rare chance event; its occurrence 
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a. Unequal segregation of acentric chromatin fragments. 
= dms, 	= normal centric chromosomes. 
cell after chromosome replication and before division containing 10 dms. 
cell division: the dms do not associate with the mitotic apparatus 
and segregate unequally. 
daughter cells ( after chromosome replication ): one has 18 dms, the 
other has 2. 
b. Change in size of ring chromosome. 
acentric ring chromosome, 	= normal centric chromosomes. 
cell after chromosome replication and before division containing one 
ring chromosome. 
a cross-over between the two sister ring chromatids produces a 
single ring chromatid of twice the original size. 
at cell division the ring chromosome segregates with only one of the 
normal chromosome complements. 
daughter cells ( after chromosome replication ): one has twice the 
amount of ring chromosome material in cell 1, the other has none. 
Fig. 6.2. Proposed mechanisms of DNA amplification. 
responsible for the observed chromosomal differences 
between the PG19 cells and the EL4 cells. HSRs on centric 
chromosomes have been found in MTX-resistant L5178Y cells 
(140) and MTX-resistant Chinese hamster cells (92, 128). 
Thus the very diverse chromosome morphologies seen in MDC-
resistant cells can be explained as manifestations of a few 
underlying processes. This is summarised in fig.6.3. 
The answer to the rearrangement switch-off 
problem (section 4.4.) is therefore that rearrangement 
generates an efficient amplicon: possibly a circular DNA 
molecule the size of one amplified unit. Once this has 
been formed, the more efficient amplification mechanisms 
described are the most frequent events leading to an 
increase in DHFR gene number, and consequently further 
DNA rearrangement is not observed. 
6.3.3. Amplification in other MTX-resistant cells 
The mechanisms discussed in sections 6.3.1 and 
6.3.2. could thus account for amplification in the PG19 
and EL4 cells. In the other cell lines examined, no 
comparable changes in chromosomes or total DNA were seen. 
Does this mean that the amplification process must be quite 
different in these cells? In the case of the L1210:MTX 10 
cells and the L5178YzMTxR44'l° 	cells, the relatively low 
degree of DHFR gene amplification and the difficulty in 
obtaining good quality DNA preparations from these cells 
could account for the absence of observed changes. 
QbS 
formation of amplified unit 
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Fig. 6.3. Some possible inter-relationships between the chromosomal 
forms of dms. HSRs and ring seen in MTX-resistant cells. 
S.= dm, -= HSR, —0= centromere, C) = ring. 
In the case of LB1 trans:MTXR 4 • 4x 10 cells, such an explanatior 
seems inadequate: the degree of amplification here is 
104M 	 _poI greater than in the PG19T3:MTXR 	Si cells,although 
good chromosome preparations were difficult to obtain, 
high molecular weight DNA could be isolated; yet bands of 
amplified DNA could not be seen (1 ig.5.2c.). This shows 
that the amplified unit does not contain sequences repeated 
within it which can give rise to visible bands in ethidium 
bromide stained gels. One explanation for this would be 
that it is small; another would be that amplified units 
within the population are heterogeneous. A small unit 
would also account for the lack of new chromosomal material 
visible in metaphase spreads; a heterogeneous collection 
of large amplified units of this number should be visible. 
Thus it is likely that the amplified unit in these cells 
is small; such a small unit could be generated and amplified 
in the ways outlined above. 
6.4. DNA AMPLIFICATION IN SOMATIC CELLS 
The processes thought to be involved in DHFR gene 
amplification in MTX-resistant cells are all potentially 
general ones: none depends specifically on DHFR or on MIX. 
Therefore it can be asked whether they are of more widespread 
occurrence. Ther are two situations where one might start 
to look. The first is where enzyme overproduction has been 
found as a mechanism of resistance to an inhibitor; the 
second is where dms o HSRs have been detected at the 
cytological level. 
Inhibitor Target enzyme References 
MTX DHFR see section 1.4.4. 
and chapter 3. 
PALA CAD 205,206,207,208. 
6-azauridine orotate phosphoribosyl 209. 
transf erase 
pyraazofurin 
orotidine 51 phosphate 
decarboxylase 
arabinosyl ribonucleotide 210,211,212,213. 
cytosine reductase 
hydroxyurea 
5-f luoro- thymidylate synthetase 214,215,216. 
deoxyuridine 
cycloleucine methionine adenosyl 217,218. 
transf erase 
3-asparty1- asparagine synthetase  
hydroxamate 
25-hydroxy- HMG-CoA reductase  
cholesterol 
canavanine argininosuccinate  
synthetase 
Table 6.1. Reports of enzyme overproduction associated with drug 
resistance in cultured mammalian cells. 
Tumour d 	c din ring 	HSR Comments Ref 
non-tumour + 	. + see text 223 
HUMAN 
neuroblastoma + 60/76 200 
It + 14/62 ..11 
U  + + it 
medulloblastoma + + it 
rhabdosarcoina + 12/20 
bronchial carcinoma + 	. + • 
neuroblastoma + 	• 8/12 • 239 
medulloblastoma + 10/10 • 240 same 
bone marrow + 	• 29/32 6/32 	
• çpatient 
it 
rhabdomyosarcoma Ri + 	• 12/20 1/20 	• 241 
IV 	 R! 	+ • 1/102 same 
patient 
It + 5-10% • 
thyroid carcinoma + + + 	• 242 
astrocytoma + 	• 1/217 • 243 
neuroblastoma + 	• 104/109 • 244 
erythroleukemia + 	• 11/18 17/18 	• 245 
leukemia + 	• 7/25 • 226 
+ 	• 25/25 2/25 It 
+ 	• 8/25 • It 
+ 11/25 14/25 	• 
+ 	• 14/25 • 
+ 	• 9/25 9/25 	• II 
+ 	. 17/25 . 
20 
Tumour d 	c dm 	ring 	HSR Comments Ref 
preleukemia + 	. 22/25 	. 	. 226 
11 + 	. 25/25 it 
glioma 3 + 	. 4( 	6.6%). 	. 53 224 
examined 
it 	4 + 9(97%). 	.it 
it 10 + 	. 6(11.8%). 	.it 
18 + 	. 2( 	5.4%). 	.it 
22 + 	. 89(80.2%).  
26 + 21(61.8%).  
29 + 	. 70(100%) 	. it 
36 + 7.4%).  
40 + 98(91.6%) 
46 + 	. 7.4%) 
48 + 	. 21(22.1%) 	. 
49 + 	. 2( 	2.7%). 
50 + 	. 12(22.2%). 
neuroblastoma + 	. 71/100 	2/100 	. 246 
tv + + 	+ 	•it 
neuroblastoma . 	+ 70% 	. 	. 42 days 247 
11 + 14% 	• 	. 244 days 11 
neuroblastoma . 	+ . 	. 	+ 90 
neuroblastoma . 	+ 44/110 	• 	66/110 227 
ovarian carcinoma + 	. 28/28 	. 	. 14 225 
examined 
tt + 	. 7/28 	. 	.it
breast + 	• . 	. 	+ 248 
It 
-1- 	. . 	. 
It + 	. • 	4.. 
Tumour d 	c dm 	ring 	HSR Comments Ref 
oesophageal + + 248 
pharangeal + 	. . 	 + it 
colon: COLO 320 . 	+ 100% 	5-10% li months 228 
11 	 IT + 51% 	 94% 16 months IT 
it 	 COLO 321 + few 	. 	98% it 
rectal carcinoma . 	+ + 	 •It 
breagt,MDA-MB-143 + 5/50 	• 203 
it 	 157 + 2/50 	 •11 
IT 	 175 + 5/50
IT 
	 • 
231 + 21/50 	• 	• see below 
TI 	253 + 7/50 
309 + 10/50 
IT 	330 + 4/50 	•IT 
415 + 13/50 it 
436 + 25/50 it 
BT-474 + 17/50 	• 	• 
II 	SW-527 + 32/50 	• 	• see below 
613 + 40/50 	• 	• II 
cervical, SW-732 + 40/50 	 • 
breast,MDA-MB-231 . 	+ + see above 249 
it 	SW-527 + + see above TI 
breast tumour + 	• + TI 
breast, SW-1403 . 	+ • 	200/200 250 
2-u 
Tumour d 	c dm 	ring 	HSR Comments Ref 
MOUSE 
Rous sarcoma + 	. + 	. 	. 9/50 251 
tumours 
SEWA and deny. + 	+ + + 	few multiple forms 
252,253,254 202, 
201,198. 
Ehrlich-Lettr + 	. . 	. 	+ 255 
RAT 
H4-II-E-C3 . 	+ . 	+ 	+ see text 229 
DOG 
venereal + 	. . 	. 	+ 235 
Table 6.2. Published reports of dms, HSRs and associated ri 
chromosomes in cells of humans and animals which have not been 
selected for MTX resistance. 
d = direct processing of tumour material for metaphase spreads 
c = cultured cells examined 
dm 
ring number of cells in which chromosome form is seen/total 
HSR 
V IL 
Table 6.1. lists reports of enzyme overproduction 
in inhibitor-resistant cultured mammalian cells. In addition, 
esterase overproduction has been found in 	insecticide- 
resistant aphids of the species Myzus persicae (222). 
The molecular basis for overproduction has only been 
investigated in one system other than MDC resistancez 
PALA-resistant Chinese hamster cells. PALA (N-(phosphonacty1)-
L-aspartate) is an inhibitor of aspartate transcarbamylase, 
an enzyme essential for the de novo biosynthesis of UMP. 
Cells resistant to PALA overproduce CAD, the multifunctional 
protein containing the enzyme activities carbamyl-P synthetase, 
aspartate transcarbamylase and dihydroorotase. CAD overproduction 
is accompanied by CAD gene amplification (208). No cytological 
observations have been reported from these cells, and the 
size of the amplified unit and the involvement of other DNA 
sequences are unknown. From this data it appears that the 
process is similar to DHFR gene amplification. In none of 
the other systems has it been shown that a mechanism other 
that gene amplification is responsible for enzyme overproduction. 
Table-6.2. lists reports of dms, HSRs and, where 
they are associated with these phenomena, ring chromosomes. 
This list is not exhaustive. It can be seen that, with one 
exception, these chromosomal forms are restricted to tumor 
cells. The exception is a short region on chromosome 14 
of a normal woman (223) which was detected because it contained 
'I 
multiple nuclecis organizing regions (NORs). It could be 
simply the translocation of NORs from another chromosome to 
chromosome 14, or it could represent a low frequency of 
HSRs in the population. 
The true frequency of dms and HSRs in tumors is 
difficult to assess because these phenomena are easily 
overlooked unless they are specifically searched for, and 
dms can be confueed with contaminants such as dirt or 
bacteria. The large number of reports of dms in neurogenic 
tumors in man almost certainly reflects a sampling bias 
workers studying these tumors have been aware of the 
presence of dms and have looked for them. No systematic 
survey of the frequency of dms and HSRs has been carried out, 
and generally, workers who have reported their presence have 
not mentioned how many negative results they have obtained. 
Some limited figures are available. Mark (224) found dms 
in 13/53 (25%) of adult neurogenic tumors; Atkin and Pickthall 
(225) found them in 2/14 (14%) of cases of ovrian. carcinoma; 
andPierre et al (226) found them in 9/65 (14%) of cases of 
leukemia or preleukemia. Thus they appear to be widespread 
amongst different tumor types and may be present, perhaps, 
in one tenth to one third of all tumors. 
It is significant that in some of these tumor lines, 
as in some of the MTX-resistant cell lines described in this 
thesis, dms and HSRs are associated. For example, Balaban-
Manelbaurn and Gilbert (227) found that in the human neuro-
-blastoma cell line CHP-126, 44/110 cells had dms and the 
other C,/110 cells in the same population had an HSR in the 
long arm of chromosome 5. All of these cells had two other 
marker chromosomes, suggesting a common origin for the 
two cell types. These workers therefore proposed that dms 
were produced by fragmentation of the HSRi the converse 
of the view proposed here. Their observations are 
consistent with either view, and although in the EL4 
cell population HSR-containing cells have arisen from 
din-containing cells, possibly as outlined in fig.6.3., 
fragmentation of HSRs to produce dms cannot definitely 
be excluded as a mechanism of dm generation in other 
cell lines. However, a second report of HSRs arising 
from dms in a human carcinoma cell line (228) suggests that 
this was the more general occurrence. Cells from a colon 
adenocarcjnorna were established in culture as COLO 320. 
In early cultures, almost all metaphases had from two to 
several hundred dms, and in addition 10°!. to 15% of 
metaphases had from one to seven ring chromosomes. After 
16 months in culture, 49% of metaphases had 0 dms and 23% 
had one; 94% of metaphases, including all cells with less 
that eight dms, had a new marker chromosome possibly 
derived from the X chromosome and with an HSR on each arm. 
Do these chromosomal changes reflect DNA 
amplification? In a trivial sense, any additional 
chromosomal material is DNA amplification. The important 
question is whether it is a high degree of amplification 
of a small amount of DNA, or one extra copy per cell of 
a large part of the genome. In other words, are the 
dms homogeneous? Do the HSRs have a repeating substructure? 
Cytological observations are not a good way of trying to 
answer these questions but, so far as they are capable, 
they do suggest that the answer is "yes". For example, 
2L5 
all observers have found that dms within a cell are uniform 
in staining properties, although not in size. If they 
Lke were derived from a random selection ofkgenome, they would 
be expected to show differences. In the mouse, for instance, 
about 10% of the genome stains darkly after C banding 
(centromeric heterochromatin), yet 1 in 10 mouse drns is 
not C-band dark. 
There is one instance where DNA amplification has been 
identified in HSRs: ribosomal DNA in the rat hepatoma line 
H-4-II-E-c3 (229). The origin of this cell line is shown 
in fig.6.4., so far as the details are known and published. 
The HSRs (called by the authors DSRs, for diferentially 
staining regions) were noticed after the cells had been in 
culture for several years. Cells had not been selected for 
properties other than the ability to grow fast in culture. 
Filter disk hybridization showed that there was about a 
ten-fold increase in the amount of rDNA, and in situ 
hybridization to metaphase chromosome spreads showed that 
about 90% of the total rDNA was located in the HSRs. Miller 
et al estimated that the HSRs Contained about 3 x 10 Kb 
of DNA. The size of the rDNA repeat unit in the rat is 
unknown, but if the figure of 44Kb is taken from the 
mouse (234), and 200 copies per diploid genome are assumed 
(229), then 9 times the normal amount of rDNA is 
9 x 200 x 44 = 7.9 x 10 Kb 
which is only about a fifth of the total amount of HSR 
material. Thus the amplified unit is considerably larger 
than the rDNA repeat. Since ribosomal genes are clustered 
DIG 
number of chromosomes 
Rattus norvegicus 
A x C strain 	
42 
N-2-fluorenyldiacetamide 
Reuber hepatoma H-35 	 42-43 (231 ) 
( ?1959-1960, 230 ) 
adapt to culture 
H4 
August 1961 
return to A x C rat 
H-35 
November 1961 
return to culture 
H4-II 
epithelial colony cloning 
( 3 times ) 
114-II-E-C3 	 1972 35-52 (232) 
(231) 1976 49-53 (233) 
Fig. 6.4. Origin of the cell line H4-II-E-C3 contair 
chromosomes with amplified rDNA in HSR-like regions. 
this suggests that either by chance the end of the cluster 
has been amplified, or that DNA rearrangement has taken place. 
The analogy with the DHFR gene amplification described in 
this thesis is therefore very striking. Another tumTr a 
venereal sarcoma in the dog, had an HSR which stained 
positively with the N-banding technique suggesting that it 
was a site of rRNA synthesis (235). and may represent another 
example of r)NA amplification. A cell line such as COLO 320 
with an HSR apparently derived from a dm in a manner similar 
to that seen in EL4/8:MTXR1.1x10 M  cells (section 5.2.3.) 
must also contain amplified DNA. Thus it is likely that dms 
and HSRs do generally represent extensive amplification of 
a small part of the genome, and therefore that DNA amplification 
of this kind is a common feature of tumor cells. 
What is its significance? Two kinds of answer 
can be given. It could be that it is DNA amplification 
which causes a normal cell to become a tumct  cell; 
alternatively it could be that the ability to amplify DNA is a 
consequence of transformation: that a normal mechanism for the 
suppression of amplification has been lost. An experimental 
approach to this problem would be to ask whether non-transformed 
cells can amplify DHFR genes in culture and, if such 
amplification can occur, whether it is accompanied by 
transformation in the tumr-cel1 related sense. It should be 
noted that cells with dms can only remain in the tunujr populatio 
for a large number of generations if they have a selective 
advantage over cells lacking dms, since dms are probably 
produced infrequently, replicated once per generation, and 
PM 
often lost at cell division. It could be thatbtumcr cell 
amplified DNA is mediating overproduction of a specific 
protein product in a manner directly analogous to the 
DHFR system, or its role could be more indirect: the 
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ABBREVIATIONS 
A adenosine 
AICAR 5-amino-4-. imidazole-carboxamide 
ALL acute lymphoblastic leukemia 
AMoL acute monocytic leukemia 
AUL acute undifferentiated leukemia 
bp base pairs 
C cytosine 
, 
CAD the multifunctional protein that catalyses the 
first three steps of UMP biosynthesis 
CF citrovorum factor or 5-f ormyl-THF 
cpm counts per minute 
d daltons 
DANPA 2 ,4-diamino-N10-methyipteroic acid 
DHF dihydrofolate 
DHFR dihydrofolate reductase 
dm double minute chromosome 
dpm disintegrations per minute 
DTT dithiothreitol 
F folate 
FdUrd 5-f luorodeoxyuridine 
G guanosine 
GAT a mutant cell line auxotrophic for glycine, 
adenosine and thymidine 
Glu glutamate 
B hypoxanthine 
HAT a selective medium containing hypoxanthine, 
aminopterin, thymidine and glycine 
HPRT hypoxanthine-guanine phosphoribosyl transferase 
HSR homogeneously staining region in trypsin-giemsa 
banded chromosome 
Kb kilobases or kilobase pairs 
Kd kilodaltons 
5mC 5-methyl cytosine 
MQ methasquin 
MDC methotrexate 
N A,C,G or T 
NOR nucleolus organizing region 
PALA N- (phosphonacatyl) -L-aspartate 
pDHFR 11 recombinant plasmids containing sequences 
pDHFR 21 complementary to mouse DHFR mRNA 
poly A polyadenylic acid 
poly C polycydidylic acid 
Pu purine 
Py pyrimidine 
SDS sodium dodecyl sulphate 
SSC standard saline citrate 
T thymidine 
THE' tetrahydrofolate 
TS thyrnidylate synthetase 
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